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Synthesis of proteins – translation – is a fundamental process of life. Quantitative
studies anchor translation into the context of bacterial physiology and reveal several
mathematical relationships, called “growth laws,” which capture physiological
feedbacks between protein synthesis and cell growth. Growth laws describe the
dependency of the ribosome abundance as a function of growth rate, which can
change depending on the growth conditions. Perturbations of translation reveal
that bacteria employ a compensatory strategy in which the reduced translation
capability results in increased expression of the translation machinery.
Perturbations of translation are achieved in various ways; clinically interesting
is the application of translation-targeting antibiotics – translation inhibitors. The
antibiotic effects on bacterial physiology are often poorly understood. Bacterial
responses to two or more simultaneously applied antibiotics are even more puzzling.
The combined antibiotic effect determines the type of drug interaction, which ranges
from synergy (the effect is stronger than expected) to antagonism (the effect is
weaker) and suppression (one of the drugs loses its potency).
In the first part of this work, we systematically measure the pairwise interaction
network for translation inhibitors that interfere with different steps in translation. We
find that the interactions are surprisingly diverse and tend to be more antagonistic.
To explore the underlying mechanisms, we begin with a minimal biophysical model
of combined antibiotic action. We base this model on the kinetics of antibiotic uptake
and binding together with the physiological response described by the growth laws.
The biophysical model explains some drug interactions, but not all; it specifically
fails to predict suppression.
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In the second part of this work, we hypothesize that elusive suppressive drug
interactions result from the interplay between ribosomes halted in different stages
of translation. To elucidate this putative mechanism of drug interactions between
translation inhibitors, we generate translation bottlenecks genetically using in-
ducible control of translation factors that regulate well-defined translation cycle
steps. These perturbations accurately mimic antibiotic action and drug interactions,
supporting that the interplay of different translation bottlenecks partially causes
these interactions.
We extend this approach by varying two translation bottlenecks simultaneously.
This approach reveals the suppression of translocation inhibition by inhibited
translation. We rationalize this effect by modeling dense traffic of ribosomes that
move on transcripts in a translation factor-mediated manner. This model predicts
a dissolution of traffic jams caused by inhibited translocation when the density
of ribosome traffic is reduced by lowered initiation. We base this model on the
growth laws and quantitative relationships between different translation and growth
parameters.
In the final part of this work, we describe a set of tools aimed at quantification of
physiological and translation parameters. We further develop a simple model that
directly connects the abundance of a translation factor with the growth rate, which
allows us to extract physiological parameters describing initiation. We demonstrate
the development of tools for measuring translation rate.
This thesis showcases how a combination of high-throughput growth rate mea-
surements, genetics, and modeling can reveal mechanisms of drug interactions.
Furthermore, by a gradual transition from combinations of antibiotics to precise
genetic interventions, we demonstrated the equivalency between genetic and chemi-
cal perturbations of translation. These findings tile the path for quantitative studies
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Escherichia coli is the most widely studied prokaryotic organism [Blount, 2015]. Yet, for
about two-thirds of its genes no regulatory mechanisms are known [Santos-Zavaleta
et al., 2019] and one third of the genes are without a functional annotation [Gao et al.,
2018]. This lack of understanding slashes the likelihood of the bottom-up prediction
of the system behavior in response to stimuli. Alternatively, rather than trying to
describe all steps in the process of response, one can try to focus on the higher-level
of the organization or a macroscopic observable – such as the rate of population
growth – that shows a distinct response to the environmental change.
One of the most fundamental properties of bacteria is their ability of autocatalytic
growth. As F. Neidhardt fascination (. . . the liquid in the flask progressed [. . . ] to a milky
whiteness thick with the stuff of life. [Neidhardt, 1999]) shows, the ability to rapidly
manufacture copies of themselves directly results in the perfect manifestation of
the equation dN/dt  λN, leading to an exponential increase in the number of
bacterial cells N  N0 exp(λt), where N0, t, and λ are the initial number of cells,
time, and growth rate, respectively.
The growth rate imposes a remarkable requirement: every cell constituent has
to (on average) double every doubling. While this might seem as an obvious
consequence and at danger of circular reasoning, it instills a notion of coupling
between the growth rate and regulation of cellular components. Essential non-
structural components of the cell either support the supply of building blocks
(e.g., amino acids, nucleotides) or synthesize new cell components from the supplied
building blocks. Thus, a plethora of supply-and-demand relationships exists within
the bacterial metabolism. Even more, these relationships and pertaining components
are all put into the context of biophysical (e.g., diffusion rates, enzyme kinetics, etc.)
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and physiological constraints.
These constraints also underlie a still under-appreciated issue of synthetic biology:
the latter holds the promise of predicting the behavior of synthetically-engineered
genetic circuits, but sometimes fails to faithfully describe the behavior of the sys-
tem [Arkin and Fletcher, 2006]. The often-mentioned reason for discrepancies is the
failure of the insulation of synthetic circuitry from the host physiology [Kwok, 2010].
This context-dependence arises from sharing expression machinery (e.g., ribosomes,
polymerases, etc.) and other resources [Andrianantoandro et al., 2006]. Without a
comprehensive mechanistic understanding of these impacts, the rational design of
genetic circuitry will remain difficult to achieve. Yet, these constraints also offer an
opportunity to facilitate understanding of global effects on gene expression [Klumpp
et al., 2009].
It is illustrative to consider gene expression in the scope of Francis Crick’s central
dogma of molecular biology [Crick, 1970], which describes the flow of information







Figure 1.1: The central dogma of molecular
biology. It describes the direction of informa-
tion transfer between DNA, RNA, and pro-
tein. The information cannot be recovered
from protein back to the DNA or RNA. Green
and yellow arrows indicate general and spe-
cial information transfers, respectively [Crick,
1970].
to make an identical copy of it or the DNA-encoded information can be transferred
into RNA in the process of transcription. From there, information is translated into a
protein. Information “stored” in protein cannot be recovered back into RNA or DNA
anymore. This is a consequence of different information encoding through sequences
of nucleotides or amino acids in nucleic acids (DNA, RNA) or proteins, respectively.
There are special information transfers (achieved in vitro or in specific organisms) in
which RNA can serve as a template for RNA replication (occurs in certain viruses),
or can be reverse-transcribed to DNA. There were even successful attempts to
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translate single-stranded DNA directly to protein [McCarthy and Holland, 1965;
Uzawa et al., 2002]. Central dogma only describes the direction of information
transfer (Fig. 1.1). Rate of information transfer from DNA over RNA into protein,
however, will directly depend on the abundance of the template and transfer
machinery, as well as the efficacy of the latter [Hausser et al., 2019; Klumpp et al.,
2009]. When these vary, global changes in gene expression are inevitable, leading to
a profound alteration of the macroscopic biochemical composition of the bacterial
cell.
1.1 Growth rate-dependent effect on gene expression
Global changes in cellular composition were actively investigated in the context of
the growth rate. Copenhagen school of bacterial physiology, led by Ole Maaløe and
inspired by Jacques Monod’s work, was spearheading the research of the interplay
between macroscopic composition of bacterial cells and the growth rate. Studies at
the Institute of Microbiology (founded by Maaløe) spurred not only the observations
we discuss below but also a school of researchers asking “How fast?”, “How many?”,
and “How long?” which led to the quantitative investigations of bacteria as integrated
systems [Andersen et al., 2006]. A remarkable number of experiments showed that
many cellular parameters largely depend on the growth rate, rather than the exact
composition of the growth medium.
Examples of these growth-rate dependent parameters are the cell size and gross
chemical compositions (protein, RNA, DNA, carbohydrates, and lipid) [Bremer and
Dennis,1996; Neidhardt,1999]. Additionally,more specific parameters (e.g., a fraction
of active RNA polymerase synthesizing ribosomal and transfer RNA or fraction of
the proteome corresponding to ribosomal proteins) vary with the growth rate in a
monotonic manner. Yet, some parameters seem to reach saturation above a certain
growth rate and remain constant over a range of growth rates (e.g., time to replicate
the chromosome). Finally, some parameters are a direct physical consequence of
growth – such as an apparent increase in “degradation” due to dilution by growth.




Figure 1.2: Growth rate dependencies of global cell parameters. Determinants of gene expression
are globally altered and affect the expression of all genes, regulated or constitutively expressed,
grouped relative to their effect on the expression. All dependencies were normalized to their value at
one doubling per hour. Data from [Klumpp et al., 2009; Bremer and Dennis, 1996]. Bottom: Equation
that connects relative gene expression to global parameters.
double every ≈20 minutes, yet the minimal time required for replication of a
chromosome is around 40 minutes. In E. coli, this apparent problem is resolved
by multiple replication rounds that are initiated from the chromosome that is still
being replicated [Cooper and Helmstetter, 1968]. In turn, this directly leads to an
increase in the DNA content per cell and an additional difference in the gene copy
number based on the chromosomal location [Schmid and Roth, 1987]. Moreover,
the synthesis of proteins directly correlates with how quickly bacteria can grow. At
growth rates above ≈ 1 h−1 translation rate per ribosome saturates at 16-17 aa/s [Dai
et al., 2016]; therefore, bacteria can increase protein synthesis only by increasing the
number of ribosomes and the fraction of those that actively synthesize proteins.
A basic unit that illustrates the remarkable impact of global changes in phys-
iological parameters on gene expression is a constitutively expressed gene: as it
lacks dedicated regulation, the differences in its expression can only arise due to
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the global changes [Wanner et al., 1977]. A model that takes into account growth
rate-dependencies of the gene copy number, transcription and translation rates, and
rates of transcript and protein removal, shows an approximately linear decrease
in proteome fraction corresponding to the constitutively expressed gene [Klumpp
et al., 2009]. Experimental confirmation of these observations shows the challenge of
attributing the dependence to any parameter alone – while some parameters might





Figure 1.3: Interdependence of growth rate
and gene expression. As the global physio-
logical parameters change with the growth
rate, the expression of the gene is changed.
The expression of a gene changes even in the
absence of specific regulation. In the case of
repression and activation, the dependence is
further altered. Shown plots are recalculated
from Ref. [Klumpp et al., 2009].
For regulated genes, these effects become even more apparent. Even though
there is a regulation (e.g., a repressor that inhibits the expression), the expressions
of both genes are under the influence of global effects (Fig. 1.3). Constitutively
expressed activator leads to an increasingly nonlinear decrease of expression of
the activator-regulated gene (Fig. 1.2). On the other hand, the expression of the
repressor-regulated gene intricately depends on the specifics of the regulatory
function that describes the repression and can result in a decrease or increase of
expression with the growth rate (Fig. 1.2). As homeostasis is often required, a growth
rate-independent expression is sought. Including negative autoregulation in the
circuit (in which repressor inhibits own expression) decouples the expression from
the growth rate [Klumpp et al., 2009; Savageau, 1974]. Growth rate-dependent effects
also shift the bistable regions of bistable circuits (e.g., autoactivator or toggle-switch).
This illustrates that unexpected behavior of a circuit (e.g., absence of the bistability)
might simply result from global feedbacks overriding the “hardwired” topology of
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the circuit [Tan et al., 2009; Klumpp et al., 2009].
A gene can, when expressed, either stimulate or hinder growth (e.g., as tox-
ins [Keren et al., 2004]). For example, if a toxin (e.g., metabolic inhibitor) is constitu-
tively expressed (i.e., its expression decreases with the growth rate), this could lead to
growth bistability (Fig. 1.4): slower growth results in more toxin expressed which in
turn leads to stronger inhibition. Such feedback creates a possibility for the existence
of heterogenous population containing a mixture of growing and non-growing
cells [Klumpp et al., 2009]. Feedbacks that spur from the interdependence of gene
expression and growth might underlie persistence [Keren et al., 2004], for example,








metabolism Figure 1.4: Interdependence of gene
expression can lead to growth bista-
bility. Positive feedback forms as the
expression of metabolic inhibitor de-
creases with the growth rate. When the
latter decreases, the inhibitor’s expres-
sion increases and the growth rate de-
creases further,completing the feedback.
This leads to an important consequence: the rate of bacterial growth results
from the combined efficacy of all growth-required types of machinery replicating
bacterial components. This in turn determines the utilization of both intra- and
extracellular resources (e.g., nutrients). Bacteria have evolved various mechanisms
that keep the physiology running smoothly, ranging from intricate feedbacks to
sensors that provide inputs required for the adjustments of the gene expression [Jun
et al., 2018]. However, not all systems that require altered response have a dedicated
regulation that would optimally adjust the physiological state to match the change
in the environment. Here, an optimal response is largely a matter of definition and
can range from growth maximization to long-term survivability.
Non-optimality of the response is especially apparent when the regulation
7
is lumped into a single or a few regulatory elements (e.g., transcription factors,
metabolites, . . . ) that regulate multiple processes. Such regulatory architecture
allows for a lean regulation, yet it can only respond to changes in a approximate
fashion [Kochanowski et al., 2017], which can be non-optimal (i.e., there might exist a
regulatory strategy in which the molecular machinery would be better utilized). Yet,
in evolutionary terms, this “good enough” regulation is likely sufficient in the long
term and thus preserved. Challenging the regulation with diverse stresses, especially
the ones perturbing the essential processes, or variations in the environment allows
the inference of regulatory strategies and hence offers a deep insight into the
physiological and evolutionary constraints that continue to shape the biology of
bacteria.
1.2 Growth laws
Systematic studies of dependencies of a particular parameter on the growth rate led
to the establishment of the bacterial growth laws [Jun et al., 2018; Scott and Hwa,
2011]. Growth laws are mathematical relations that formalize these dependencies.
One of the first growth laws was the nutrient growth law, which describes the
exponential dependency of cell size on the growth rate [Schaechter et al., 1958].
Cooper and Helmstetter derived the expression for the average amount of DNA per
cell [Cooper and Helmstetter, 1968]. Donachie later introduced the concept of the
initiation mass, i.e., a new round of replication is initiated when protein mass per
replication origin exceeds a certain threshold [Donachie, 1968]. This together allowed
prediction of the cellular composition even in the absence of exact knowledge of
molecular details. What is particularly remarkable is the fact that the underlying
molecular regulation is strikingly complex, yet these relations occur robustly and in
a simple mathematical form.
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1.2.1 Translation and the growth laws
A growth law that is of high importance for this thesis is describing the abundance of
the translation machinery. Ribosomal protein fraction ϕR increases linearly with the
growth rate when the latter depends on the nutrient quality [Schaechter et al., 1958;
Bremer and Dennis, 1996; Scott et al., 2010]




where ϕR,min and κ′t are empirical parameters describing the minimal fraction
of ribosomal proteins (when λ → 0) and κ′t is the translational capacity, respec-
tively (Fig. 1.5; [Scott et al., 2014]). Due to the centrality of this relationship, it is
insightful to derive the meaning of the parameters. To note: protein fractions can be
converted into concentrations, which is useful for modeling in later chapters [Scott






Figure 1.5: Increase in the ribosomal pro-
tein fraction. Red circles show an increase in
ϕR [Eq. (1.1)], when the growth rate is varied
by the nutrient quality (green arrow). However,
when the experiment is repeated using a strain
with genetically perturbed translation, the slope
is increased. Data from Ref. [Scott et al., 2010].
This growth law arises from the mass-balance of autocatalytic growth. As
the abundance of every cell constituent increases exponentially, it follows that
dM/dt  λM, where M is total protein mass. Because proteins are made by
actively-translating ribosomes, it follows that
λM  k (NR − NR,min) , (1.2)
where NR and NR,min are the total number of ribosomes and the number of ribosomes
not actively translating. The latter are ribosomes in search of the ribosome-binding
sites on mRNA and ribosomes being recycled or waiting for the charged tRNA.
Because components of translation are co-regulated, we assign all these auxiliary
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proteins and ribosomal proteins into ribosomal protein mass mr . Then, because Mr 
NRmr we can rewrite Eq. (1.2) into Eq. (1.1). Translational capacity is proportional
to the protein translation rate, as κ′t  k/mR. This also puts a bound on how quickly
bacteria could grow: By setting ϕR  1 and ϕR,min  0, and noting that ribosomal
proteins together contain 7,336 amino acids [Scott et al., 2010; Bremer and Dennis,
1996] and the maximal elongation rate is around 20 amino acids per second, this
yields a doubling time of around six minutes. Additionally, this implies that if
translation is perturbed (lower k) the relation Eq. (1.1) will result in a steeper
slope (Fig. 1.5) [Scott et al., 2010].
This consideration assumes that the supply of the building blocks matches the
demand. The supply is facilitated by metabolic proteins, whose combined mass
is Mp . Yet, every cell can allocate only a particular fraction of the proteome to the
translation and metabolic proteins. The allocation of the proteome depends on the
efficacy of individual components in support of growth. On the other hand, there
exists a constant fraction of the proteome, allotted to housekeeping proteins [Scott
et al., 2010]. Thus, in this simplified case, we have one fixed fraction and the two
variable fractions. In the limiting case, the whole growth-dependent fraction is
allotted to translation machinery – we denote this limiting value as ϕR,max. This
value is a maximal “dynamic range” of proteome allocation, i.e., ϕR,max  ϕR + ϕP ,
where ϕp  Mp/M.
We can illustrate the implication of this constraint by a short derivation [Scott
et al., 2014]. If we assume that growth rate is proportional to the supply of the
building blocks, we note
dMz
dt




Here, Mz , Jz ,in, and Θ are the mass of a limiting building block, supply rate, and
fraction of the building block usage in the growth of biomass. Normalizing by the










(Θ + z) , (1.4)
where z  Mz/M. Because the mass fraction of a “free” building block is much
smaller than the frequency of its usage (i.e., z ≪ Θ), this leads to λ  Jz ,in/(ΘM) [Scott
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Figure 1.6: Second ribosomal growth law. (A) Perturbations of translation at a fixed nutrient quality
result in another linear dependence of ribosomal protein fraction ϕR (dashed lines). Increasing
the nutrient quality (green arrow), results in a decrease in the slope of the response. Data from
Ref. [Scott et al., 2010]. (B) Supply-and-demand chain: metabolic fraction processes nutrients into
building blocks, which are consumed by translation. Translation synthesizes proteins from metabolic,
ribosomal, and housekeeping fraction. (C) Partitioning of the proteome. Beside a fixed housekeeping
fraction (Q), two proteome fractions, metabolic and ribosomal (P and R, respectively) are adjusted
according to the efficiency of translation and quality of nutrients.
et al., 2014]. We can express Jz ,in  kzΓzMp , where Γz and kz are the fraction of
metabolic proteins of the pathway that provides the building block z, and the













which is the second ribosomal growth law. Empirical parameter κ′n is termed
nutritional capacity. This law is observed if the growth rate is varied by translation
perturbations. Variations of the growth rate by translation perturbation or by the
quality of the nutrients are orthogonal to one another as they reveal different
parameters governing proteome allocation.
The growth laws together [Eqs. (1.1, 1.5)] give rise to a smooth, Michaelis-Menten
relation for the growth rate that depends on both translational and nutritional














Importantly, if we fix the translation capacity κ′t in Eq. (1.6), the function becomes
identical to the Monod equation describing the growth dependence on nutrient
availability. Here, however, the expression describes the nutrient quality rather than
its availability and reflects the amount of resources the cell has to allocate towards
metabolism. Namely, low κ′n corresponds to poor quality of nutrients and extensive
proteome allocation towards metabolic pathways.
Figure 1.7: Dependency of the growth rate on
translation and nutritional capacities. Growth
rate changes smoothly as the capacities are varied.
Here, we normalized the capacities with respect
to wild-type translational capacity κ′t ,0. Shown
are two examples (green) change in the growth
rate as we vary the nutritional capacity, resulting
in a Monod-like dependency.
1.3 Growth-variations reveal trade-offs in physiology
Identification of orthogonal (distinct) modes of growth variation by perturbation of
individual growth-supporting modules is crucial in the identification of regulatory
schemes. As these can be challenging to identify purely by genetics, chemical means
can be of use. Similarly, as the variation of a nutrient quality revealed the linear
upregulation of translation machinery, orthogonal means of growth variation can
validate the proteome allocation postulate at and beyond a two sector model.
Proteome partitioning offers a direct prediction for growth decrease due to pro-
tein overexpression. Overexpressedprotein causes the dynamic rangeϕR,max − ϕR,min
to shrink as if a fixed fraction would increase [Scott et al., 2010]. The theory from
above [Eq. (1.6)] would suggest that the growth rate would linearly decrease with
shrinking amount of the proteome available for allocation towards the metabolic
and translation sector. This reasoning also offers a testable hypothesis about the
growth under a protein overexpression, since the latter does exactly that [Scott et al.,
2010]. Indeed, this hypothesis has been experimentally confirmed; importantly, the
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prediction required no free parameters.
The metabolic sector can be further refined by imposing different orthogonal
perturbations of growth. Limiting catabolism or anabolism by genetic or chem-
ical means [You et al., 2013; Hui et al., 2015] reveals a similarly constrained sub-
partitioning within the metabolic sector. This observation led to the putative
coarse-grained metabolic regulation scheme in which pools of α-ketoacids and
amino acids act as the “gauge” of the cell state and serve as inputs that govern the
proteome allocation [You et al., 2013; Hui et al., 2015].
1.4 Molecular details of translation
Protein synthesis – translation – is the basis of gene expression. Translation as a
central part of cellular machinery is both component- and resource-demanding [Scott
et al., 2010; Li et al., 2014]. Yet, bacterial translation is also a very efficient system as it
can incorporate close to twenty amino acids every second into a nascent peptide chain.
With its plethora of components and constraints, translation presents a remarkable
evolutionary achievement that is shaped by different evolutionary pressures as is, for
example, a eukaryotic translation, which is four-times slower [Olofsson et al., 1987].
Even more strikingly, bacterial translation is remarkably precise as it incorporates a
wrong amino acid between 5 × 10−5-3 × 10−3 per correct one (BioNumbers 107702),
which depends on specific codon context and is comparable to the errors in
transcription [Traverse and Ochman, 2016]. Below we briefly describe the main
components of translation, constraints under which it operates, and underlying
regulation that together allow translation to achieve these remarkable features.
1.4.1 The ribosome
The main macromolecular machine of translation is the ribosome. It is composed
of two subunits (small and large, denoted as the 30S and 70S, respectively, where
“S” stands for Svedberg sedimentation unit). Both subunits are composed of RNAs
and proteins, thus making the ribosome a ribonucleoprotein complex [Rodnina
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et al., 2011]. In E. coli, smaller subunit contains 1,542 nt long 16S rRNA (ribosomal
RNA), whereas the 50S contains 2,904 nt 23S and 120 nt 5S rRNA. Ribosomal
RNAs contain catalytic centers for peptide bond synthesis, mRNA hybridization,
and provide a structural scaffold for the binding of ribosomal proteins [Rodnina
et al., 2011]. Ribosomal proteins (in E. coli, 22 and 34 in a small and large subunit,
respectively [Arnold and Reilly, 1999]) stabilize the structure of the ribosome and
aid the catalysis of processes. Evolutionary speaking, this together suggests that
the ribosome ancestor has emerged first as a ribozyme: a complex of RNAs that
catalyzed reactions of primitive protein synthesis [Noller, 2014; Petrov et al., 2015].
P1 P2
16S 23S 5S
tRNA tRNA Figure 1.8: Ribosomal RNA operon and the
ribosome. Top: Schematic structure of the rrn
operon. Indicated are the position of tRNAs
(for general operons, exceptions are described
in the text), organization of promoters (P1 and
P2), and order of rRNA genes. Bottom: Molec-
ular details of ribosomal subunit arrangements
of r-proteins (blue) and rRNA (orange and yel-
low). Peptidyl transferase center is highlighted
in green. Structure from Protein Data Bank,
https://pdb101.rcsb.org/motm/10.
The ribosome is a bulky molecular complex with a mass of ≈2.7 MDa [Yamamoto
et al., 2006] and volume between 3−4×103 nm3 [Zhu et al., 1997]. In turn, this means
that while at rapid growth around 5% of the cell volume is occupied by ribosomes,
they represent nearly one-third of the dry mass. The composition of a ribosome
is additionally considered to be optimized for autocatalytic production and fast
growth [Reuveni et al., 2017; Kostinski and Reuveni, 2020]. A mathematical model
explains why it is beneficial for autocatalytic growth to partition protein fraction
of a ribosome into many short peptides while keeping two-thirds of the mass in
only three long rRNAs [Reuveni et al., 2017]. Additionally, mathematical analysis
demonstrates that the proportion of ribosomes making other ribosomes is simply
equivalent to the fraction of the proteome allotted to ribosomes [Scott et al., 2014].
We briefly discuss the regulation that underlies such properties later.
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Since ribosomes are two-thirds RNA by mass, the regulation of expression of
rRNA is of crucial importance. Escherichia coli K-12 has seven rRNA operons rrnA,
B, C, D, E, G, and H. The rrn operon copy number in various bacterial geneomes
ranges from a single to fifteen copies [Acinas et al., 2004; Gyorfy et al., 2015]. These
operons are one of the most highly transcribed regions (accounting for more than
half of total RNA synthesis at rapid growth [Kaczanowska and Rydén-Aulin, 2007])
because the production of rRNA is at the core of ribosome biogenesis required
for rapid growth. Operons have very similar sequences and overall organization.
Ribosomal RNAs are transcribed as a single RNA and processed afterward: they are
ordered as 16S, 23S, and 5S. The region between 16S and 23S contains one or two
tRNAs, while two operons (rrnC and rrnH) contain additional tRNAs downstream
of 5S. The rrnD operon has two 5S genes with tRNA in-between [Kaczanowska and
Rydén-Aulin, 2007].
1.4.2 Translation cycle and translation factors
Broadly considered, translation consists of four phases: initiation, elongation, termi-
nation, and recycling (Fig. 1.9) [Rodnina, 2018]. Each of these phases is composed of
several steps and requires multiple dedicated translation factors. Translation factors
catalyze the progression of the ribosome throughout the translation cycle and
deliver building blocks required for translation. In principle, we can consider any
step that is factor-mediated as regulated and directed. Below we coarsely summarize
the main steps in translation.
When translation machinery encounters a pool of mRNAs as templates for
protein synthesis, the first step is the “locking” of the mRNA into the small subunit,
finding of the start codon, locking of the large subunit into the assembled ribosome,
and initiating the elongation. In the process of initiation, two initiation factors (IF1
and IF2) bind to the small subunit, followed by recruitment of another initiation
factor (IF3) [Milon and Rodnina, 2012; Rodnina, 2018] and initiator fMet-tRNAfMet,
yielding a pre-initiation complex [Milon et al., 2012]. Here, IF2 aids the binding














Figure 1.9: Main phases in translation. Ribosomes transit through different phases and steps during
translation. Main phases (in bold) are composed from a multitude of orchestrated steps (see text).
site selection. Recruitment of mRNA is mediated by the hybridization between
Shine-Dalgarno (SD) sequence on mRNA and anti-SD (aSD) on 16S [Duval et al.,
2015]. Upon locking the start codon and mRNA, the 30S pre-initiation complex
becomes stable 30S initiation complex (Fig. 1.10) and the arrival of the large subunit
completes the assembly of the 70S ribosome, which in turn enters into the elongation
phase [Rodnina, 2018].
Elongation starts as the second codon becomes available for “reading” by the
elongator aa-tRNAs [Rodnina, 2018]. During elongation, the ribosome progresses














Figure 1.10: Formation of the 30S initiation complex. Top: Assembled initiation complex with
translation factors and mRNA. The rectangle and the circle highlight the crucial RNA-RNA hy-
bridizations between aSD-SD and start codon-anticodon, respectively. Bottom: Sequence of steps, as
















formation of peptide bond
departure of EF-G and
tRNA on E-site
Figure 1.11: Key steps in elongation. Schematic shows a typical sequence of events during elongation.
Nascent chain (colored chain) is extended by one amino acid. For this to happen, (i) EF-Tu delivers
a new amino acid on a cognate tRNA, (ii) peptide bond is formed, (iii) ribosome and all auxiliary
parts arrange into the pre-translocation step, (iv) which is followed by translocation and departure
of EF-G and tRNA on E-site.
acids to the nascent peptide chain (Fig. 1.11). This process consists of decoding,
peptide bond formation, and translocation. Decoding refers to the association of the
codon with a correct amino acid. The process is based on Watson-Crick base-pairing
of an exposed codon in the A-site and the anticodon of the arriving aa-tRNA (charged
tRNA). Charged tRNA is delivered to the ribosome by the elongation factor Tu
(EF-Tu) [Nierhaus and Wilson, 2004]. Successful codon-anticodon pairing triggers a
complex cascade of conformational and chemical changes in the ribosome and EF-Tu.
Notably, the hydrolysis of GTP on EF-Tu after the initial pairing of codon-anticodon
represents the irreversible step required for kinetic proofreading initially proposed
by Hopfield [Hopfield, 1974]. Kinetic proofreading is an error-correcting mechanism
that at the energy expense allows higher accuracy than expected solely on the energy
difference between correct or incorrect base pairing of codon-anticodon.
After the hydrolysis of GTP on EF-Tu, the correct amino acid on tRNA on A-site
and peptidyl-tRNA on P-site are close together in the vicinity of the peptidyl trans-
ferase center (PTC). The active site that catalyzes the reaction is a part of the rRNA of
the 50S; the PTC increases the rate of peptide bond formation by 107 [Rodnina, 2018;
Sievers et al., 2004]. In the process, the nascent polypeptide chain is transferred from
P- to A-site tRNA (Fig. 1.11). The ribosome requires no additional translation factor
for the formation of the peptide bond; however, long stretches of proline residues or
doublets of prolines flanked by specific amino acids cause stalling that is alleviated
by non-essential elongation factor P [Ude et al., 2013; Peil et al., 2013].
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After a successful formation of a peptide bond, translocation follows during
which the ribosome moves (translocates) along the mRNA by one codon further,
thus freeing the A-site [Rodnina and Wintermeyer, 2011; Wilson, 2014; Nierhaus
and Wilson, 2004]. Likewise, the tRNA on P-site moves onto the E-site (Fig. 1.11).
During this process, both tRNAs spontaneously move relative to the large subunit
(thus forming a so-called hybrid state). Vacating of P and A sites relative to the
small subunit requires an intricate movement of the small subunit that is catalyzed
by GTPase elongation factor G (EF-G) [Rodnina and Wintermeyer, 2011]. During
the process, small subunit rotates and some of its parts swivel, during which GTP
on EF-G is hydrolyzed. After the movement, EF-G is partially inserted into the
A-site from which it eventually departs, thus leaving the ribosome ready for a new
elongation step (Fig. 1.11).
In the process of elongation, the nascent polypeptide chain extends through the
exit tunnel (which is ≈30 amino acids long) and starts to fold partially inside but
predominantly outside the tunnel [Rodnina, 2018]. When the ribosome reaches the
stop codon, release factors (RF) 1 and 2 recognize it and release the newly made
peptide by hydrolyzing the peptidyl-tRNA bond [Rodnina, 2018; Nierhaus and
Wilson, 2004]. Another release factor (RF3) catalyzes the release of RF1/2. The reuse
of the ribosome requires the release of mRNA and tRNA, which are still within the
assembled ribosome. The factor for ribosome recycling (Frr) and EF-G orchestrate
the disassembly of the ribosome into individual subunits [Janosi et al., 1994; Janosi
et al., 1998; Rodnina, 2018].
1.4.3 Auxiliary enzymes, factors, and tRNAs
Above we briefly discussed the core translation machinery, directly involved in the
synthesis of proteins. Yet, the core translation apparatus is blanketed by another set
of auxiliary machinery that is involved in the delivery and processing of building
blocks, handling of the ribosomes, and processing of newly synthesized proteins.
Below we discuss this auxiliary machinery only coarsely.
A crucial element of decoding are the tRNAs. E. coli has 79 tRNA genes, with
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46 different amino acid acceptor species, coding for 61 sense codons [Dong et al.,
1996]. Transfer RNAs, upon delivery to the ribosome by EF-Tu [Nierhaus and
Wilson, 2004], are directly involved in the decoding: they bridge the gap between
the nascent protein chain and mRNA sequence through codon-anticodon pairing.
Correct pairing leads to conformational changes of 30S subunit which affect the
GTP hydrolysis by EF-Tu [Rodnina, 2018]. Some tRNA species – isoacceptors – are
aminoacylated with the same amino acid but have a different anticodons. The
rarity of the codon is also reflected in the level of charging of the respective tRNA.
The abundance of charged tRNA corresponding to a specific codon will partially
determine how quickly the ribosome can pass over said codon; the rate of the
latter are correlated with a rarity of the codon as well [Sørensen and Pedersen,
1991]. The expression of tRNA species, especially for abundant codons, increases
with the growth rate, albeit less prominently than the ribosome content [Dong
et al., 1996; Bremer and Dennis, 1996]. Additionally, individual amino acids (e.g.,
serine or cysteine), when internalized, are toxic and this manifests in different
charging levels: higher toxicity of the amino acid will correlate with low levels of
charging [Avcilar-Kucukgoze et al., 2016].
An important part of decoding starts before charged tRNAs arrive at the ribosome.
Charging itself is a very specific process, in which aminoacyl-tRNA synthetases
charge tRNAs [Nierhaus and Wilson, 2004]. Synthetases in E. coli are encoded by
twenty-three genes. With the exception of three synthetases, most are encoded by a
single gene [Giegé and Springer, 2016]. A single tRNA synthetase charges different
tRNAs with synonymous anticodons, except for methionine and tryptophan which
are encoded by only one codon. This remarkable feature is again possible due to
kinetic proofreading [Hopfield, 1974]. The charging of tRNA is selective when a
particular amino acid becomes limiting [Elf et al., 2003]. Charging is therefore a very
intricate process, as both aminoacyl-tRNA synthetases and tRNAs have a highly
complex regulation and dynamics, involving multiple different molecular species.
Translation of the ORF begins with the N-Formylmethionine (fMet), which is
a derivative of the amino acid methionine [Rodnina, 2018]. It is exclusively used
for initiation of translation and is delivered by special initiator tRNAfMet [Guillon
19
et al., 1993]. While non-formylated methionine can be loaded onto both elongator
and initiator tRNA, only when charged onto the latter a dedicated transferase Fmt
(10-formyltetrahydrofolate:L-methionyl-tRNAfMet N-formyltransferase) attaches
a formyl group onto the methionine [Kahn et al., 1980; Guillon et al., 1992]. As
the synthesized protein partially exits the ribosome through the tunnel, a pep-
tide deformylase (encoded by def), cleaves the formyl group from the N-terminal
methionine residue of the nascent chain [Bingel-Erlenmeyer et al., 2008]. Formyl
on methionine has been suggested to serve as a cotranslational degradation sig-
nal [Piatkov et al., 2015]. Upon removal of the formyl group on the leading me-
thionine, another enzyme methionine aminopeptidase (encoded by map) modifies
the nascent chain: depending on the first three amino acids downstream of me-
thionine, the latter can be cleaved-off [Ben-Bassat et al., 1986; Frottin et al., 2006;
Hirel et al., 1989].
Besides the delivery of the building blocks and processing of finished proteins,
various assembly, maturation, stability, modulation, and hibernation-promotion
factors affect the ribosome throughout its life cycle. Ribosome assembly and mat-
uration is very complex, as it involves a high number of components that need to
be positioned correctly. This issue is particularly pressing for rRNA components,
as these tend to form complex and unwanted secondary and tertiary structures
through base-pairing that would prevent the formation of a functional rRNA scaf-
fold [Kaczanowska and Rydén-Aulin, 2007]. Therefore, a cohort of RNA chaperons,
RNA helicases, and ribosome-dependent GTPases (such as Era [Bunner et al., 2010]
or Der [Hwang and Inouye, 2006]) aids the correct folding and assembly, which
drives the assembly across the protein-folding landscape and prevents sinking of




We discussed above some of the molecular details somewhat out of biological
context and ignored some of the biological, chemical, and physical details. Most
are out of the scope of this thesis; however, some physical limitations directly affect
parameters we will later use in the mathematical analysis.
As the ribosomes are loaded onto the transcript, each occupies a certain stretch of
codons. Estimates of this “footprint” differ [Kang and Cantor, 1985; Mitarai et al., 2008;
Shaw et al., 2003b; Mohammad et al., 2019; Woolstenhulme et al., 2015] but range
somewhere between 7-16 codons. This exclusion limits the number of translation
rounds that can happen simultaneously. This spatial constraint couples the dynamics
of the ribosomes on the same transcript as we will show later.
Another aspect comes from the crowdedness of the intracellular environment.
Diffusion of, for example, a 30 kDa protein (e.g., green fluorescent protein) is around
ten-times slower in the cytoplasm of E. coli compared to water (7.7 µm2 s−1 versus
87 µm2 s−1, [Elowitz et al., 1997; Swaminathan et al., 1997; Milo and Phillips, 2016]).
Thus, bulky proteins have to “navigate” through crowded cytoplasm, which can
limit the rapidity of processes they catalyze [Klumpp et al., 2013]. This aspect can
additionally emphasize the differences between experiments performed at more
sparse in vitro experimental conditions compared to the observations in the in vivo
observations.
1.4.5 Regulation
To counter various constraints, minimize the costly expression of translation ma-
chinery, and meet the requirements of rapid growth, a translation regulation has
evolved. Yet, as noted earlier, gene expression is driven by both global effects and
topology of genetic regulatory circuitry.
During the fast growth, copies of rrn in the cell will exceed native seven due to
multiple simultaneous replication rounds (Fig. 1.12 [Bremer and Dennis, 1996]).
This effect is even more pronounced as the rrn operons tend to cluster around the
origin of replication. Cooper-Helmstetter relation [Cooper and Helmstetter, 1968;
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Figure 1.12: The expression of ribosomal constituents has a physical limit. (A) The E. coli
chromosome contains 7 rrn operons, which are all oriented at the direction of replication and
mostly centered in the vicinity of the ori. (B,C) Due to growth rate-dependent gene copy number,
relative gene expression is increased when growth is faster and depends on the gene location on the
chromosome [Cooper and Helmstetter, 1968; Schmid and Roth, 1987].
Bremer and Churchward, 1977], which mathematically describes the dependency
of chromosomal gene copy number on the growth rate, allows us to estimate the
increase in effective copy number to≈35.9 [Bremer and Dennis, 1996], thus exceeding
the copy number per chromosome by more than five times. This suggests a likely
existence of a feedback regulation that curbs the tentative overexpression of rrn
operons. Conversely, when operons are deleted, the expression from the remaining
ones is increased [Condon et al., 1993]. When the number of translating ribosomes is
reduced by lowering the amount of initiation factor 2, upregulation of rrn operons
is observed, indicating that the feedback is (at least in part) coupled to the number
of translating ribosomes [Cole et al., 1987]. Taken together, these considerations
support the existence of feedback regulation, albeit it is less clear to what extent the
regulation of rrn operons is active and to what extent passive.
The expression of each rrn operon is controlled by two promoters, P1 and
P2 (Fig. 1.13) [Condon et al., 1995]. Promoter P1 is most active during fast growth,
while P2 tends to overtake at lower growth rates [Kaczanowska and Rydén-Aulin,
2007]. Upstream of both promoters are FIS binding sites (two of which overlap with
binding sites of H-NS DNA-bending protein that counters the action of FIS), and a
UP element (another is between P1 and P2) [Kaczanowska and Rydén-Aulin, 2007;
Condon et al., 1995]. The UP element enhances binding of RNAP by interacting










Figure 1.13: Details of the regulatory region of ribosomal RNA operons. Regulation of rrn
operons involves multiple transcription and regulatory factors. Additionally, operons are regulated
by two promoters of a different character. Since rrn operons are one of the most highly transcribed
chromosomal segments, traffic jams can form.
response, which we describe below. Additionally, there is an antiterminator sequence
nut downstream of P2 and in spacer regions between 16S and 23S: antitermination
allows for enhanced transcription of the operons, reflected in a decreased probability
of pausing [Vogel and Jensen, 1995]. Due to the dense traffic of polymerases,
antitermination becomes even more important as it partially removes the detrimental
effects of traffic jams [Klumpp and Hwa, 2008]. Active regulation is highlighted
in dynamic changes in the translation requirements, e.g., during the change in the
growth environment from rich to poor or vice versa.
If bacteria grow in a nutrient-rich environment, cells do not have to synthesize
all building blocks (e.g., amino acids) from other compounds. Yet, if the switch to a
poor environment happens, a depletion of internal amino acid pools will manifest
in the reduced supply of building blocks. When a supply-demand relationship is
disrupted, a quick series of events unfolds in which the expression of translation
machinery is inhibited [Condon et al., 1995]. This cascade is called the “stringent
response.” It depends on the charging levels of eight amino acids [Zhang et al.,
2006]. This response was directly linked to the aminoacylated-tRNA deprivation,
sensed by the RelA protein [Potrykus and Cashel, 2008]. The latter recognizes
a stalled ribosome that lacks a codon-specific, charged tRNA on the A-site of
the ribosome [Kaczanowska and Rydén-Aulin, 2007]. RelA then uses adenosine
triphosphate (ATP) as a source of pyrophosphate and catalyzes the synthesis of
(p)ppGpp [guanosine (penta)tetra phosphate] [Cashel and Potrykus, 2001]. Level
of alarmone (p)ppGpp is also controlled by SpoT – a bifunctional enzyme with





















Figure 1.14: Stringent response and post-transcriptional regulation. Regulation of rrn operons
involves multiple transcription and regulatory factors. (A) Upon change to an environment poor
with nutrients, a decrease in expression of translation machinery takes place. High-level molecular
details of stringent response are in a box. (B) Post-transcriptional regulation of translation-related
operons by autogenous feedback regulation. A protein (dark green) binds to its mRNA if there are
too few free rRNAs.
2008]. SpoT hydrolyzes (p)ppGpp, thus reducing its intracellular levels, which is
important for recovery from the repressed state. During stress, the hydrolase activity
is inhibited and consequently increases the levels of (p)ppGpp [Kaczanowska and
Rydén-Aulin, 2007]. Increased levels of the alarmone (p)ppGpp lead to intricate
changes in the expression of the translation machinery.
The intracellular concentration of (p)ppGpp can increase by more than ten-fold
during a stringent response [Kaczanowska and Rydén-Aulin, 2007; Chatterji and
Ojha, 2001]. Elevated levels of (p)ppGpp cause the shutdown of transcription from
the P1 promoter of rrn operons and reduced transcription of tRNA genes [Cashel and
Potrykus, 2001; Potrykus and Cashel, 2008]. Alarmone directly affects the activity of
RNA polymerase [Bremer and Dennis, 1996] by binding to the vicinity of the active
center [Artsimovitch et al., 2004]. Furthermore, ppGpp not only lowers the initiation
but also increases the rate of the pausing of RNA polymerase [Kaczanowska and
Rydén-Aulin, 2007]. Additionally, ppGpp skews the synthesis rate of RNA towards
mRNA rather than stable RNA (tRNA and rRNA) [Dennis et al., 2004]. At very low
growth rates, the majority of rRNA comes out of transcription from the P2 promoter.
However, it was additionally shown that a strain without relA and spoT still exhibits
growth rate-dependent control of rRNA synthesis described by the growth law [Gaal
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and Gourse, 1990]. This suggested that growth rate-dependent control and stringent
response use different, but potentially overlapping mechanisms for regulation of
rRNA synthesis.
Regulation of the expression of ribosomal proteins further demonstrates the
importance of rRNA. There are nineteen operons of ribosomal proteins (r-protein), in
which other translation-related genes (EF-G, EF-Tu, EF-Ts, etc.) appear together with
r-proteins [Kaczanowska and Rydén-Aulin, 2007]. As these genes are transcribed as
a part of a polycistronic mRNA, an autogenous feedback regulation controls the
expression of the whole operon [Nomura et al., 1984]. Ribosomal proteins have a
high affinity for binding to rRNA: when the latter is present in excess, r-proteins
bind rapidly to form the ribosome. However, certain r-proteins have additionally
a binding affinity to their polycistronic mRNA: when free rRNA is scarce (i.e.,
r-proteins are overproduced), they will bind to their mRNA and halt its translation.
Such autogenous feedback directly couples the expression of rRNA to the rest
of translation machinery and keeps the stoichiometry between the ribosome and
factors relatively constant (Table 1.1) [Bremer and Dennis, 1996].







Table 1.1: Stoichiometric values of translation factors and tRNA relative to the ribosome. Values
are from Refs. [Bremer and Dennis, 1996; Dai et al., 2016; Dong et al., 1996]. Note, that number of
tRNA species per ribosome varies wildly between different tRNAs [Dong et al., 1996].
1.5 Translation perturbations
This compendium illustrates that translation is a highly dynamic process, during
which ribosome passes through numerous states in which different factors catalyze
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(or prevent) the movements of the ribosome and auxiliary components. Since the
process contains numerous steps, it is unclear how perturbation of a specific step
affects the kinetics of the whole process, especially in the light of constraints and
regulation that intertwine translation-related processes. Many of the aspects of
translation that we discussed above were deducted through targeted perturbations
of translation. These perturbations can be genetical or chemical. A particular way of
perturbing bacterial physiology and translation in particular is by application of
antibiotics.
1.6 Antibiotics
Antibiotics are small molecules that inhibit or outright kill bacteria, classifying
antibiotics as bacteriostatic or bactericidal, respectively [Walsh, 2003]. A revo-
lution in medicine started with one of the most fruitful laboratory mishaps –
Fleming’s accidental discovery of penicillin [Tan and Tatsumura, 2015; Fleming,
1929]. Together with synthetic sulfonamide drugs, these early antibiotics made
many of the previously deadly diseases treatable almost overnight [Aminov, 2010;
Walsh, 2003]. Penicillin became one of the most important chemical compounds
of the first half of the 20th century, altering a human perception of infections
forever. However, it was difficult to produce – best illustrated by the fact that it
was recrystallized for reuse from the urine of patients receiving penicillin [Barry,
2004]. Soon after, isolation and the whole manufacturing processes of penicillin and
other antibiotics were optimized and industrial production increased quickly to
meet the need for antibiotics. As an illustration, mold grown in early fermentors in
the 1950s produced only about 0.5-1.0 g/L of penicillin, while nowadays modern
techniques allow yields as high as 40 g/L [Elander, 2003]. Such advances made
antibiotics affordable (e.g., penicillin price dropped from $300 to $17 per kg in the
same period [Elander, 2003]), while a whole new industry was spawned this way.
The demand drove the discovery of new antibiotic compounds.
Over the years, many additional different chemicals were discovered, either as
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Figure 1.15: Timeline of antibiotic deployment and the evolution of antibiotic resistance. Snap-
shot of the period between 1930s and 1990s; deployment and occurrence of resistance are shown
above and below the timeline, respectively. Data from Ref. [Palumbi, 2001].
activity. While certainly a breakthrough,widespread use of antibiotics instilled a high
selection pressure for the occurrence of antibiotic resistance [Clatworthy et al., 2007;
Palumbi, 2001]. The time between the deployment and occurrence of resistance
varies between antibiotics, yet the timeline in Fig. 1.15 illustrates a sobering reality –
bacteria seem to exhibit the ability to evolve resistance to any antibiotic compound
given sufficient time. While it is unlikely that we will obtain a silver bullet to which
bacteria cannot evolve resistance, antibiotics remain a powerful tool in medicine and
basic research. It is fascinating that even after a rather long period of extensive use,
effects of antibiotics on bacteria remain a fruitful area of research, which uncovers
intricate responses and resistance mechanisms in bacteria.
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1.7 Antibiotic targets
The antibiotics inhibit crucial cellular processes. Common targets of antibiotics
are the essential processes: synthesis of the cell wall, RNA and proteins, DNA
replication/modification, and folate biosynthesis (Fig. 1.16). Folate synthesis is
crucial for the synthesis of DNA building blocks and other metabolites such as
certain amino acids [Dias et al., 2018; Walsh, 2003]. Alternatively, some antibiotics
(such as nitrofurantoin) cause a formation of free radicals that damage the cell. The
main reason for the efficacy of antibiotics in the treatment of infections lies in the
sufficient differences between the physiology of pathogenes and the host. Some of
the antibiotic targets (such as the cell wall) do not exist in the host organism, while
others [e.g., dihydrofolate reductase (involved in folate synthesis) or a ribosome] are
sufficiently different to prevent the binding of the antibiotic in the host.
Antibiotics differ in many aspects besides their mode of action. Antibiotics enter
into the cell either passively or actively [Choi and Lee, 2019; Smith and Chopra, 1984;
Braun et al., 2001], and can be effluxed out of the cell by dedicated antibiotic
Figure 1.16: Main antibiotic targets. Upon entry into the cell, antibiotics inhibit essential cellular
processes, pertaining to catabolism (e.g., protein synthesis), metabolism (e.g., folate synthesis),
structural (e.g., cell wall synthesis) or replication processes (e.g., DNA replication).
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pumps (e.g., multiple efflux pump AcrAB-TolC [Bergmiller, 2017]). Abundances of
antibiotic targets per cell also differ significantly, ranging from tens of thousand
for ribosomes [Bremer and Dennis, 1996] to a few dozen for gyrases and reduc-
tases [Taniguchi et al., 2010]. Antibiotics can act as competitive inhibitors, in which
case antibiotic competes with the substrate for binding (e.g., trimethoprim competes
with dihydrofolate for binding to the dihydrofolate reductase [Dias et al., 2018;
Walsh, 2003]), or can divert metabolic flux of substrates (e.g., sulphonamides cova-
lently bind to the pteridine diphosphate, which cannot be used by the cell [Brown,
1962; Rolland et al., 1979; Palmer and Kishony, 2014]) and drain the pool of essen-
tial metabolites. This diversity in details of antibiotic modes of action is further
emphasized by the diverse responses to antibiotic-induced stresses.
1.8 Bacterial responses to antibiotics
Bacteria can aptly change their physiology in response to environmental changes.
This remarkable flexibility allows bacteria to dynamically alter the expression of
genes coding for metabolic pathways, and in turn attempt to match the supply and
demand set by the rapid bacterial growth.
Growth rate λ is one of the most important macroscopic parameters that can
be measured in the laboratory. Deviations of the growth rate from unperturbed
one indicate the irregularities in the core metabolic processes, altered regulatory
responses or point towards some genetical change. Thus, precise quantification
of the growth rate in the response to antibiotics is a necessary first step towards
understanding the effects of antibiotics on bacterial physiology [Neidhardt, 1999].
Measuring the growth rates at various antibiotic concentrations aex produces
a dose-response curve [Chevereau and Bollenbach, 2015; Chevereau et al., 2015;
Mitosch and Bollenbach, 2014]. Various attributes can describe the dose-response
curve: its steepness, a concentration at which the growth rate is halved (i.e., IC50)
or completely inhibited (minimal inhibitory concentration or MIC). Dose-response
curves are usually monotonically decreasing, i.e., the growth rate decreases with
increasing antibiotic concentration. Various mathematical functions can be used
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to describe the dose-response, as long its parameters allow for sufficient flexibility
in the shape of the curve. One frequently used mathematical description is a Hill
function:




where n is a steepness parameter. This function quantifies the response with only










Figure 1.17: Hill function charac-
terizes typical dose-response curve.
Curves of growth rate-change in the
response to an increasing antibiotic
concentration can have different steep-
nesses. Here, shallow and steep re-
sponse correspond to n  2 and 4, re-
spectively.
offers a very practical way of describing the effect of the antibiotic, it cannot associate
the parameters (such as n or IC50) with characteristics of the antibiotic or physiology.
Said differently, the mechanistic origins of the specific shape of the dose-response
curve are not traced back to molecular and biological details. Yet, – as we discuss
later – Hill functions allow comparisons between different antibiotics invariantly of
the molecular and physiological origins of the response. Importantly, they formalize
the concept of the dose-response curve in a tractable manner and illustrate how
antibiotics effects transpire over narrow or wide concentration window (for high or
low n, respectively).
Here, antibiotics appear particularly useful as they gradually inhibit essential cel-
lular processes and in turn allow studies of bacterial responses to such perturbations.
This adds another dimension to the use of antibiotics in the laboratory – apart from
their clinical relevance, antibiotics can perturb cellular functions that are otherwise
difficult to probe by classical approaches from genetics (e.g., gene deletions) [Falconer
et al., 2011]. Changes in gene expression in response to antibiotic stress are very
diverse [Shaw et al., 2003a; Goh et al., 2002]. In some cases, bacteria might simply
upregulate the antibiotic target or any auxiliary genes that in turn partially alleviate
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the antibiotic effects, e.g., as is the case of protein synthesis inhibitors [Scott et al., 2010;
Bennet and Maaløe, 1974; Harvey and Koch, 1980] or under folate synthesis inhi-
bition [Flensburg and Sköld, 1987]. While this reasoning sounds intuitive, recent
studies have shown that simple upregulation of the target is rarely sufficient to
alleviate the antibiotic action [Palmer and Kishony, 2014; Palmer et al., 2018]. Addi-
tionally, as the growth rate is reduced, expression of many genes and physiology of
the whole-cell are altered due to global cellular feedbacks [Goh et al., 2002]. The
specific and global response intertwine and should thus be considered together [Bol-
lenbach and Kishony, 2011; Lukačišin and Bollenbach, 2019]. Due to these effects,
genes that are unrelated to the target or targeted pathway can attribute to the net
effect of the antibiotic. Genome-wide studies in which genes are systematically
deleted or overexpressed and changes in the response to antibiotics are investi-
gated can identify such effects [Chevereau and Bollenbach, 2015; Palmer et al., 2018;
Palmer and Kishony, 2014].
The choice of the measurement technique critically determines the level from
which we aim to discern the regulatory responses. High-dimensional, genome-wide
datasets are increasingly abundant since the advent of laboratory automatization
and affordable sequencing technologies. Strains libraries containing promoter-
reporter [Zaslaver et al., 2006] or protein-reporter fusions [Taniguchi et al., 2010]
are available and allow investigations of gene expression on both population and
single-cell level. Multiplexed sequencing of the transcriptome, for example, allows
an insight into the transcriptional intricacies [Lukačišin and Bollenbach, 2019] of
responses while proteomic studies directly investigate abundances of individual
proteins [Hui et al., 2015]. Furthermore, single-cell studies are becoming increasingly
accessible and offer unprecedented insights into bacterial responses to changes in
the environment [Wang et al., 2010]. These techniques complement classical and
modern approaches from genetics. These approaches together allow quantitative
studies of response to antibiotics that reach beyond steady-state response of the
batch cultures towards understanding of dynamical responses to antibiotics, single-
cell responses and population heterogeneity [Bergmiller, 2017; Deris et al., 2013],
and tracking the emergence of evolutionary changes [Tomanek et al., 2020]. In this
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regard, these techniques can reveal temporal sequences of responses [Mitosch et al.,
2019] and even uncover unexpected pleiotropic effects such as cross-protection to
other environmental stresses [Mitosch et al., 2017]. An important and more recent
component of the studies of gene expression is inclusion of the mathematical
modeling and evolutionary considerations.
1.9 Antibiotic resistance
Apart from changing their gene expression to alleviate the impact of antibiotics,
bacteria occasionally become tolerant to antibiotics or acquire antibiotic resistance.
The crucial difference between resistance and other means of tolerance is that
resistance is a genetically inherited trait. Tolerance on the other hand allows bacteria
to survive the transient exposure to antibiotics [Brauner et al., 2016]. Many of
known antibiotics are of natural origin and produced by bacteria (predominantly
of the genus Streptomyces) [Walsh, 2003]. These antibiotic-producing bacteria have
self-protection mechanisms; this in turn constitutes a pool of resistance-conveying
elements that can be acquired by other organisms.
The most common resistance mechanisms are reduced drug influx, active
efflux, target mutation or modification, overproduction of target mimic, factor-
associated protection, and drug modification or degradation [Wilson, 2014; Lukačiši-
nova and Bollenbach, 2019]. These mechanisms arise de novo from spontaneous
mutations or are acquired from another species by the means of mobile ge-
netic elements (e.g., plasmids, bacteriophages,. . . ) in the process of horizontal
gene transfer [Frost et al., 2005]. While genetic determinants were cataloged for
many of these mechanisms [McArthur et al., 2013], it is still not clear how many
of these resistance mechanisms depend on the physiological state of the cell
or on the environment [Lukačišinova and Bollenbach, 2019; Gilbert et al., 1990;
Brown et al., 1990]. Tracking of resistance evolution dynamics is another area of
active research. Tracking of evolutionary dynamics became possible due to recently
developed technologies such as next-generation sequencing [Goodwin et al., 2016] or
devices for dynamical tracking of evolution, such as morbidostat [Toprak et al., 2012;
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Lukačišinova et al., 2020], in which antibiotic concentration is constantly adjusted to
keep the selection pressure constant throughout gradual increase in resistance.
Evolutionary trajectories are affected by many factors; however, it was recently
shown that the shape of the dose-response curve is one of the crucial determi-
nants [Chevereau et al., 2015]. The latter has proved to be remarkably robust to the
genetic perturbations, which mostly rescaled the dose-response curves [Wood et al.,
2014; Chevereau and Bollenbach, 2015; Chait et al., 2007]. The dose-response curve
relates the distribution of effective concentrations to the distribution of fitness effects
arising from mutations [Chevereau et al., 2015]. This in turn highlights the impor-
tance of understanding the mechanistic origins of the shape of the dose-response
curve.
1.10 Modeling of antibiotic action
Providing a mathematical basis for the shape of the dose-response curve is of
fundamental importance for understanding the effect of antibiotics. Connecting the
known physiological constraints (e.g., rate of protein synthesis, number of targets,. . . )
with biochemical properties of antibiotics (e.g., uptake rate, the dissociation constant
of binding,. . . ) to yield dose-response curve would isolate the crucial parameters
that determine the response. This would consequently formalize the observations
and offer predictions for altered physiological and biochemical parameters. With an
increasing number of experimental observations, a rising number of unexpected
and potentially unintuitive outcomes are establishing mathematical modeling as an
integral part of investigations.
Antibiotics that target translation have received the most modeling attention.
Antibiotics that bind to the ribosome have a mathematical advantage over cer-
tain other targets: ribosomes are relatively abundant compared to other cellular
components and due to recently established physiological response to translation
perturbation (discussed above). High number of ribosome makes the effects of
stochasticity less prominent and can be therefore described in a continuous manner.
Dose-response curves for translation inhibitors have been modeled within this
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framework in Ref. [Greulich et al., 2015; Elf et al., 2006]. These theoretical models
have well defined molecular parameters; yet, if these parameters (e.g., binding
constants, antibiotic transport) change due to resistance mutations, these mod-
els become useful in understanding of resistance evolution [Deris et al., 2013;
Pinheiro et al., 2020].
While the shapes of the dose-response curves are largely unchanged by mu-
tations [Wood et al., 2014; Chevereau and Bollenbach, 2015], certain observations
challenge this robustness. In particular, it was demonstrated that when the antibiotic-
degrading enzyme was a part of the positive, growth rate-dependent feedback loop,
the dose-response curve changed from shallow to steep [Deris et al., 2013]. Moreover,
the dose-response curve exhibited a bistable region in which the clonal population
branched into two subpopulations with different growth rates, which was observed
experimentally. This observation was further supported by a mathematical model
that included the intertwining of global effects on gene expression and antibiotic
action. We discuss this model further in Chapter 4.
Despite its usefulness, mathematical modeling of antibiotic action is still under-
utilized. Beside improving the understanding of antibiotic action, mathematical
models can help us understand the constraints under which the antibiotic resistance
develops and how it integrates into the overall physiological picture [Allen and
Waclaw, 2016]. While modeling of antibiotic action for individual antibiotics remains
challenging, it is a necessary stepping stone for understanding of combined antibiotic
stresses.
1.11 Antibiotic combinations
A particularly promising strategy to increase the efficacy of treatments and curbing
rampant antibiotic resistance is the use of more than one antibiotic simultane-
ously [Bollenbach, 2015; Yeh et al., 2009]. Therapies using combinations of antibiotics
sometimes arise out of necessity, e.g., when multiple pathogens susceptible to dif-
ferent antibiotics are present. Here, however, we focus on a question: what is the
combined effect of multiple antibiotics on a single strain, and what are the underlying
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Figure 1.18: An illustration of combinatorial explosion for twenty different antibiotics at twelve
different concentrations. We can fit all measurements for individual drugs onto three standard
microtiter plates (left). Yet, if we measure all pairwise combinations, we already need around
three-hundred plates (middle) that yield a nearly three-meter tower if stacked! If we consider all
ultra-high combination cocktails of seven drugs, the stack of plates will span over two-thirds of the
distance to the Moon with its height of 290,000 km (right, not to scale).
mechanisms? This question becomes increasingly challenging as combinations of
antibiotics are burdened by the combinatorial explosion, which becomes even more
problematic when more than two drugs are combined.




, where k is a number
of drugs in the combination. For example, if we consider N  20, we can see that
the number of distinct combinations increases as 190, 1140, and 4845 for 2-, 3-, and
4-drug combinations, respectively. Additionally, multiple different concentrations of





× Dk , where D is the number of concentrations per drug. This dramatic
increase in the number of required measurements quickly becomes prohibitive
for brute-force experimentation. The automation of experimental workflows can
partially alleviate the effects of combinatorial explosion [Yeh et al., 2006; Chevereau
and Bollenbach, 2015; Russ and Kishony, 2018; Brochado et al., 2018].
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1.11.1 Antibiotic interactions
The combined effect of multiple antibiotics results in a drug interaction. Drug
interactions are defined by comparing the measured to the expected effect. If the
combined effect is stronger or weaker than the expected effect, a drug interac-
tion is either antagonistic or synergistic, respectively. A special case of antago-
nism is suppression, in which combined response is not only weaker than the
null expectation, but also weaker than at least of the drugs alone. Here, differ-
ent expectations for the combined effect can be used. Loewe additivity [Loewe,
1928] and Bliss independence [Bliss, 1939] are most frequently used expectations
and both use responses to individual drugs in the combination as inputs. Bliss
independence is particularly suited for a low number of measurements, as it re-
quires only four measurements (no drug, individual drugs, and combination) and
expectation is simply a product of responses to individual drugs [Bliss, 1939;
Mitosch and Bollenbach, 2014]. Here, responses yi are relative growth rates,
normalized by the drug-free growth rate, and Bliss independence is given as
yBliss  yA × yB [Mitosch and Bollenbach, 2014].
The definition of Bliss independence is intuitive and simple to evaluate; yet, it
generally fails to recognize that the same drug should exhibit additivity, i.e., the
combined effect the drug with itself should be y(a+b)  y(c+d), if a+b  c+d. If this
is the case, then for Bliss independence y(a+b)  y(a)×y(b) – this relation holds only
if the dose-response curve is exponential [Mitosch and Bollenbach, 2014]. Therefore,
it is not possible to recognize additive interaction using Bliss independence for
drugs with non-exponential dose-response curve. Loewe additivity – as the name
suggests – alleviates this issue and is defined such that the expected responses are
additive in the concentrations [Loewe, 1928]. It is based on the shape of the dose-
response surface, which is obtained by measuring the growth rate over the grid of
concentrations (Fig. 1.19). The lines of equal growth (contours of the dose-response
surface) are called the isoboles.
The shape of isoboles defines the type of interaction (Fig. 1.19). Linear isoboles










Figure 1.19: Definition of drug interactions per Loewe. Interactions are defined relative to the
additive expectation. Synergy indicates that the combination is more potent than the additive
expectation. In contrast, antagonism indicates that the combination is less potent. Suppression is an
extreme case of antagonism in which at least one of the drugs has lost potency [Bollenbach, 2015;
Mitosch and Bollenbach, 2014; Loewe, 1928].
curve, then additive isoboles are parallel [Loewe, 1928]. Additive surface can be
calculated from individual responses by systematically connecting concentrations
of each drug that leads to the same response. Curving of isoboles towards (isoboles
are convex) or away (isoboles are concave) from the origin is indicative of synergy
or antagonism, respectively (Fig. 1.19). Determining the type of interaction requires
measuring the growth rate for multiple concentration combinations and is thus
more comprehensive.
Dose-response surface resulting from such checkerboard assay has the added
advantage of discerning multiple additional features of the interaction: (i) its con-
centration dependence, as isoboles might change the shape based on the particular
pair of concentrations, and (ii) the direction of interaction. The latter is impossible to
evaluate reliably for point measures required in Bliss definition and especially prob-
lematic for suppression. On the other hand, Bliss definition of interaction is based on
expected independence of applied drugs, which can be a plausible assumption for
particular drug combinations, and can serve as a useful expectation [Yeh et al., 2006;
Russ and Kishony, 2018].
Both Bliss and Loewe definitions can be generalized to higher-order drug
combinations with appropriate modifications. Upon measuring drug interactions for
many drug combinations, we can evaluate a drug interaction network [Yeh et al., 2006;
Cokol et al., 2011; Cokol, 2014; Brochado et al., 2018]. A network of this sort can
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reveal clusters of drugs that interact similarly with drugs from other clusters but can
interact diversely within the cluster [Yeh et al., 2006]. When such investigation was
performed for twenty-one drugs and corresponding pairwise interactions, drugs of
similar mode of action ended up in the same cluster [Yeh et al., 2006]. This suggests
that the drug interactions are mostly determined by the mode of action, rather than
exact chemical details of combined drugs.
1.11.2 Antibiotic interactions in the context of drug resistance and
evolution
Antibiotic combinations offer a lucrative opportunity to counter the emergence of
antibiotic resistance [Yeh et al., 2009; Bollenbach, 2015]. A naïve expectation is that
already the requirement to develop resistance to multiple simultaneously applied
antibiotics with different modes of action will curb the emergence of resistance [Pillai
et al., 2005]. However, such reasoning is challenged when considered in the light
of cross-resistance and collateral sensitivity between antibiotic pairs [Imamovic
and Sommer, 2013], epistatic interactions between mutations, and the impact of
mutations on the type of interaction [Chevereau and Bollenbach, 2015].
The impact of drug interactions on the rate of resistance evolution is still a subject
of active investigation. Compelling arguments were suggested for considering
the interplay of drug interactions and resistance evolution purely in a geometric
manner [Chait et al., 2007; Wood et al., 2014]. If we assume that mutations only rescale
the effective drug concentrations, interaction remains unchanged. Such rescaling
and consequent invariance of interactions postulate a useful null expectation when
libraries of mutants are considered; deviations from these expectations point towards
mutants that change the interaction type and suggest the potential mechanisms
underlying the interaction [Chevereau and Bollenbach, 2015].
This geometric framework has several important implications on the understand-
ing of resistance and its evolution. It suggests that antagonistic interactions – while
less potent – slow down the evolution of resistance; synergistic interactions on the








Figure 1.20: Drug interactions affect resistance evolution. (A) Synergy and antagonism affect the
rate of resistance evolution differently. If a mutation does not change the interaction, but only rescales
the effective concentration; see arrow from sensitive (yellow) to resistant (green). In the case of
antagonism this does not result in the increase in fitness, while it does for synergistic interaction.
This effect depends on the particular details of rescaling and strength of interaction. (B) Suppressive
interaction selects against resistance. In the point denoted with a purple pentagon, sensitive strain
can grow whereas resistant cannot. However, for higher concentrations (triangle) the situation is
reversed.
has been challenged in a recent study [de Evgrafov et al., 2015], in which Staphy-
lococcus aureus was evolved in the presence of different antibiotic combinations;
cross-resistance and collateral sensitivity were shown to be important in the degree
of resistance evolution against a particular antibiotic combination.
While evolutionary determinants of drug resistance remain elusive, rescaling
of effective concentrations by resistance mutations can explain the occurrence of
differential selection. A particular example of the latter are drug interactions that
select against resistance [Chait et al., 2007]. In this study, suppressive interaction
between quinolone ciprofloxacin and translation inhibitor doxycycline leads to the
existence of a concentration region in which only sensitive strain grows (Fig. 1.20B).
Such effects of drug interactions suggest an untapped potential that can be employed
in the design of therapies, as these phenomena can potentially revert the evolutionary
trajectories leading to ever-increasing drug resistance.
In sum, pairwise drug interactions and their mechanistic origins are important
in the evolutionary context as they can affect the rate of resistance evolution, impose
differential selection, or are themselves altered by the resistance mutations. Knowing
the mechanisms of drug interactions would help us understand the role of drug
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interactions in resistance evolution.
1.11.3 Gene expression in response to drug combinations
Drug combinations offer a unique opportunity to investigate changes in bacterial
gene expression to the combinations of environmental signals. While changes in
gene expression in response to some antibiotics might be consistent (i.e., each of
antibiotics leads to the same response), for others responses might be conflicting.
Additionally, knowing responses to individual stresses can be difficult to consolidate
to the combined stress; are responses averaged, prioritized to a particular drug, or
biased? Additionally, on a single-cell level these responses might be determinis-
tic (i.e., all cells show roughly the same response to the combination of signals) or
stochastic (i.e., respond “randomly” to a particular signal from a combination) [Bol-
lenbach and Kishony, 2011]. Studies of gene expression in response to combinations
of antibiotics are of great interest, as these responses can reveal general strategies of
gene regulation that govern the responses to mixed signals and can reveal intricate
mechanisms of drug interactions [Bollenbach et al., 2009].
Tacking the mechanisms of responses to mixed signals is especially challenging
due to the overwhelming number of genes that can potentially lead the response.
Various techniques have been employed, ranging from high-throughput microscopy
and laboratory-automatization employing fluorescent reporters [Bollenbach and
Kishony, 2011], to flow-cytometry and batch-sequencing of transcriptome (in fission
yeast S. cerevisiae [Lukačišin and Bollenbach, 2019]). In analysis of these high-
dimensional datasets in which number of readouts (e.g., expression data for genes)
far exceeds the number of conditions, various dimension-reduction methods were
employed to identify combinations of genes that co-vary.
Dimension-reduction methods have the added benefit of delineating global, spe-
cific and emergent gene expression responses. Global response emerges due to the
effects of antibiotics on macroscopic parameters such as the growth rate [Lukačišin
and Bollenbach, 2019; Bollenbach and Kishony, 2011]. Specific responses are per-
tinent to individual drugs and can be conflicting or consistent between drugs in
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the combination. In the combination these responses can prioritize one response
over the other or can be averaged. Emergent gene expression occurs when genes
are strongly up- or down-regulated in the presence of both drugs but not for any
drug alone [Lukačišin and Bollenbach, 2019]. Emergent behavior in the presence
of drug combination was shown to be predictive of higher-order drug interactions
in which more than two antibiotics are present [Lukačišin and Bollenbach, 2019].
Here, a combination of two drugs could cause an upregulation of a particular path-
way, suggesting that a drug targeting this pathway would be antagonized by this
combination. Interestingly, it was demonstrated in S. cerevisiae that a combination
of translation inhibitor and sphingolipid synthesis inhibitor, which caused upreg-
ulation of DNA replication checkpoint-machinery, antagonized DNA-damaging
drug [Lukačišin and Bollenbach, 2019]. This example in which emergent response
to pairs predicted the emergence of antagonism suggests that the higher-order drug
interaction might arise as a “mixture” of pairwise interactions.
1.11.4 Mechanism-independent models of higher-order drug in-
teractions
A methodological framework developed in Ref. [Wood et al., 2012] showed that while
experimental complexity increases with numberof combined drugs beyond pairs, the
prediction can actually become simpler. In their work, they considered growth rates
as variable drawn from a probability distribution P(x1, x2, . . . , xk)  P(x), where
x  {x1, x2, . . . , xk} is a vector of k stochastic variables, defined such that measured
response is given as yi  ⟨xi⟩. By construction, this probabilistic framework dictates
that the drug interactions arise as correlations between stochastic variables xi , or
yi j  ⟨xix j⟩. The central premise of the maximum entropy models is based on:
(i) probability distribution has to recover experimentally determined moments
(or any expected value), and (ii) distribution with highest entropy (maximally
unstructured distribution) is chosen [Jaynes, 1957]. This allows estimation of higher-
order drug interactions, and – under some assumptions – results in a simple formula
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for three-drug combination:
yABC  yA yBC + yB yAC + yC yAB − 2yA yB yC , (1.8)
where yi and yi j are relative growth rates at the given concentration of drug i and
at the combination of drugs i and j, respectively [Wood et al., 2012]. This is an
example of Isserlis’ theorem, in which higher moments are constructed from known
covariance matrix. While predictive, this framework requires knowledge of pairwise












Figure 1.21: Higher-order drug interactions mainly depend on pairwise interactions (A) A
schematic of three-antibiotic combination between drugs of known pairwise interactions. Mechanism-
free models can predict the combined effect. (B) Schematic representation of the expression obtained
for mechanism-free model as obtained by entropy-maximization. (C) Schematic representation of the
effective-dose model. Addition of the second drug increases or decreases the effective concentration
for synergistic and antagonistic/suppressive interactions, respectively.
Maximum entropy framework and its Isserlis’ model [Eq. (1.8)] successfully
predicted higher-order interactions; however, it is prone to errors arising from
experimental inaccuracies in yi and yi j [Zimmer et al., 2016]. An alternative approach
for predicting the effect of combinations of chemotherapeutic drugs was suggested
by Zimmer et al., in which drug interaction materialize through rescaling of effective
















Here, d′j,eff  d j,eff/d j,0 and d j,0 is concentration leading to 50% inhibition. Since
yi(di) is the known response to a single drug, what remains is determination of
ai j from pairwise interactions. This model has been generalized to predictions of
ultra-high-order antibiotic combinations based on pairwise interactions [Katzir
et al., 2019]. Both Isserlis’ and effective-dose models demonstrate that pairwise
interactions are at the core of understanding higher-order drug combinations. It is
hence imperative to uncover the mechanisms that govern the pairwise interactions.
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2 Aims of this thesis
The work presented in this thesis aims to investigate the interplay of perturbations
of cell physiology and the growth rate. Specifically, by focusing on the translation,
we investigate the effects of antibiotics and antibiotics combinations that perturb
the synthesis of proteins. The main body of the thesis (Chapters 3-6) consists of the
work presented in two manuscripts: “Minimal biophysical model of combined antibiotic
action” and “Mechanisms of drug interactions between translation-inhibiting antibiotics”.
To integrate the material consistently into the thesis, we made several changes to
the manuscript text and figures.
The disposition of the thesis is as follows:
Aim 1: Determination of a drug-interaction network
We selected several antibiotics that target various steps in translation and do so
by binding to different sites of the translation machinery. This provides us with a
diverse repertoire of chemical perturbations that allows investigation of combined
perturbations of translation. Chapter 3 describes the determination of the drug
interaction network and highlights the features of the diverse interactions between
translation inhibitors.
Aim 2: Construction of a minimal model of drug interactions
Next, we construct a minimal model of combined antibiotic action, described in
Chapter 4. We build a mathematical model of antibiotics targeting the ribosome; the
model takes into account bacterial growth laws and kinetic properties of antibiotic
transport and binding. It allows the prediction of drug interactions based on the re-
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sponses to individual drugs alone. We systematically refine the model by including
the direct physical interactions of different antibiotics on the ribosome. We elaborate
on the correspondence between mechanism-free models of higher-drug interactions
and limiting cases of our model. We additionally extend the model to include the
effects of resistance genes and drugs that mimic a poor nutrient environment. We
experimentally test the model predictions and isolate the cases in which the model
did not correctly predict the experimental results.
Aim 3: Establishing the equivalence between genetic perturbations and antibi-
otics As we hypothesized that drug interactions might spur from the interplay of
the ribosomes halted at different points in translation, we developed a synthetic sys-
tem that allowed us to impose artificial bottlenecks in translation, which is described
in Chapter 5. This directly leads to probing of the effects translation bottlenecks have
on the efficacy of antibiotics. We integrate these effects into a series of “antibiotic
fingerprints” that provide an insight into the workings of the antibiotics. We directly
illustrate the equivalency of genetic and chemical perturbations by remapping. This
further allows us to directly predict drug interactions from genetic interventions in
translation.
Aim 4: Associating the simultaneous variation of rates of two essential processes
with continuous epistasis and developing the TASEP-based model of translation
Chapter 6 builds further on the idea that interactions between translation inhibitors
arise from fundamental interplays between inhibited processes. By constructing
a strain with two translation factors under inducible control, we showcase how
the suppression emerges between the initiation and translocation inhibitors. Next,
we construct the Totally Asymmetric Simple Exclusion (TASEP) model of transla-
tion. It takes into account the growth laws, and does not consider ribosomes as
self-propelled particles, but rather establishes the kinetic rates on the catalysis by
translation factors. As we associate the chemical and genetic perturbations, we
develop the notion of continuous epistasis, which quantifies the deviations from
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expected independence of two processes.
Aim 5: Construction of tools that allow quantitative characterization of translation
Motivated by these insights we develop a set of experimental tools for quantitative
characterization of translation. We design the tools for measuring the translation
rate and for precise quantification of intracellular abundances of translation factors.
In Chapter 7 we showcase the construction of these tools and demonstrate the
characterization of the physiological state of the cell. By titration of a translation
factor, we quantitatively probe the state of the translation and try to infer the
relationships between processes. We further develop these insights by constructing
simple models of translation that allow us to infer the physiological parameters. We
conclude by laying out the next steps in studies of translation.
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3 Pairwise interactions between translation
inhibitors
Inhibiting translation is one of the most common antibiotic modes of action, cru-
cial for restraining pathogenic bacteria [Walsh, 2003]. Antibiotics targeting trans-
lation interfere with either the assembly or the processing of the ribosome, or
with the proper utilization of charged tRNAs and translation factors (Fig. 3.1;





































Figure 3.1: Antibiotics targeting different translation steps. Schematic of the translation cycle and
translation inhibitors. Translation factors are shown in dark gray boxes. Stability of the large subunit
is mediated by Der and initiation by initiation factors (IFs). Elongation factors Tu and G (EF-Tu,
EF-G) catalyze ribosome progression. Release of GDP from EF-Tu is facilitated by EF-Ts. Release
factors (RFs) facilitate the ejection of the finished peptide from the ribosome, whose recycling is
mediated by the factor for ribosome recycling (Frr). Translation inhibitors are shown in white boxes
(abbreviations in Table 1).
sponses to many such translation inhibitors are unclear. Responses to drug com-
binations, which may offer effective ways to combat antibiotic resistance [Yeh
et al., 2009], are even harder to understand. Apart from their clinical relevance,
antibiotic combinations provide powerful quantitative and controlled means of
studying perturbations of cell physiology [Falconer et al., 2011] – conceptually
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similar to studies of epistasis between double gene knockouts [Yeh et al., 2006;
Segre et al., 2005]. Recently, mechanism-independent mathematical approaches to
predict the responses to multi-drug combinations were proposed [Zimmer et al., 2016;
Wood et al., 2012], yet these approaches rely on prior knowledge of pairwise drug
interactions, which are diverse and have notoriously resisted prediction. One of
the main reasons for this situation is that the underlying mechanisms of drug
interactions are largely unknown. They include synergism (drug effect is stronger
than predicted), antagonism (drug effect is weaker), and suppression (one of the
drugs loses potency) [Bollenbach, 2015; Mitosch and Bollenbach, 2014] (Fig. 1.19).
To design optimized treatments, the ability to predict or alter drug interactions is
crucial. Such predictions would be facilitated by understanding their underlying





























































































































































































































































































































































































































































































































































































































































































































































































































































































Predictions of drug interactions should ideally only require information about
responses to individual antibiotics. This information, together with an account
of the global physiological response to drug action, could provide us with an
improved null model of drug interactions. Established null models are based on
mechanism-independent expectations such as Loewe additivity (Fig. 1.20) [Loewe
and Muischnek, 1926], which mainly serve as a reference for classifying drug
interactions. In contrast, an improved null model would capture well-understood
processes such as drug uptake, target binding, and the physiological response to
target inhibition, which are relevant for all drugs that share the same target. In this
work, we experimentally challenge quantitative predictions of such a theoretical
model of drug interactions. Any deviations from model predictions expose drug
interactions that cannot be explained by established biological and physical processes
alone. In this way, an improved null model could offer a plausible mechanism for
some drug interactions and at the same time expose more complex situations where
additional molecular or physiological details are crucial.
Here we focus on translation inhibitors and their interactions, because trans-
lation is a fundamental, yet complex multi-step process that still lacks a com-
prehensive quantitative description. A key step toward such a description are
bacterial “growth laws,” which quantitatively capture the compensatory upregula-
tion of the translational machinery in response to perturbations of translation [Scott
et al., 2010]. Growth laws have enabled a model that explains the growth-rate
dependent bacterial susceptibility to individual translation inhibitors [Greulich
et al., 2015]. These empirical relations offer a phenomenological description of the
growth-dependent state of the bacterial cell and provide a solid foundation for
quantitative studies of bacterial physiology. Similar to laws in physics, such as
Fourier’s law of heat conduction or Ohm’s law, these phenomenological relations
enable the construction of predictive mathematical models without free parameters
even if their microscopic origins are not yet understood [Scott and Hwa, 2011].
Well-defined translation steps cannot only be perturbed chemically [Wilson, 2014;
Blanchard et al., 2010], but also genetically, as these steps are regulated by transla-















Figure 3.2: Translation inhibitors bind to differ-
ent sites of the ribosome. Antibiotics (in color)
bind to either of the subunits, the interface be-
tween both (CRY), or to the translation factor. The
binding site of the translation inhibitordetermines
which process it inhibits.
catalyze the assembly of 70S ribosomes and initiation, deliver charged tRNAs to the
ribosome, release finished peptides, and mediate ribosome recycling (Fig. 3.1). Both
genetic and chemical perturbations obstruct the progression of ribosomes along the
translation cycle, which generally results in a lower growth rate. Comparing the
effects of antibiotics to those of precisely defined genetic perturbations offers an
opportunity to elucidate the mechanisms responsible for drug interactions between
translation inhibitors and could quantitatively test the equivalence of genetic and
chemical perturbations of bacterial physiology.
As drug interactions are largely determined by the modes of action of the
combined antibiotics [Yeh et al., 2006], we hypothesized that a key determinant
of interactions between pairs of translation inhibitors are the specific steps in the
translation cycle where the two inhibitors halt ribosomal progression (Fig. 3.1). As a
second key determinant of these drug interactions, we considered the compensatory
physiological response to translation inhibition captured quantitatively by ribosomal
growth laws [Scott et al., 2010] together with the kinetics of antibiotic transport
and ribosome binding. We show that these determinants suffice to explain most
drug interactions between translation inhibitors and that these interactions can be
predicted solely from known responses to the individual drugs. To establish this
result, we used a combination of precise growth measurements, quantitative genetic
perturbations of the translation machinery, and theoretical modeling.
To systematically map the network of drug interactions between translation
inhibitors, we selected eight representative antibiotics that interfere with different
stages of translation and bind to different sites on the ribosome (Fig. 3.2; Table 3.1). We





































Figure 3.3: Response surfaces and examples of
growth curves. Left: Dose-response surfaces for
different drug combinations. Gray scale shows
normalized growth rate as a function of concentra-
tions of two antibiotics. Symbols show drug condi-
tions in which growth curves shown in the right
column were measured. Right: Growth curves
(i.e., time courses of luminescence) for four condi-
tions (no drug, individual drugs and a combina-
tion); thin gray line shows additive expectation of
the growth curve for the combined stress. Sym-
bols on the growth curves indicate the condition
used: no symbol, triangle, square and a circle cor-
respond to no drug, CHL-only, second drug only
(see y-axis), and the combination of both, respec-
tively. The growth curves were shifted in time so
as to originate from the same point at time zero.
these antibiotics by measuring growth rates in two-dimensional drug concentration
matrices using a highly precise technique based on bioluminescence [Yeh et al., 2006;
Kishony and Leibler, 2003; Chait et al., 2007] (Fig. 3.3 and Fig. E.2; see Appen-
dices B, C). The shape of the contour lines, along which growth rate is constant
in two-drug space, reveals the drug interaction type (Fig. 3.3). To quantify the
drug interactions, we defined the Loewe interaction score LI, which integrates
deviations from Loewe additivity (Methods). In this way, we characterized all
twenty-eight pairwise interactions and constructed the interaction network between
the translation inhibitors (Fig. 3.4).
The translation inhibitor interaction network (Fig. 3.4) we measured has several
notable properties. First, antibiotics with similar mode of action tend to exhibit
additive drug interactions: In particular, there are purely additive interactions
between capreomycin (CRY) and fusidic acid (FUS), which both inhibit translocation,
and streptomycin (STR), which interferes with tRNA binding and also slightly lowers
the translocation rate. Chloramphenicol (CHL) and lincomycin (LCY), which both










Figure 3.4: The drug-interaction network of
translation inhibitors. Color-code is as in Fig. 3.3;
dashed gray lines denote additivity. Note the
prevalence of antagonism and suppression.
consistent with the view that drugs with similar mode of action can substitute
for one another. Second, kasugamycin (KSG) is a prominent hub in the network:
it shows almost exclusively antagonistic and suppressive interactions with other
translation inhibitors. Third, we identified a previously unreported synergy between
CRY and CHL. A number of other interactions confirm previous reports. For
example, synergy between erythromycin (ERM) and tetracycline (TET) was observed
before [Yeh et al., 2006; Russ and Kishony, 2018]. Additivity between CHL and
TET was also reported; moreover, this interaction proved to be highly robust to
genetic perturbations [Chevereau and Bollenbach, 2015]. Finally, antagonism and
suppression are more common in the translation inhibitor interaction network
than synergy, consistent with a general prevalence of antagonistic interactions
between antibiotics [Brochado et al., 2018]. We reasoned that general trends like the
prevalence of antagonism in the drug interaction network may be due to a general
physiological response to translation inhibition.
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4 Minimal model of antibiotic action
As a first step toward understanding the origin of the observed drug interactions,
we developed a mathematical model that predicts such interactions from the effects
of the individual drugs alone. We generalized a biophysical model for the effect of a
single antibiotic on bacterial growth [Greulich et al., 2015] to the situation where two
antibiotics are present simultaneously. In the spirit of Ref. [Greulich et al., 2015], our
model aims to predict the response to a pair of “generic” translation inhibitors whose
action leads to a physiological response that obeys established bacterial growth
laws [Scott et al., 2010]. Considerable experimental support from observations of
the effects on translation by diverse chemical and genetic perturbations strengthens
the generality of growth laws [Cole et al., 1987; Olsson et al., 1996; Bennet and
Maaløe, 1974]. This parsimonious approach keeps the number of unknown model
parameters to a minimum. Cases where the response to a drug pair deviates
from the predictions of this physiologically relevant null model indicate that more
complex mechanisms – specific to one or both of the drugs used – are essential for
understanding the drug interaction.
Here, we present a biophysical model that predicts bacterial growth responses to
combinations of translation inhibitors. Starting from responses to single antibiotics,
we derive approximate analytical solutions of this model and investigate the effects
of direct physical or allosteric interactions between antibiotics on the ribosome.
We discuss several relevant extensions of the model, in particular (1) interactions
with antibiotics that induce starvation, (2) the effects of resistance genes, (3) the
correspondence to non-mechanistic models of interactions between more than two
drugs, and (4) predictions for interactions of translation inhibitors with antibiotics








Figure 4.1: Main components of the model for a single translation inhibitor. Ribosomes (double
ovals) are synthesized with the rate s(λ) and are initially unbound by antibiotic (ru). Unbound
ribosomes contribute to growth. Antibiotics enter the cell (aex → a) and bind to and detach from
ribosomes with second-order and first-order rate constants kon and koff, respectively. Bound ribosomes
(rb) do not contribute to growth.
by the biophysical model in experiments.
4.1 Model for a single translation inhibitor
First,we recapitulate the biophysical model fora single translation inhibitor [Greulich
et al., 2015]. The model captures the kinetics of antibiotic transport into the cell and
binding to the ribosome (Fig. 4.1), as well as the physiological response of the cell
to translation perturbation. This physiological response is described by bacterial
growth laws, which summarize the interdependence of the intracellular ribosome
concentration r and the growthrateλ (Fig. 4.2). Bacterialphysiology and the response
to antibiotic treatment strongly depend on the nutrient environment. In particular,
the number of ribosomes per cell varies over approximately 5 − 75 × 103 [Bremer
and Dennis, 1996]. The ribosome concentration increases linearly with the growth
rate when the latter is varied by changing the quality of the growth medium:
ru  rmin + λ/κt , (4.1)
where κt  0.06 µM−1h−1, ru and rmin  19.3 µM are the translational capacity, the
concentration of unperturbed ribosomes, and a minimal ribosome concentration,
respectively [Scott et al., 2010; Greulich et al., 2015]. This first growth law, which
we introduced in the Introduction, states that unperturbed ribosomes synthesize
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Figure 4.2: Bacterial growth laws. When the
growthrate is variedby changing the quality of the
nutrient environment, the ribosome concentration
increases linearly with growth rate (solid line). If
growth is inhibited by a translation inhibitor, the
ribosome concentration increases with decreasing
growth rate (dashed lines). The intercepts of the
solid and dashed lines determine the minimal
(rmin) and maximal ribosome concentration (rmax),
respectively, which are ∆r apart.
new proteins, whose overall synthesis rate is proportional to the growth rate. Here,
we expressed the quantities in the units of concentrations, rather than proteome
fractions [Greulich et al., 2015; Klumpp et al., 2013; Scott et al., 2014]. This relation
holds across diverse growth media and different Escherichia coli strains [Scott et al.,
2010]. Typical values for doubling times range from hours to approximately twenty
minutes, corresponding to growth rates up to around 2.5 h−1. However, when
the growth rate is lowered by addition of a translation inhibitor in a constant
nutrient environment, the total ribosome concentration rtot and growth rate become
negatively correlated [Scott et al., 2010]. Mathematically, this dependency is given
as:
rtot  ru + rb  rmax − λ∆r[1/λ0 − 1/(κt∆r)], (4.2)
where rmax  65.8 µM is the maximal ribosome concentration, ∆r  rmax − rmin 
46.5 µM is the dynamic range of ribosome concentration, rb is the concentration
of antibiotic-bound ribosomes, and λ0 is the maximal growth rate in the absence
of antibiotics [Scott et al., 2010]. Eq. (4.2) quantitatively describes the upregulation
of ribosome production that occurs in response to translation inhibition: Bacteria
produce more ribosomes to compensate for the ribosomes blocked by antibiotics.
When antibiotics enter the cell, they can bind to ribosomes. The net rate of forward
and reverse binding of antibiotics to the ribosome is given by f (ru , rb , a)  −kona(ru−
rmin)+ koffrb , where koff and kon are first and second order rate constants, and a is the
intracellular antibiotic concentration (Fig. 4.1). Here,we assumed that only ribosomes
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capable of translation (ru − rmin) can be bound by the antibiotics [Greulich et al., 2015;
Greulich et al., 2017].
The intracellular antibiotic concentration is affected by the kinetics of antibiotic
entry into the cell, which is given by J(aex, a)  pinaex − pouta, where aex is the
extracellular antibiotic concentration. Typical influx and efflux rates, pin and pout,
for different translation inhibitors range from 1 − 1000 h−1 and from 0.01 − 100 h−1,
respectively. Typical rates of forward and reverse binding, kon and koff, are around
1000 µM−1h−1 and between 0 − 105 h−1, respectively [Greulich et al., 2015; Greulich
et al., 2017]. Here, koff  0 corresponds to antibiotics with effectively irreversible
binding such as streptomycin [Greulich et al., 2015; Davis, 1987]. All molecular
species in the cell are effectively diluted at rate λ as cells grow and divide. Since the
ribosome concentration is determined by Eq. (4.2), the ribosome synthesis rate s
depends on the growth rate, i.e., s  s(λ). Together, these terms constitute a closed
system of ordinary differential equations:
da
dt
 −λa + f (ru , rb , a) + J(aex, a), (4.3a)
dru
dt
 −λru + f (ru , rb , a) + s(λ), (4.3b)
drb
dt
 −λrb − f (ru , rb , a). (4.3c)
Here,the ribosome synthesis rate reads s(λ)  λrtot  λ {rmax − λ∆r[1/λ0 − 1/(κt∆r)]}.
The steady-state solution of Eqs. (4.3) represents a balanced-growth state of the sys-
tem – the situation that is commonly investigated in experiments. The steady-state





































where λ∗0  2
√︁
poutκtKD with KD  koff/kon, and IC∗50  ∆rλ∗0/2pin. We can recast
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Figure 4.3: Dose-response curves and bistability phase diagram. (A) Examples of dose-response
curves. The model can produce both (i) steep and (ii) shallow dose-response curves, depending
on the parameter α (see text). The steep dose-response curve has a region of concentrations (gray
shaded area) where one unstable (dashed line) and two stable (solid lines) solutions exist. (B) Exact
phase diagram for dose-response curves. The shaded area shows the region of drug concentrations
where two stable solutions exist. Gray arrows show α for the examples from (A); black arrow shows
the critical value αcrit  2/3
√
3 above which no bistability can occur.
by defining aex  c×IC50, λ  y×λ0 and λ∗0  α×λ0, where IC50 is the extracellular
antibiotic concentration that leads to 50% growth inhibition, a common measure
of drug sensitivity. Here, we call α the response parameter, as it describes the
dose-response curve shape: The higher the value taken by α, the shallower the
dose-response curve (Fig. 4.3A).
Since Eq. (4.5) is cubic in the relative growth rate y, there are generally either
one or three real solutions for y (Fig. 4.3A). This indicates that there is a parameter
regime in which the dynamical system can exhibit bistability [Greulich et al.,
2015; Elf et al., 2006]. Previous studies identified the bistable parameter regions
numerically or in closed expression with many parameters [Greulich et al., 2015;
Greulich et al., 2017]. Notably, the rescaling shown above enables the exact calculation
of the bifurcation point (see Appendix A.1): When α < αcrit  2/(3
√
3) ≈ 0.385
the system can be bistable (Fig. 4.3B), i.e., there is a region of concentrations with
stable solutions at two different growth rates. In this region, the growth rate sharply
declines when a critical concentration is exceeded. It is difficult to measure such steep
dose-response curves experimentally since very low growth rates are challenging
to detect and quantify. Additionally, bistability cannot be observed in population-
level experiments since the high-growth-rate branch will quickly dominate the
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population; single-cell experiments are needed to observe growth bistability [Deris
et al., 2013]. On the other hand, if the antibiotic concentration can be varied during the
experiment, bistability can be tested by determining the hysteresis of the response,
as observed for synthetic gene networks [Kramer and Fussenegger, 2005].
Steep dose-response curves (α < αcrit) occur for antibiotics with tight binding
to the ribosome (KD → 0) or inefficient efflux (pout → 0). Alternatively, if these
two quantities are growth-rate invariant, dose-response curves become steeper
with increasing growth rate in the absence of drug, as α ∝ 1/λ0. For typical values
of the relevant parameters (discussed above), α ranges from 0 to ∼ 10. We have
experimentally observed values of α for different translation inhibitors in the range
0 − 2. In the limit α ≫ 1, Eq. (4.5) simplifies into y  1/(1 + c); if α → 0 then






/2 for c ≥ 1, [Greulich et al., 2015]. This
biophysical model for a single translation inhibitor provides the foundation for
a predictive theory of multiple drug interactions between different translation
inhibitors.
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4.2 Model for interaction between two translation in-
hibitors
When combinations of two different translation inhibitors are present, each ribosome
can be bound by either of them alone or by both simultaneously. To generalize
the model described in Sec. 4.1 to this situation, we need to introduce additional




 −λai + fi(ru , rb ,i , ai) + Ji(aex,i , ai)+
+ δoff,ikoff,ird − δon,i kon,iairb , ī (4.6a)
drb ,i
dt















fi(ru , rb ,i , ai) + s(λ). (4.6d)
The terms fi(ru , rb ,i , ai) and Ji(aex,i , ai) describe the first binding step and mem-
brane transport of antibiotic i, respectively. The additional terms δoff,ikoff,i rd and
δon,ikon,iairb , ī describe the unbinding of antibiotic i from double-bound ribosomes
rd and the binding of antibiotic i to ribosomes already bound by the other antibiotic ī
(e.g., for antibiotics A and B, Ā  B), respectively. The dimensionless parameters
δσ,i with σ ∈ {on, off} denote the relative change of the rate of forward and reverse
binding of antibiotic i to ribosomes already bound by the other antibiotic. When
the binding kinetics for both antibiotics are independent, all δσ,i  1. When both
antibiotics compete for the same binding site on the ribosome, δon,i  0. In general,
the parameters δσ,i can vary continuously to capture any changes in ribosome
binding of one antibiotic due to the binding of the second.
What is the main consequence of including the double-bound ribosomes? Below,
we show that in the absence of double-bound ribosomes, drug interactions are
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generally expected to be additive. If we assume that no double-bound ribosomes
can form, e.g., by setting δon,i  0, Eq. (4.6c) becomes equal to zero and all terms
associated with the second binding event disappear. To show that this situation
necessarily yields an additive drug interaction, we examine the system along the
isobole. At the fixed growth rate, i.e., along an isobole, ru  λ/κt + rmin is constant.
This implies that the total concentration of ribosomes bound by either antibiotic
(i.e., rb  rb ,A + rb ,B) remains constant for all different concentration pairs (cA , cB)
along the isobole. In a steady state, the concentration of ribosomes bound by the






. The bound ribosome
concentration reads
rb  rb ,A + rb ,B  rtot − ru  ∆r (1 − λ/λ0) (4.7)
where we have taken into account Eqs. (4.1) and (4.2). We express ai as a function of
aex,i from Eq. (4.6a), which yields:
ai  aex,i
pin,i[︁
λ (kon,i/κt + 1) + pout,i − ξi koff,i
]︁⏞ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ⏟⏟ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ⏞
Υi
. (4.8)
The proportionality constant Υi in this expression depends only on λ and kinetic
parameters; in particular, it is invariant of the concentration of the other antibiotic.






 aex,AΥAξA + aex,BΥBξB , (4.9)
which is the equation of the isobole because coefficients Υiξi are independent of
the other antibiotic. This argument shows that additivity generally occurs when
double-bound ribosomes cannot form. Additionally, this confirms that the model
correctly predicts additivity when the antibiotic is combined with itself–double-
bound ribosomes cannot form in this case.
In the limit where koff , pout ≫ λ, i.e., α → ∞, the Eq. (4.9) takes a simple form of
cA + cB  λ0/λ − 1, where ci  aex,i/IC50,i . To derive this expression, we noted the
definitions of α and IC∗50,i used for a single antibiotic (see preceding section) as well













Figure 4.4: Ribosomes already bound by a sin-
gle antibiotic (black and white circles) can be
bound by another one. If the binding is indepen-
dentof the presence ofan already boundantibiotic,
the second binding step follows the same kinetics
as for a single antibiotic.
clearly shows the linear dependency between external concentrations supporting
growth rate λ.
To study the effect of double-bound ribosomes (Fig. 4.4), we systematically
calculated dose-response surfaces for both competitive and independent binding
(Fig. 4.5A; Appendix A.3). The Loewe interaction score (LI) is a convenient way to
characterize the type and strength of drug interactions by a single number, with
negative values corresponding to synergy and positive values to antagonism. The LI







where yadd is the response surface of the additive expectation, which is calculated
directly from the responses to the individual drugs (see Appendix A.2). By calcu-
lating the LI score of the dose-response surfaces for varying response parameters
αA , αB of the two antibiotics that are combined, we determined the complete phase
diagram of drug interactions (Fig. 4.5B). This procedure revealed that antagonism
generally occurs for combinations of antibiotics with steep dose-response curves,
and the interaction becomes additive and then synergistic with increasing response
parameters (Fig. 4.5A). This transition from antagonism to synergy is smooth and
partitions the phase diagram into two regions (Fig. 4.5B). However, suppressive
interactions remain elusive.
The fact that combinations of antibiotics that bind the ribosome irreversibly yield
antagonism can be understood intuitively. If a low concentration of an irreversibly-
binding antibiotic is added to a bacterial population in the presence of a high
concentration of another such antibiotic, it will mostly bind ribosomes that are



















Figure 4.5: Biophysical model of two antibiotics that can bind the ribosome simultaneously
produces different types of drug interaction. (A) Examples of dose-response curves of different
steepness and corresponding dose-response surfaces calculated from the model. Top: Dose-response
curves with low or high α are steep (left) or shallow (right), respectively. Bottom: Depending on
the shape of the dose-response curves of the antibiotics that are combined, the calculated drug
interactions range from antagonism (left, low α) to synergy (right, high α). Combining antibiotics
with different α results in a dose-response surface of more complicated shape (middle). (B) Phase
diagram of drug interactions: LI score for dose-response surfaces of antibiotic pairs with response
parameters αA , αB ; white dashed line shows additive interactions (LI  0). The left- and right-hand
antibiotic pairs from (b) are shown by a purple triangle and a purple square, respectively.
lower the growth rate further since the ribosomes were already inactivated by the
first antibiotic that bound. Irreversibly-bound ribosomes thus effectively act as a
“sponge” that soaks up antibiotics which can then no longer contribute to growth
inhibition – a situation that results in antagonism.
What causes the transition from antagonism to synergy as α increases? Increasing
α implies that the binding of the antibiotic becomes more and more reversible or
efflux becomes high (i.e., KD pout → ∞). If the growth rate is low due to inhibition,
then the rtot ≈ rmax as the ribosome synthesis is upregulated to its maximum.
In this case, the typical rate of dilution by growth is much slower than that of
antibiotic-ribosome binding and we obtain ai ≈ aex,ipin,i/pout,i . In this regime, we
can derive an approximate solution that yields a synergistic dose-response surface,


















Figure 4.6: Combining antibiotics with rapidly reversible ribosome binding yields synergistic
drug interactions. (A) Comparisons of numerically calculated dose-response surfaces and approxi-
mate solution. Purple isoboles (dashed and solid lines correspond to 50% and 20% relative growth
rate, respectively) show the approximate solution on top of the dose-response surface calculated
from the biophysical model (gray scale). Examples are shown for two pairs of antibiotics with
identical (left) or different α (right). (B) Pearson correlation ρ between approximate and numerically
calculated growth rate, evaluated for 121 × 121 equidistant concentration pairs. Solid and dashed
line correspond to the cases with identical or different α, respectively. The correlation increases for
antibiotics with higher α. The arrow shows α for the example on the left in A.
the drug interaction type. The system becomes linear and analytically solvable (see
























/(α2i λ0). This expression for y is simply a product of
relative responses, which is equivalent to the definition of Bliss independence. This
approximate solution agrees well with the full numerical solution at lower growth
rates and for antibiotics with higher α (Fig. 4.6). Equation (4.11) becomes even
simpler in the limit λ0  λmax and α → ∞ as these two limits yield a product of
two Langmuir-like equations with only relative concentrations cA, cB as arguments,
i.e., y  1/[(1 + cA)(1 + cB)], which is independent of λ0 and α.
Using this model, we calculated the predicted response surfaces for all translation
inhibitor pairs and compared them to the experimentally measured surfaces (Fig. 4.7).














KSG-ERM ERM-TET ERM-CHL KSG-STR
Figure 4.7: Mathematical model of combined antibiotic action based on growth laws partially
predicts drug interactions. Examples of predicted dose-response surfaces. The scatter plot depicts
the correlation between predicted and measured growth rates. Means and error bars (standard
deviation) of predicted growth rates are estimated from n  100 bootstrap repetitions. The binding
scheme assumed is indicated on the bottom right and Pearson’s ρ on the top left. Predicted and
measured dose-response surface are shown below the scatter plot. Color of 20% isobole (bottom) and
plot markers (top) denotes the type of predicted interaction. The model correctly predicts response
surfaces for KSG-ERM, ERM-TET, and ERM-CHL, yet it fails to predict the interaction between STR
and KSG.
TET-ERM in Fig. 4.7), indicating that binding kinetics and growth physiology alone
suffice to explain these interactions. Correctly predicted drug interactions include
additive cases which often involve antibiotics that have either similar modes of
action (CRY-FUS, CHL-LCY) or partially overlapping binding sites (CHL-LCY,
ERM-CHL) [Wilson, 2014]. For the latter, the assumption that the formation of
the doubly-bound ribosome population is prohibited, which yields an additive
response surface, offers even better agreement with the experimental data (Fig. 4.7).
Occasionally,drug interactions are betterexplained if competitive binding is assumed
(e.g., CHL-TET) even though the binding sites of the antibiotics involved do not
overlap.
4.2.1 Symmetric direct interactions on the ribosome amplify drug
interactions
We next asked how more general binding schemes, in which two different antibiotics


























Figure 4.8: Direct interactions between antibiotics on the ribosome can amplify drug interactions.
(A) Schematic of antibiotics symmetrically affecting their binding on the ribosome. (B) Changes in
the shape of the dose-response surfaces for pairs of antibiotics with (i) identical α  2−5 and (ii)
identical α  22, when δ is increased from 1 (left) to ≈ 5.0 (right). Purple dashed and solid line in
the bottom-right panel show the approximate solution in Eq. (4.14) for the 50% and 20% isoboles,
respectively. (C) Increase in absolute value of the LI score as a function of δ for pairs of antibiotics
with different response parameters. Solid lines (i) and (ii) correspond to the examples in B; arrows
show increase in |LI | at δ ≈ 5.0. Note, that for both antibiotic combinations, LI collapses to 0 for
competitive binding, i.e., δ  0. The dotted line shows the LI score calculated using the approximate
solution in Eq. (4.14).
resulting drug interactions. Two antibiotics do not need to come into direct, physical
contact to affect each other’s binding: Allosteric effects (i.e., changes in ribosome
structure due to antibiotic binding) can produce the same result. In the most
plausible scenario, the antibiotics affect each other’s binding in a symmetric way, i.e.,
δσ,i  δσ, ī (Fig. 4.8A). For example, the antibiotics lankamycin and lankacidin (which
interact synergistically [Auerbach et al., 2010]) are near each other when bound to the
ribosome; their binding is stabilized by a direct physical interaction [Wilson, 2014;
Belousoff et al., 2011]. Yet, it is unclear if the mutual stabilization of binding necessarily
leads to synergy. In principle, stabilization of binding could also increase the
sequestration of tightly binding antibiotics or “lock” an antibiotic that would
rapidly unbind on its own in the bound state, thus potentially promoting prolonged





ter Figure 4.9: Diagonal cross-section (αA  αB)
through the phase diagram for different δ. Black
solid line corresponds to the case of independent
binding (cf. Fig. 4.5B); the two gray lines show
examples with either δ < 1 or δ > 1. Irrespective
of drug interaction type, the drug interaction is
amplified for δ > 1 and weakened for δ < 1.
destabilize their binding to the ribosome. The limiting case of this scenario is
competition for the same binding site. To investigate such effects systematically, we
computed dose-response surfaces for antibiotics with different response parameters
α and varying kinetics for the second binding step.
We focused on pairs of antibiotics in which both drugs either have low or high
α, corresponding to steep or shallow dose-response curves, respectively. Numerical
solutions for continuously varying δon,i  δ at fixed δoff,i  1 (Fig. 4.8B,C) showed
that a stabilizing interaction (δ > 1) enhances the resulting drug interaction. If the
drug interaction is antagonistic for δ  1, stabilization amplifies this antagonism;
synergistic interactions are amplified analogously (Fig. 4.8B). If one antibiotic
destabilizes the binding of the other, i.e., δ < 1, a smooth transition to additivity
occurs, independent of whether the dose-response curve of the antibiotic pair is
steep or shallow (Fig. 4.8C). This result is further corroborated by fixing δ and
continuously varying α for the combined antibiotics (Fig. 4.9). Taken together, these
numerical results indicate that direct positive interactions of translation inhibitors
on the ribosome (δ > 1) essentially amplify the drug interaction that occurs in the
absence of such direct interactions, irrespective of drug interaction type.
To corroborate these numerical results, we investigated the limit of reversibly
binding antibiotics with rapid binding kinetics at low growth rates as for Eq. (4.11).
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, and ΦA (︂
1 + c′Aδon,A
)︂
. This closed-form expression facilitates the analysis of several limiting
cases. For example, if the antibiotics mutually stabilize their binding to the extreme
extent that they cannot detach from the double-bound ribosomes anymore (δoff,i  0),
Eq. (4.12) returns y  0 indicating strong synergism. In contrast, prohibiting the
formation of double-bound ribosomes by setting δon,i  0, yields
yadd ≈
λmax/λ0




which corresponds to perfect additivity. This corroborates the previous result that
competitively binding antibiotics interact additively. For the case δon,i  δ and
δoff,i  1 the expression in Eq. (4.12) simplifies to:
y ≈ λmax/λ0








which becomes Eq. (4.11) if δ  1. We can further show that the effect of increasing
δ on drug interaction strength depends on the concavity of the individual dose-
response curves; for response parameters α > 2, increasing δ amplifies synergy (see
Appendix A.5). Overall, this analysis corroborates the general result that direct
stabilizing interactions of reversibly-binding antibiotics on the ribosome amplify
synergistic interactions, while destabilizing interactions weaken them up to the
point where any drug interaction becomes additive.
4.2.2 Asymmetric direct interactions alter the phase diagram
More generally, direct interactions between the antibiotics on the ribosome could
be asymmetric. For example, binding of only one of the antibiotics could trap the
ribosome in a conformation that facilitates the binding of the other antibiotic but
















0] ... shallow, A ... steep BDose-response:
Figure 4.10: Asymmetric direct interactions reshape the phase diagram of drug interactions.
Dose-response surfaces for different instances of asymmetric direct interaction and response parame-
ters; insets on top show schematics of the type of direct interaction and top-right symbols correspond
to those in Fig. 4.10. Antibiotics with shallow (αA  22) and steep (αB  2−3) dose-response curves
are shown by black and white disks, respectively. Left: Antagonism occurs when an antibiotic
with a steep dose-response asymmetrically hinders the binding of another one with a shallow
dose-response, which in turn promotes the binding of the former. Middle: Symmetrizing the direct
interaction almost completely abolishes antagonism. Right: Inverting the scenario from the left-most
panel results in mild synergy.
antibiotics with different response parameters α (Fig. 4.10). The resulting difference
in kinetic parameters describes an asymmetric direct interaction on the ribosome. We
systematically calculated the shape of the dose-response surface for this situation.
When antibiotics with identical response parameters α are combined, the same
trend as for symmetric direct interactions occurs: Increasing δon enhances the drug
interaction. For combinations of antibiotics with different dose-response curve
shapes, asymmetric direct interactions on the ribosome result in a different behav-
ior (Figs. 4.10-4.11). If an antibiotic with a steep dose-response curve asymmetrically
hinders the binding of an antibiotic with a shallow dose-response, while the binding
of the former is stabilized by the latter, antagonism emerges (Fig. 4.10). In contrast,
synergy occurs if the roles of the antibiotics are inverted. The latter can be ratio-
nalized by interpreting the direct interaction on the ribosome as a change of the
effective binding characteristics of the antibiotics. Specifically, in the case where the
steep-response antibiotic promotes the binding of the shallow-response antibiotic,
the latter will in turn destabilize the binding of the former – effectively, the steep-
response antibiotic will thus behave as if it had a shallower response. As a result,








Figure 4.11: Phase diagram of drug interactions for asymmetric direct interactions between
antibiotics with different response parameters. Different response parameters (αA  22 and
αB  2−3) profoundly affect the resulting drug interaction: A continuous transition from antagonism
to synergy occurs (white dashed line denotes LI  0). Purple symbols show the examples from
Fig. 4.10 in the phase diagram.
combined (Fig. 4.5B). In the opposite situation, the binding of the shallow-response
antibiotic becomes even looser and the binding of the steep-response antibiotic is
stabilized. From the phase diagram in Fig. 4.5B, antagonism is the expected outcome
in this case as we combine antibiotics with steep and shallow responses, respectively.
Taken together, these results show how complicated direct interactions between
antibiotics bound to their target can lead to unexpected emergent drug interactions.
4.2.3 Relation to mechanism-independent models of higher-order
drug interactions
The biophysical model described above can predict the pairwise drug interactions
that are needed to apply recently proposed mechanism-independent models for
higher-order drug interactions [Wood et al., 2012]. While a detailed analysis of
higher-order drug interactions is beyond the scope of this work, it is instructive
to demonstrate how the pairwise interactions bridge the gap between responses
to individual drugs and higher-order drug combinations. In the framework of
Ref. [Wood et al., 2012], higher-order drug interactions can be predicted using an































Growth rate is proportional to the
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Total target concentration is constant
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B
Figure 4.12: Assumptions and binding kinetics diagram underlying the calculation of higher-
order drug interactions. (A) Assumptions that simplify the system to allow obtaining a closed
solution. (B) Binding kinetics diagram shows allowed transitions between ribosome subpopulations.
Different symbols on the ribosomes denote different antibiotics.
by the responses to the individual drugs (yi) and their pairwise combinations (yi j):
yABC  yA yBC + yB yAC + yC yAB − 2yA yB yC . (4.15)
In the limit of reversibly binding antibiotics used in Secs. 4.2 and 4.2.1, it is
straightforward to analyze the effects of higher-order drug combinations. The
approximate results below are based on the assumptions that: (i) the growth rate
is directly proportional to the concentration of unblocked ribosomes, (ii) growth
rate is nearly zero, (iii) intracellular concentration depends only on transport
kinetics (i.e., a ≈ aexpin/pout), and (iv) the growth rate is directly proportional to
the concentration of unblocked ribosomes (Fig. 4.12A). Under these assumptions,
analytical solutions can be obtained. For example, we can construct a system of
differential equations describing the binding of three different antibiotics (A, B, C);
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the steady-state solution of this system is:




To derive this result, we considered three different kinds of single- and double-
bound ribosomes as well as triple-bound ribosomes (Fig. 4.12B); for simplicity, all
binding steps were considered to be independent of already bound antibiotics. To
verify the consistency of mechanism-independent model with this fully specified
but approximative mechanistic model, we need to obtain responses to individual
drugs yi and pairwise combinations yi j . We obtain responses yi  1/(1 + c′i) and
yi j  1/[(1+ c′i)(1+ c
′




k≠i , j to zero, respectively.
If mechanism-independent expression is consistent with our simplified model, then
plugging these responses into Eq. (4.15) should yield Eq. (4.16), which is indeed the
case.
Next,we tested if the mechanism-independent formula for three drugs [Eq. (4.15)]
can be reconciled with our model when there is one direct competitive interaction on
the ribosome. If the antibiotics B and C cannot bind to the ribosome simultaneously,









By following same reasoning as for the independent case above, we see that the
mechanism-independent and simplified mechanistic model are consistent.
The assumptions described above can be generalized to antibiotics with other
modes of action, provided that the combined antibiotics bind to the same target. For
example, if growth is limited by a specific enzyme due to antibiotic inhibition, we can
consider the growth rate to be proportional to the abundance of this limiting enzyme.
If enzyme concentration does not change (due to lack of compensatory mechanism
or due to inability of bacteria to increase its expression further), the approximative
mathematical framework from this section is applicable to antibiotics targeting
this enzyme. These results provide a potential mechanistic explanation for the
apparent validity of the mechanism-independent model, at least for combinations
of antibiotics binding the same target.
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4.3 Extensions of the model
Other phenomena than those treated so far can shape drug interactions. Below, we
discuss two cases in which (1,2) antibiotics perturb translation in orthogonal ways
and (3) the expression of antibiotic resistance genes alters a drug interaction. While
certainly not exhaustive, these two cases illustrate relevant extensions of the model.
4.3.1 Effects of antibiotic-induced starvation
Translation inhibitors target the protein synthesis machinery, which is carefully
regulated in response to changes in the nutrient environment [Scott et al., 2014].
Thus, if an antibiotic effectively interferes with cellular state variables that represent
the nutrient environment, it should be possible to predict its effect on the action of a
translation inhibitor and, in turn, its drug interaction with a translation inhibitor.
Bacterial growth strongly depends on the availability and quality of nutrients.
Protein synthesis requires that amino acids are delivered to the translation machinery
(ribosomes) by dedicated proteins [elongation factors (EF-Tu)] [Rodnina, 2018].
The latter bring charged tRNAs (i.e., tRNAs with an attached amino acid) to the
ribosome (Fig. 4.13). tRNAs are charged (i.e., amino acids are attached to them)
by tRNA synthetases. Usually, the supply and demand of amino acids can be
considered to be nearly optimally regulated [Scott et al., 2014] (see Introduction).
However, under starvation, a mismatch between the supply and demand of amino
acids occurs [Elf and Ehrenberg, 2005]. Bacteria respond to amino acid starvation by
triggering the stringent response. This starvation response is primarily controlled
by the alarmone ppGpp (guanosine tetraphosphate) which down-regulates the
expression of the translation machinery (see Introduction) [Maaløe, 1979]. Amino
acid starvation is reflected in reduced tRNA charging and usually occurs when
the nutrient environment becomes poor. However, amino acid starvation can
also be caused by a starvation-mimicking antibiotic (SMA) that blocks tRNA
synthetases (Fig. 4.13) [Durfee et al., 2008; Cassels et al., 1995].
We can capture the effect of an SMA in our model and thus make predictions











Figure 4.13: Starvation-mimicking antibiotic.
Translation inhibitors (TI) inhibit progression of
the ribosome, while a starvation-mimicking an-
tibiotic (SMA) perturbs the amino acid supply.
The ribosome progresses along the mRNA (black
wavy line), if charged tRNAs (black fork with gray
circle) deliver amino acids (gray circles) at a suffi-
cient rate to support the rapid synthesis. A SMA
inhibits tRNA charging and thus mimics amino
acid depletion, a hallmark of starvation.
we assume that the growth rate in the absence of drug λ0, which characterizes the
quality of the nutrient environment in Eq. (4.4), depends on the concentration cs of
the SMA only. Under this assumption, the growth rate in the simultaneous presence
of an SMA and a translation inhibitor can be derived directly from the previous
results for a single antibiotic [Eq. (4.5)]. In the absence of translation inhibitor,

















where αF and IC50,F are α and IC50 in the absence of the SMA, respectively. It follows
that ψ increases monotonically with SMA inhibition if αF > 1; this condition is
obtained by solving ∂gψ  0 for g(cs) ≤ 1. If αF ≤ 1, then the minimal ψ is reached
at g(cs)  αF. We further note that two functional limits exist: in the limits α → 0
and α → ∞, Eq. (4.18) becomes ψ  g(cs) and ψ  1/g(cs), respectively.
The dose-response curve for a single antibiotic is given by y  f (α, c) [a solution
of Eq. (4.5)]. Since we know how IC50 [Eq. (4.18)] and α change as a function of
g(cs), we can evaluate the entire dose-response surface:





Equation (4.19) deviates from a simple multiplicative expectation since the SMA





































Figure 4.14: Effects of a starvation-mimicking antibiotic on the efficacy of translation inhibitors.





of Eq. (4.18) were calculated for chloramphenicol (CHL; black line with αF  1.04, white circles show
experimental data) and streptomycin (STR; gray line with αF  0.46, gray squares show experimental
data). In the experiments, mupirocin (MUP) was used as SMA. The horizontal dashed line indicates
no change with respect to g(cs). Response parameters are from Table F.1. (B) Measured (top) and
predicted (bottom) dose-response surfaces for CHL-MUP (left) and STR-MUP (right). Insets show
scatter-plots of predicted and measured non-zero growth rates.
well. This result illustrates how deviations from Bliss independence occur when
the combined drugs mutually affect their dose-response characteristics. Hence, this
generalization of our model makes non-trivial quantitative predictions for drug
interactions that occur between an SMA and translation inhibitors.
A specific example of an SMA is the antibiotic mupirocin (MUP), which re-
versibly binds to isoleucin tRNA synthetase and prevents tRNA charging [Hughes
and Mellows, 1978]. MUP, which is used against clinically problematic methicillin-
resistant Staphylococcus aureus (MRSA) infections [Rode et al., 1989], induces the
stringent response [Durfee et al., 2008; Cassels et al., 1995] and can thus be used
to test our theoretical prediction. To this end, we measured the change of the IC50
at different levels of growth inhibition caused by MUP g(cs) for two translation
inhibitors: chloramphenicol (CHL) and streptomycin (STR). CHL and STR have
extremely different response parameters α, which leads to different dependencies
of ψ on SMA inhibition (Fig. 4.14A), an effect that is closely related to the results
for different nutrient environments in Ref. [Greulich et al., 2015]. Similarly, we
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measured the complete dose-response surfaces for both drug pairs. The theoreti-
cally predicted dose-response surfaces qualitatively agree with the experimentally
observed ones (Fig. 4.14B). Below (Section 4.3.2) we discuss further examples of
pairwise antibiotic combinations in which a translation inhibitor is combined with
a drug that alters the growth law parameters. Together, these results illustrate how
our theoretical model can be extended to predict the effects of drug combinations
beyond antibiotics that directly target the ribosome.
4.3.2 Combinations of translation inhibitors with drugs that alter
growth law parameters
We elaborated above on a specific example of a starvation mimicking antibiotic,
which invokes a response that is similar to shifting bacteria to poorer media (i.e.,
change in λ0). As growth laws capture this change, a response could be analytically
predicted and was experimentally tested. Below we show two more hypothetical
examples of antibiotic combinations in which translation inhibitor is combined
with a drug that alters growth law parameters. We consider the case in which this
hypothetical drug alters either rmin alone or in concert with rmax; in either case a shift
in growth laws happens, which affects both dynamic range∆r as well as the apparent
response parameter α. Here, we note that there is some experimental data illustrating
that such shift could be achieved by antibiotics inhibiting transcription, e.g., rifampicin
(Fig. 4.15 and Supplementary Information of Ref. [Scott et al., 2010]). However, the
combined effect of transcription and translation inhibition of translation machinery
has not be experimentally assessed.
Ifwe consideran antibiotic thataffects the rmin,yet itdoes notaffect the κt (Fig. 4.15),
then the following modification to the growth law arises:




+ rmin − r′min
)︃







Here,we denotedby gmin(x) a dose-response function of a rmin-varying antibiotic and
x its concentration; r′min denotes an apparent new rmin as a function of gmin(x). Thus,
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Δr variationrmin variation
Figure 4.15: Changes in growth laws as a function of variation in rmin (left) and ∆r (right). Purple
arrow denotes the effect of growth law-varying drug, which alter the “origin” of the translation
inhibition growth law line (dashed gray lines). Slope of dashed lines is altered when rmin is varied;
when rmax is varied simultaneously with rmin the slope is invariant of the “origin.” Purple squares is
data describing the ribosome abundance in response to rifampicin from Ref. [Scott et al., 2010]; we
converted reported RNA/protein measurements to ribosome concentrations by fixing the drug-free
data point to the concentration predicted by the Eq. (4.1) at λ0  0.78 h−1. Note, that the data points
lie approximately on the horizontal dashed line.













, where we defined r0  λ0/κt . Taken together, these
relations rescale the response parameter α  αF/gmin(x) (where αF is the response
















If we consider that gmin(x)  1/(1 + xn), where x is the concentration of rmin-varying
antibiotic measured in units of IC50, we can calculate the whole dose-response
surface as





where f is a translation inhibitor dose-response curve. Examples are shown
in Fig. 4.16.
Model variation discussed above can be expanded in a model in which both rmin
and rmax are varied simultaneously (Fig. 4.15). Here, we assume that rmin increases














































Figure 4.16: Impact of the variation in rmin and ∆r on drug interactions. Examples of dose-response
surfaces for different translation inhibitors (concentration c; different response parameters α) and
different dose-response curves for ∆r- and rmin-varying antibiotic (concentration x; Hill-function
with different steepness parameter n). For easier comparison we overlaid the dose-response surfaces;
the purple contours correspond to ∆r-varying case.
It follows
∆r′  r′max − r′min 
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)︁ × g∆r(x). (4.24)
With this at hand, dose-response surfaces can be evaluated (Fig. 4.16). Here we note
that the both models give the same result if r0  ∆r, which requires λ0  ∆rκt . This
is intuitive since the ribosome concentration is already at its maximum and only







Figure 4.17: Effects of constitutively expressed resistance genes on the shape of dose-response
curve. (A) Schematic of positive feedback loop for unregulated antibiotic resistance gene. A drug-
resistance enzyme degrades the antibiotic, thus reducing growth inhibition and boosting its own
expression. However, if the antibiotic concentration exceeds the capacity of removal by the enzyme,
growth rate starts to drop and so does the expression of the resistance enzyme, amplifying the
growth rate drop. Lightly drawn part (right) illustrates how two antibiotics can get coupled via the
growth-rate dependent loop. (B) Examples of dose-response curves in the presence or in the absence
of a constitutively expressed resistance gene (CERG). Black line shows dose-response curve for α  1.
When a CERG is added (Vmax  1000 µM h−1, Krem  0.1 µM), the dose-response curve becomes
steeper and exhibits an abrupt drop. Inset shows the increase in antibiotic concentration required to
halve the growth rate relative to the no-CERG case as a function of Vmax.
4.3.3 Effect of constitutively expressed resistance genes
Our results show that the steepness of the dose-response curve and the coupling
between growth laws and antibiotic response play a key role in determining drug
interactions. Recent work showed that dose-response curve steepness can change
if genes that convey antibiotic resistance are present [Deris et al., 2013]. Thus, we
investigated how the presence of such resistance genes affects the resulting drug
interaction.
Bacterial resistance genes often code for dedicated enzymes that degrade the
antibiotic or pump it out of the cell. Resistance genes can be constitutively expressed,
i.e., they lack specific regulation and their expression depends only on the state of
the gene expression machinery. The expression of such constitutively expressed
resistance genes (CERGs) under translation inhibition is quantitatively predicted
by a theory based on bacterial growth laws [Scott et al., 2010; Deris et al., 2013]:
Expression q decreases linearly with decreasing growth rate as q  q0λ/λ0, where
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q0 is the expression of the gene in the absence of the drug. An experimentally
verified mathematical model that is based on this dependence predicts growth
bistability (i.e., coexistence of growing and non- or slowly-growing cells) in bacterial
populations that constitutively express resistance genes [Deris et al., 2013]. In this









where Krem is a Michaelis-Menten dissociation constant and Vmax is the maximal
antibiotic removal rate, which bundles the maximal enzyme abundance and catalytic
rate per enzyme.
Due to the linear relation between growth rate and the expression of the resistance
gene, the rate of antibiotic removal decreases with decreasing growth rate under
translation inhibition. This constitutes a positive feedback loop that leads to growth
bistability (Fig. 4.17A,B), which is reflected in a steep dose-response curve of bacterial
batch cultures [Deris et al., 2013]. However, note that for very high values of Krem ≫ a,
Eq. (4.25) becomes linear and the steepness of the dose-response curve decreases,
rendering the otherwise bistable system monostable (see Appendix A.1.2).
By extending this scenario to a pair of antibiotics, we can directly test how the
presence of resistance genes affects drug interactions. In the most relevant case,
there are two CERGs each of which specifically provides resistance to one of the
antibiotics. For simplicity, we assume that there is no cross-resistance, i.e., each
enzyme specifically degrades only one of the drugs (Fig. 4.17A). We found that
the synergistic interaction between two independently binding antibiotics with
shallow dose-response curves turns slightly antagonistic due to the presence of
resistance genes (Fig. 4.18, top). For competitively binding antibiotics, this effect
becomes more pronounced (Fig. 4.18, bottom). In brief, our model predicts drastic
qualitative changes in drug interaction type when resistance genes are present.
To test this prediction, we constructed a bacterial strain (see Appendix B) that
carries two constitutively expressed resistance genes. We chose TetA [a tetracy-
cline (TET) efflux pump] and CAT [an enzyme that degrades chloramphenicol





















Figure 4.18: Effects of CERGs on the type of drug interaction. Dose-response surface for indepen-
dently (top) and competitively (bottom) binding antibiotics with α  1; resistance activity Vmax
(assumed to be identical for both antibiotics) increases from left to right: 0, 100, and 950 µM h−1.
Concentration axes were rescaled with respect to the increased IC50. Note the qualitative change in
dose-response surface shape.
laws (Fig. 4.19A; [Deris et al., 2013]). Furthermore, the interaction between CHL and
TET is additive. Our model predicts this interaction to change into antagonism when
CERGs are present. Consistent with previous results [Deris et al., 2013], the steepness
of the dose-response curve increased upon inclusion of each CERG (Fig. 4.19B). We
measured the dose-response surface of the sensitive and the double-resistant strain:
Notably, the resistant strain showed a clear antagonistic drug interaction, while
this interaction was additive in the strain without CERGs (Fig. 4.19C). This change
to antagonism qualitatively agrees with the theoretical prediction (Fig. 4.18). This
example shows how resistance genes can drastically alter drug interactions – a phe-
nomenon caused by a non-trivial interplay of gene-expression and cell physiology
predicted by our biophysical model.
In future work, this framework could be expanded to include resistance mecha-
nisms other than the efflux and degradation of the drug. Other resistance mech-
anisms include the target modification, overproduction of the target mimic, and































Figure 4.19: Constitutively expressed resistance genes alter a drug interaction as predicted by
theory. (A) Schematic showing two common resistance mechanisms: Resistance can result from
degradation of the drug [left: chloramphenicol acetyltransferase (CAT) degrades chloramphenicol
(CHL)] or from drug efflux [right: an antibiotic efflux pump (TetA) removes tetracycline (TET) from
the cell]. (B) Change in dose-response curve shape due to a constitutively expressed resistance gene.
CHL dose-response curves of sensitive (white circles) and resistant strain (gray circles). (C) Measured
CHL-TET dose-response surfaces for (i) sensitive and (ii) resistant strain. Concentrations were
normalized to the IC50 of respective strains. The strain with CERGs is 50.5 and 91.5 times more
resistant to TET and CHL, respectively, as measured by increase in IC50. Drug interaction changes
from additive to antagonistic as suggested by theory (Fig. 4.18).
eling and experimental opportunities. On the modeling side, these additional
mechanisms require the introduction of new sub-populations of ribosomes (modi-
fied or factor-associated) or target mimics. Experimentally, handling these highly
resistant strains is challenging as minimal inhibitory concentrations approach the
solubility limits of a particular antibiotic, which requires fine-tuning of the expres-
sion system. While these extensions are of high basic and clinical importance, they
are outside of the scope of this study. Here we included only the best-characterized
examples that required minimal genetic intervention into the system.
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4.4 Interim discussion
We constructed a minimal biophysical model of antibiotic interactions that takes
into account the laws of bacterial cell physiology. Most parameters in our model are
constrained by established results or by the dose-response curves of the individual
antibiotics that are combined (Fig. 4.5). Our approach offers a scalable theoretical
framework for predicting drug interactions: The number of parameters required
for the independent binding model scales linearly with the number of antibiotics.
This framework is readily generalized to combinations of more than two antibiotics.
Ribosomal growth laws [Scott et al., 2010] were essential for building this predictive
framework, highlighting the importance of quantitative phenomenological descrip-
tions of physiological responses to drugs and other perturbations (Fig. 4.2). The
discovery of similar quantitative relations between physiological parameters and
growth rate for other classes of antibiotics and other types of cells would greatly
facilitate more general predictions of drug interactions.
Our work highlights the advantages of a physiologically relevant “null model,”
which captures all effects that are generally relevant for ribosome-binding antibiotics
without trying to describe any molecular details of specific antibiotics (Fig. 4.5).
While general multiplicative (Bliss) or additive (Loewe) expectations are simple to
construct, our work demonstrates that their utility as a reference has clear limitations.
Specifically, our model shows that both are expected to be valid only in certain
limits (Figs. 4.6 and 4.8). Moreover, these standard null models do not capture known
effects of antibiotic binding and growth physiology, which suffice to produce strong
deviations from the standard null models. Our biophysical model captures these
effects and thus offers an improved expectation for drug interactions. Generalizing
this model to three drugs demonstrated that mechanism-independent predictions of
higher-order interactions [Wood et al., 2012] are consistent with simplified first-order
kinetics. In summary,our model serves as a bridge between mechanism-independent
general predictions of drug interactions and elusive quantitative descriptions of
detailed molecular mechanisms that capture the idiosyncrasies of each drug.
We showed that direct physical (or allosteric) interactions of antibiotics on their
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target do not necessarily lead to synergy (Figs. 4.8 and A.3). Synergy only occurs if
the dose-response curves of the individual drugs are sufficiently shallow. While this
insight is not easily applied in the design of drug combinations, the identification
of cooperatively binding drug pairs still has considerable potential. Our results
highlight that altering the steepness of individual drug dose-response curves may
offer under-appreciated opportunities for drug design.
The predictions of our model are directly testable in experiments (Figs 4.19, 4.14,
and 4.7). Perhaps the most striking experimental validation of our model is the
change in drug interaction type due to the presence of antibiotic resistance genes
(Fig. 4.18, Fig. 4.19C). This observation is notable since previous work concluded
that most mutations and mechanisms that provide resistance to individual drugs
only rescale the effective antibiotic concentrations while preserving the shape of
the dose-response curves and surfaces [Chevereau et al., 2015; Wood et al., 2014;
Chevereau and Bollenbach, 2015; Chait et al., 2007]. In contrast, our results show
that specific resistance genes for two antibiotics targeting the ribosome inevitably
alter the drug interaction, even in the absence of more complicated mechanisms.
Discrepancies between experimental results and model predictions can expose
cases in which more complicated mechanisms cause the observed drug interaction.
A limitation of our model is that it considers fully assembled translating ribosomes
as sole targets of the antibiotics, without taking the exact stage of the translation cycle
into account. In principle,a model that describes ribosome assembly and more details
of the translation cycle and the transitions between its different steps could provide
a more detailed mechanistic picture. However, since we currently do not know the
in vivo parameter values that characterize the translation cycle, such a model would
not be predictive, but would rather rely on extensive fitting of free parameters to
limited experimental data. Instead, the underlying mechanisms of drug interactions
that cannot be captured by the minimal biophysical model presented here, and in
particular suppression, can be elucidated by targeted phenomenological approaches,
which we focus on next.
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5 Inducible genetic bottlenecks in
translation
Certain drug interactions clearly deviated from the model predictions. An example
is the suppressive/antagonistic interaction between STR and KSG, which was
predicted to be additive (Fig. 4.7). Such clear deviations could originate from direct
molecular interactions of the drugs on the ribosome, and thus be specific for every
drug pair. Alternatively, these drug interactions could result from the multi-step
structure of the translation cycle itself, which our model does not take into account.
Simple partitioning of ribosomes into different populations that are susceptible to
different antibiotics does not alter the drug interaction (Appendix A.5.1). In the most
complex cases, drug interactions could result from drug effects that are unrelated to
the primary drug target [Chevereau and Bollenbach, 2015], in particular from effects
on drug uptake or efflux [Lazar et al., 2013]. We focused on the plausible hypothesis
that drug interactions are caused by the interplay of ribosomes halted in different
stages of translation cycle such as initiation, translocation, recycling, etc. (Fig. 3.1).
To test this hypothesis, we developed a technique for measuring how halting
ribosomes in different stages of the translation cycle affects the efficacy of various
antibiotics. Specifically, we imposed artificial bottlenecks in translation by genetically
limiting the expression of translation factors that catalyze well-defined translation
steps [Cole et al., 1987]. We constructed E. coli strains with translation factor genes
under inducible control of a synthetic promoter [Lutz and Bujard, 1997]. These
genes were integrated into the chromosome outside of their endogenous loci
and the endogenous copy of the gene was disrupted (Fig. 5.1A; Methods). This
procedure yielded six strains that enable continuous control of key translation
processes (Fig. 5.1B): stabilization of the 50S subunit (der), initiation (infB), delivery































Figure 5.1: Artificial translation bottlenecks. (A) Schematic of synthetic regulation introduced to
control the expression of a translation factor x, which creates an artificial bottleneck in translation at
a well-defined stage; lacI codes for the Lac repressor, which represses the PLlacO-1-promoter (Meth-
ods, [Lutz and Bujard, 1997]). (B) Constructs were made for six translation factors mediating 50S
stability (der), initiation (infB), recycling (frr), translocation (fusA), tRNA delivery (tufAB) and GDP
release (tsf), respectively. Higher expression alleviates the artificial bottleneck. Thicker lines or arrows
indicate higher rates.
(fusA) and recycling of ribosomes (frr) [Rodnina, 2018].
Reducing translation factor expression by varying the inducer concentration
resulted in a gradual decrease in growth which stopped at almost complete cessation
of growth, reflecting the essentiality of translation factors (Fig. 5.2; Appendix B and
Fig. E.5). Since the endogenous regulation of translation factors generally follows
that of the translation machinery [Maaløe, 1979; Gordon, 1970; Blumenthal et al., 1976;
Furano and Wittel, 1975], limiting the expression of a single translation factor imposes
a highly specific bottleneck as all other components get upregulated. Any global feed-
back regulation is left intact as we removed the factor from its native operon. Similar
genetic perturbations further conform to bacterial growth laws [Scott et al., 2010;
Cole et al., 1987; Olsson et al., 1996], supporting that translation factor deprivation
is a suitable means of assessing responses to targeted perturbations of translation.
While antibiotics often have secondary targets and other non-specific effects on the
cell, thus obfuscating experiments, translation factor deprivation is highly specific.
Our synthetic strains offer precise control over artificial translation bottlenecks
that determine the rates of different translation steps and enable disentangling
phenomena that are caused by the primary mode of action of antibiotics from those




















Figure 5.2: Artificial translation bottlenecks strongly affect antibiotic efficacy. Translation factor
induction curves (upper row) and response surfaces over the inducer-antibiotic grid for different
antibiotics (KSG and FUS, middle and bottom row, respectively) in combination with different
bottlenecks (50S stability, initiation, and translocation). Full induction of the translation factor rescues
wild type growth; increasing bottleneck severity leads to a smooth decrease in growth rate to zero.
Induction curves were measured in n  8 technical replicates, and median value of non-zero growth
rates was calculated. Comparison of the response surfaces with independent expectation (dashed
purple line) identify alleviation (orange line) or aggravation (blue line).
We used these synthetic strains to assess the impact of bottlenecks on antibiotic
efficacy. We measured growth rates over a two-dimensional matrix of concentrations
of inducer and antibiotic for each of the six strains (Fig. 5.2; Appendix B). To assess if
the action of the antibiotic is independent of the translation bottleneck, we analyzed
these experiments using a multiplicative null expectation. Note that additivity, as
used forantibiotics (Fig. 3.3), is not a suitable null expectation here since the responses
to increasing concentrations of antibiotic and inducer are opposite. However, if
antibiotic action is independent of the translation bottleneck, the growth rate should
be a product of the relative growth rates of each of the two perturbations acting
individually. Independence implies that the dose-response surface is obtained as a
multiplication of the antibiotic dose-response and the translation factor induction








Figure 5.3: Bottleneck-dependency scores. Columns show bottleneck dependency vectors in color
code; dependency vectors quantify the response of a given antibiotic to the translation bottlenecks
(see C.3.2 and Fig. C.2).
bottleneck and the antibiotic action.
We systematically identified interactions between translation inhibitors and
bottlenecks by their deviation from independence. In general, antibiotic action can
be alleviated or aggravated by a given bottleneck, i.e., the bacteria can be less or
more sensitive to the antibiotic due to the bottleneck, respectively. We quantified
the magnitude of these effects by bottleneck dependency (BD) scores (Appendix C)
and collected them into a single bottleneck dependency vector per antibiotic. The
components of this vector describe the interactions between the antibiotic and all
six translation bottlenecks. Bottleneck dependency vectors were diverse (Fig. 5.3),
indicating that bottlenecks at different stages of the translation cycle differentially
affect antibiotic efficacy. These results are consistent with the hypothesis that the
high diversity of drug interactions between translation inhibitors (Fig. 3.4) originates
in the diversity of translation steps targeted by the drugs (Fig. 3.1).
5.1 Antibiotic fingerprinting
The bottleneck dependency vector of a given antibiotic provides a quantitative,
functional summary of its interactions with the translation cycle. In this sense, it
is a characteristic “fingerprint” of the antibiotic. Clustering of antibiotics based on
their bottleneck dependency vectors (Fig. 5.4) robustly grouped antibiotics with
a similar mode of action (CRY and FUS, LCY and CHL in Fig. 5.4, respectively).
Notably, this approach separated the translocation inhibitors CRY and FUS from
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Figure 5.4: PCA projections of BD vectors. Clustering of the bottleneck dependency vectors
upon dimensionality-reduction by Principal Component Analysis (PCA; see C.3.3). Circles show
dependency vectors projected onto the two principal components (PC1,2 and PC2,3 on the left and
right, respectively); colors indicate cluster identity. The extended cluster areas shown are convex
hulls of bootstrapped projections (denoted by dots). Projections of the three additional antibiotics
LAM, NIT, and TMP are denoted by a purple triangle, blue square, and green pentagon, respectively.
We estimated the p-value≈ 3 × 10−4 by clustering n  104 reshuffled datasets with added noise and
counting the fraction of instances that matched the shown clustering result. See Appendix C and
Eq. (C.4); we did not use a standard statistical test.
STR, which only weakly affects translocation [Peske et al., 2004]. Drug interactions
between antibiotics from the same cluster were strictly additive (Figs. 3.4 and 5.4).
These results show that interactions of antibiotics with translation bottlenecks have
explanatory power for drug mode of action and can expose antibiotics acting as
substitutes for one another.
While the clustering of certain antibiotics can be rationalized from their presumed
modes of action, this is more challenging for others. To further assess the value of
this analysis, we measured bottleneck dependencies for three additional antibiotics:
lamotrigine (LAM), trimethoprim (TMP), and nitrofurantoin (NIT). As we elaborate
below, using drugs with a defined mode of action (LAM and TMP) corroborates the
utility of clustering by bottleneck dependencies, while the similarity of STR to NIT,
which has multiple modes of action, suggests a plausible reason for the separation
of STR from other clusters of translation inhibitors.
To challenge the predictive power of translation bottlenecks, we tested whether
the mode of action of a partially characterized antibiotic can be inferred from its
bottleneck dependency vector. We focused on lamotrigine (LAM), an anticonvulsant
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drug which was recently identified to inhibit maturation and in turn reduce the
number of translating ribosomes, potentially by interfering with initiation factor 2
(IF2, encoded by infB) [Stokes et al., 2014]. The bottleneck dependency vector of LAM
was most similar to that of KSG (Fig. 5.4). As for LAM, a reduction of translating
ribosomes is a signature of the initiation inhibitor KSG [Kaberdina et al., 2009]. Hence,
this observation further corroborates that similar bottleneck dependency vectors
for translation inhibitors indicate similar mode of action. Bottleneck dependency
vectors indicated an unexpected similarity in effective mode of action between ERM
and KSG (Fig. 5.4), an initiation inhibitor. These data suggest that ERM, which
cannot block the synthesis of some proteins above a certain length [Kannan et al.,
2012], may effectively act as an initiation inhibitor. These results show that bottleneck
dependency vectors often confirm established similarities but can also provide
complementary insights into effective drug mode of action.
We further tested how an antibiotic with a mode of action unrelated to translation
interacts with translation bottlenecks. If drug interactions are primarily determined
by their mode of action [Yeh et al., 2006; Brochado et al., 2018], antibiotics interfering
with processes unrelated to translation should be affected similarly by all different
translation bottlenecks as the net effects of translation bottlenecks are indistinguish-
able – all lead to cessation of protein synthesis. To test this idea, we chose the
antibiotic trimethoprim (TMP), which inhibits folate synthesis by binding to dihy-
drofolate reductase and is not known to directly perturb translation [Walsh, 2003]. Its
bottleneck dependency vector indicates that all bottlenecks alleviated TMP’s action
to various degrees (Fig. 5.3) – a characteristic that is incompatible with any of the
clusters of translation inhibitors (Fig. 5.4). Furthermore, TMP is known to primarily
interact antagonistically or suppressively with translation inhibitors [Yeh et al., 2006;
Bollenbach et al., 2009]. These results support the idea that the effects of specific
translation bottlenecks are diverse for antibiotics targeting translation, but not for
antibiotics with modes of action unrelated to translation.
Streptomycin stands out among translation inhibitors, as its action is aggravated
by all translation bottlenecks (Fig. 5.3). This might be a consequence of its multiple
modes of action: besides interfering with tRNA binding, it slightly lowers the
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translocation rate [Peske et al., 2004] and causes protein mistranslation, changes in
membrane potential, and membrane permeabilization [Davis, 1987]. These phenom-
ena can lead to unspecific downstream effects in the cell. Therefore, we probed if
such unspecific effects can explain its distinct response to translation bottlenecks by
measuring the bottleneck dependency vector of the prodrug nitrofurantoin (NIT).
Nitrofurantoin has complicated effects on the bacterial cell, including the formation
of non-native disulfide bonds in protein structures [Bandow et al., 2003], DNA dam-
age, and oxidative stress [Mitosch et al., 2017]. The similar bottleneck dependency
between STR and NIT (Fig. 5.3) is likely due to unspecific effects common to both
drugs, such as the production of dysfunctional proteins.
5.2 Drug interactions can be predicted from antibiotic
responses to translation bottlenecks
We reasoned that the effects of translation bottlenecks on antibiotic action should
also have predictive power for drug interactions between translation inhibitors.
We therefore sought a quantitative way of probing the contribution of translation
bottlenecks to drug interactions between translation inhibitors.
Ribosomes progress throughthe translation cycle in a sequence of steps (Fig. 5.5A).
Antibiotics and genetic translation bottlenecks hinder this progression by reduc-
ing the transition rates between these steps. If an antibiotic specifically targets a
single translation step and reduces the same transition rate as a genetic translation
bottleneck, the effects of the drug and the bottleneck should be equivalent, i.e., the
consequences of any perturbation elsewhere in the translation cycle should be
independent of the exact means by which such a reduction is achieved (Fig. 5.5B).
5.2.1 Additive interactions and remapping
To establish the equivalence of specific translation bottlenecks and antibiotic action,
we first transformed the measurements of growth rate as a function of translation

























Figure 5.5: Translation factor deprivation mimics the action of equivalent antibi-
otics. (A) Schematic of translation as a sequence of steps (white), catalyzed by translation factors
(gray). In the absence of perturbations, ribosomes progress through the steps unimpeded, resulting
in unperturbed growth. (B) Schematic of perturbed translation. Top: as the abundance of factor F1 is
lowered (smaller factor symbol), the rate of step 1 decreases (thinner arrows) and ribosomes queue
in front of the bottleneck. Bottom: the same rate is reduced by an antibiotic. The effects of factor
deprivation and antibiotic action on growth are equivalent.
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that targets a single translation step with perfect specificity. In essence, this procedure
converts inducer concentrations into equivalent antibiotic concentrations: the two
concentrations are identified as equivalent if they lead to the same relative growth
rate (Fig. 5.6A,B; Appendix C). If the perturbations of factor and antibiotic are
equivalent, then the true and the idealized antibiotic should act as substitutes for
each other, and exhibit an additive drug interaction. Conversely, we can use this
comparison (Fig. 5.6C and Fig. E.6) to test systematically if the action of antibiotics















Figure 5.6: Translation factor deprivation mimics the action of equivalent antibi-
otics. (A) Schematic of conversion of inducer concentration b (here for the translocation factor)
into the mimicked antibiotic concentration c (here: CRY). For each inducer concentration b, the
growth rate from the induction curve g(b) is determined and the same growth rate on the antibiotic
dose-response curve y(c) is identified (gray dashed line); the inverse function of the dose-response




. (B) The resulting conversion
of inducer concentration b into antibiotic concentration c for three different pairs of equivalent
perturbations: CRY-translocation (gray), KSG-initiation (yellow), and TET-tRNA delivery (orange).
(C) Inducer-antibiotic response surface (left) and mimicked antibiotic-antibiotic response surface
(right) upon conversion of inducer concentration as in C and D. Purple dashed line shows isobole
for multiplicative responses at relative growth rate 0.2. The remapped response surface is additive,
corroborating the equivalence of CRY and translocation factor deprivation.
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We found that the effect of certain translation inhibitors is almost perfectly
mimicked by translation bottlenecks. Within our selection of antibiotics, several
strong candidates for equivalent perturbations exist (Fig. 3.1): CRY, FUS, and
potentially STR with EF-G (translocation); KSG with IF2 (initiation); and TET with
EF-Tu (tRNA-delivery). For example, remapping the response to CRY and EF-G
yields an additive surface (Figs. 5.6C, 5.7A), corroborating that CRY and the EF-G
translocation bottleneck are equivalent perturbations. In contrast, if the bottleneck is
A B C D
Figure 5.7: Comparison of response surfaces remapped to the additive expectations. The bottle-
necks and antibiotics are shown on the bottom right, respectively. Errors in LI and in expected and
remapped responses were evaluated by bootstrapping (see Sec. C.4.1 and Fig. E.6). (A) Additive
expectation from Fig. 5.6C and remapped response surface agree (ρ  0.99). (B) As A, but for a
recycling bottleneck. The large and statistically significant discrepancy in LI from 0 indicates that
CRY and a recycling bottleneck are not equivalent. (C) As A, but for KSG and an initiation bottleneck
(ρ  0.98). (D) As A, but for TET and a tRNA delivery bottleneck (ρ  0.99).
not equivalent to the drug, remapping does not yield an additive response surface;
an example is CRY and the recycling bottleneck (Fig. 5.7B). Occasionally, marginal
effects dominate the apparent equivalence: STR lowers translocation rate only two-
fold [Peske et al., 2004], but inhibiting translocation by deprivation of EF-G is still
the best mimic of STR. In general, demonstrating that the action of an antibiotic is
equivalent to a specific translation bottleneck provides strong quantitative evidence
for its primary mode of action, since translation factors control individual steps
with high specificity.
In contrast, the common approach of overexpressing the drug target does not
provide useful insights into the mode of action of ribosome-targeting antibiotics.
Simple overexpression requires a well-defined drug target like a single protein;
overexpressing the ribosome is impractical [Jinks-Robertson et al., 1983] and would
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not help distinguish the precise action of different ribosome-targeting antibiotics.
Even for less complex drug targets, the interpretation of overexpression assays is
challenging [Palmer and Kishony, 2014]. Still, we tested if simple overexpression of
translation factors can provide similar insights into the mode of action of TET as
translation bottlenecks. Overexpression of translation factors only weakly affected
antibiotic efficacy (Fig. B.4). The effects of overexpressing different translation factors
were not specific for antibiotic mode of action (Fig. B.4). Hence, unlike the depletion
of translation factors, their overexpression provides no information about drug
interactions with other antibiotics.
5.2.2 Prediction of drug interactions
For antibiotics that are equivalent to specific translation factors (Fig. 5.7), drug inter-
actions with other antibiotics can be directly predicted from translation bottleneck
measurements. In practice, this is done by remapping the antibiotic-translation


















Figure 5.8: Information drug-interaction is contained in bottleneck-antibiotic interaction. (A) The
drug interaction between CHL and an antibiotic that targets initiation can be predicted through
mimicking the initiation inhibition by limiting the expression of initiation factor (infB). (B) The
response surface of CHL combined with the inducer for the initiation (infB) bottleneck shows mild
alleviation. This response surface contains information about the interaction between CHL and
any antibiotic that interferes with initiation. The inducer axis is remapped into mimicked antibiotic
concentration (Fig. 5.6).
the biophysical model (Chapter 4), the predictions made in this way are not based
on a mathematical model, but rather on empirical effects of genetic perturbations,





























Figure 5.9: Example of drug-interaction prediction based on the equivalent translation bottle-
necks. (A) Left: resultant prediction of the response surface for the initiation-inhibiting antibiotic KSG
and CHL. Right: measured KSG-CHL response surface for direct comparison; strong antagonism
is observed as predicted.(B) A point-by-point comparison of predicted and measured response
surfaces (Pearson’s ρ  0.98).(C) Schematic showing antibiotics and their equivalent translation
factor bottlenecks. Drug interactions with these antibiotics can be predicted for any antibiotic with a
known response to the equivalent bottleneck. Color-code shows cluster identity from Fig. 5.1.
are independent of the assumptions underlying the biophysical model. While the
biophysical model is only valid for antibiotics that conform to bacterial growth
laws, the predictions based on the observed effects of translation bottlenecks are
independent of whether or not the growth laws hold for the specific perturbations
of translation used. The resulting prediction will be faithful if the drug interaction
originates exclusively from the interplay of two translation bottlenecks.
Drug interactions predicted using this procedure were often highly accurate
(Fig. 5.10). In particular, some of the most striking cases of antagonistic and suppres-
sive interactions were correctly predicted. For example, the prediction of antagonism
between CHL and KSG was quantitatively correct (Fig. 5.9). The same interactions
were correctly predicted for LCY (Fig. 5.10), which is similar to CHL (Figs. 3.1 and
5.4). Remapping qualitatively accounted for nearly all observed interactions of KSG
with quantitative agreement in several cases (Fig. E.7), including the previously
unexplained KSG-STR interaction (Fig. 5.10). Further, suppression of FUS by CHL
was correctly predicted: FUS loses potency when CHL is added (Fig. 5.10). In this
way, several drug interactions with previously elusive mechanisms are explained
by the interplay of the specific steps in the translation cycle that are targeted by the
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Figure 5.10: Comparison of predicted and measured response surfaces for different antibiotics in
combination with antibiotics that have a factor analog. Top row: scatter plots as in (D); bottom row:
predicted and measured response surfaces, respectively. Remapping correctly predicts antagonism
(KSG-LCY), suppression (FUS-CHL), strong antagonism (KSG-STR), and additivity (TET-CHL).
antibiotics involved.
Remapping correctly predicted additive drug interactions between antibiotics
that could not be easily explained by the biophysical model. As noted above,
additivity between CHL-TET was predicted for the competitive binding scheme;
yet, competitive binding is difficult to rationalize as TET and CHL bind to different
subunits. Similarly, the additive pair KSG-ERM is even more puzzling since, unlike
ERM, KSG does not act within the elongation cycle (Fig. 3.1).
Our remapping approach further explained nontrivial additive interactions. In
particular, the additive interaction between CHL and TET is hard to rationalize:
these antibiotics have completely different binding sites on the ribosome. However,
CHL and TET interacted similarly with translation bottlenecks (Fig. 5.4) and their
interaction was faithfully captured by the remapping approach (Fig. 5.10). This
observation suggests that the action of CHL is largely equivalent to inhibiting tRNA
delivery. As CHL binding interferes with an aminoacyl moiety of tRNA on the
A-site [Wilson, 2014; Dunkle et al., 2010], this suggests that perturbation of tRNA
dynamics might be at the heart of the drug interaction between TET and CHL.
At a more detailed level, CHL was shown to cause context-specific translation
arrest by interfering with tRNA delivery only at specific codons [Marks et al., 2016;
Choi, 2019]. Our approach cannot capture such more detailed molecular aspects of
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antibiotic mode of action; instead, it indicates that the global effect of CHL is largely
equivalent to hindered delivery of all tRNAs. The recently suggested effect of TET
on initiation [Nakahigashi et al., 2016] is not reflected in our analysis, indicating at
least that the effect of TET is not equivalent to initiation inhibition (Fig. E.6).
KSG and ERM constitute anotherantibiotic pair that interacted additively and was
clustered together (Fig. 5.4). Remapping correctly predicted additivity between KSG-
ERM (Fig. E.6); however,unlike KSG,ERM does not directly inhibit initiation (Table 1).
Yet, ERM’s inability to inhibit translation when the nascent peptide chain of some
proteins [Kannan et al., 2012] is extended beyond a certain length may effectively
lead to a global functional equivalence with KSG, suggesting a possible cause of
co-clustering and additivity between ERM and KSG (Fig. 5.4). While plausible,
these possibilities require further experimental investigation, especially since ERM
selectively blocks the egress of peptide chains and reshapes the proteome [Kannan
et al., 2012; Vazquez-Laslop and Mankin, 2018].
For some antibiotic pairs, the predictions based on equivalent translation bot-
tlenecks failed to explain the observed drug interactions (e.g., for LCY-CRY and
CHL-CRY; Fig. E.7), indicating that these interactions have origins outside of the
translation cycle. We expect that these cases are often due to idiosyncrasies and
secondary effects of the drugs, which will require separate in-depth characterization
in each case. In contrast, our results show that various non-trivial drug interactions
between antibiotics are systematically explained by the interplay of specific transla-
tion bottlenecks caused by the antibiotics. While the growth-law based biophysical
model already explained ≈57% (16 of 28) of the observed interactions (Fig. E.4),
these included many weak or additive interactions; the most striking suppressive
interactions were only captured after taking into account the multi-step nature of
translation (Fig. E.7), thereby increasing the explained fraction to ≈71% (20 of 28).
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6 Simultaneous titration of translation
factors and continuous epistasis
If suppressive drug interactions are caused by the interplay of different translation
bottlenecks alone, it should be possible to recapitulate these interactions in a purely
genetic way. We thus expanded our translation bottleneck approach by introducing
multiple genetic bottlenecks in the same cell. We focused on the interactions between
initiation inhibitors (such as KSG) and translocation inhibitors (such as CRY and
FUS), which were exclusively antagonistic or suppressive (Fig. 3.4). Moreover, the
initiation inhibitor KSG alleviated a genetic translocation bottleneck and an initiation
bottleneck suppressed the effect of the translocation inhibitor FUS (Fig. 5.2). These
observations suggest that a universal mechanism underlies the suppression between
initiation and translocation inhibitors.
We constructed a synthetic strain that enables simultaneous independent con-
trol of initiation and translocation factor levels. We integrated the initiation and
translocation factors outside their native loci under the tight control of promot-
ers inducible by isopropyl β-D-1-thiogalactopyranoside (IPTG) and anhydrote-
tracycline (aTc), respectively, in a strain in which their endogenous copies were
deleted (Fig. E.8 and Appendix B). To maximize the precision of induction that is
achievable with different inducer concentrations, we put both factors under negative
autoregulatory control by chromosomally integrated repressors [Scott et al., 2010;
Klumpp et al., 2009]. The resulting strain showed virtually no growth when at least
one of the inducers was absent but unrestricted wild type growth in the presence of
both inducers (Fig. 6.1A). These observations confirm that both translation factors
are essential and show that their expression can be varied over the entire physiolog-








































Figure 6.1: Suppression between inhibition of translocation and initiation. (A) Results of all-or-
nothing growth assay: bacteria grow only when both essential factors are induced. (B) Measured
growth rate response surface for the dual inducible promoter strain as a function of both inducer
concentrations; the red line shows the ridge of maximum growth. (C) Cross-section of the response
surface along the dashed purple line (gray circles) and at maximal aTc induction (white circles);
solid lines are smoothed profiles. Black arrow denotes a decrease in translocation; if initiation is
lowered simultaneously with translocation (orange arrow), growth reduction is smaller.
Curtailing translation initiation suppresses the effect of a genetic translocation
bottleneck. We determined the bacterial response to varying translocation and initi-
ation factor levels by measuring growth rates over finely resolved two-dimensional
concentration gradients of both inducers. The resulting response surface clearly
showed that inhibition of initiation alleviates the effect of translocation inhibition
(Fig. 6.1 and E.8). This phenomenon exactly mirrors the antibiotic-antibiotic (KSG-
FUS, Fig. 3.4) and bottleneck-antibiotic interactions (initiation-FUS, Fig. 5.2). An
all-or-nothing approach (Fig. 6.1A), analogous to common genetic epistasis mea-
surements [Constanzo et al., 2010], would miss this suppressive effect, highlighting
the importance of using quantitatively controlled perturbations. Taken together,
these data show that the interplay of translation initiation and translocation alone
is sufficient to produce strong suppression: dialing down initiation cranks up
growth stalled by translocation bottlenecks. The widespread suppression between
antibiotics targeting initiation and translocation is thus explained as a general
consequence of the combined inhibition of specific translation steps alone.
What is the underlying mechanism of the suppressive interaction between
initiation and translocation inhibitors? We hypothesized that this suppression results
















Figure 6.2: Schematic of ribosomes progressing along a transcript – a stuck ribosome can cause a
traffic jam. Ribosomes undergo factor-mediated initiation events with attempt rate ζ and translocation
with attempt rate γ.
low translocation rates (Fig. 6.2). The traffic of translating ribosomes that move along
mRNAs can be dense [Mitarai et al., 2008]. When a ribosome gets stuck, e.g., due
to a low translocation rate, it blocks the translocation of subsequent ribosomes.
The resulting situation is similar to a traffic jam of cars on a road. Traffic jams can
form due to the asynchronous movement and stochastic progression of particles
in discrete jumps, which is a good approximation for the molecular dynamics of a
translating ribosome. If particle progression were deterministic and synchronous,
no traffic jams would form. A classic model of queued traffic progression, which
can be applied to translation [MacDonald et al., 1968; MacDonald and Gibbs, 1969],
is the Totally Asymmetric Simple Exclusion Process (TASEP) [Shaw et al., 2003b;
Zia et al., 2011].
6.1 TASEP model of translation within growth law
framework
We developed a generalization of the TASEP that describes the traffic of translating
ribosomes on mRNAs and takes into account the laws of bacterial cell physiology.
There are several differences between the classic TASEP and translating ribosomes
moving along a transcript. First, a ribosome does not merely occupy a single
site (codon), but rather extends over 25 nucleotides (≈ 8.33 codons) [Mohammad
et al., 2019; Woolstenhulme et al., 2015]. Second, the total number of ribosomes in
the cell is finite and varies as dictated by bacterial growth laws [Scott et al., 2010;















Figure 6.3: Schematic of the theoretical model of translation. Translation is described as an
ensemble of transcripts competing for the limited and growth-rate-dependent pool of ribosomes.
Ribosomes advance on transcripts as described by a generalized totally asymmetric simple exclusion
process (TASEP) for particles of size L (see Fig. 6.2 and text). When γ < ζ(1 + L1/2), ribosomes
saturate and traffic jams develop, resulting in a drop in elongation and growth (black arrow, the
transition happens at the black triangle) [Klumpp and Hwa, 2008; Lakatos and Chou, 2003]. When
ζ < γ/(1 + L1/2), a phase transition occurs (green triangle): traffic jams dissolve – elongation and
growth increase (along the green arrow).
to the ribosome in a specific state and push the ribosome into another state [Rodnina,
2018]. These transitions are stochastic with rates that depend on the abundance of
ribosomes in a specific state and on the abundance of translation factors available to
catalyze the step. Thus, the initiation- and translocation-attempt rates, which are
constant in the classic TASEP, depend on the state of the system. We formulated a
generalized TASEP that captures these extensions, estimated all of its parameters
based on literature, and derived the model equations analytically. The resulting
growth rate was calculated numerically. In brief, our generalized TASEP model
provides a physiologically realistic description of the factor-mediated traffic of
ribosomes on multiple transcripts.
There are several specific differences between the classical open TASEP system
and translation in the context of the bacterial cell (Fig. 6.3). Firstly, the pool of
ribosomes is finite and variable in size (as dictated by the growth laws). Secondly,
the ribosomes span over more than one site – it occupies 25 nucleotides, i.e., L ≈
8.33 codons [Mohammad et al., 2019; Woolstenhulme et al., 2015]. Thirdly, steps
in translation are mediated by translation factors that bind to the ribosome in a
specific state and (stochastically) push the ribosome into another state. The rates
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depend on the abundance of ribosomes in a specific state and the abundance of
the factor catalyzing the step. Thus, the rates, which are kept fixed in the classical
TASEP, become variable and system-state dependent.
6.2 Analytical results for TASEP of extended particles
In the absence of ribosome pausing, established analytical results for the TASEP of
extended particles can be used [Klumpp and Hwa, 2008; Lakatos and Chou, 2003;
Shaw et al., 2003b; Zia et al., 2011]. If the release of ribosomes at the end of the
transcript is not limiting, two different regimes of ribosome traffic exist, namely
the initiation- and translocation-limited regime. These regimes are separated by a
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where ζ and γ are initiation and translocation attempt-rates, respectively (Fig. 6.3).
The ribosome coverage density ρ reads:
ρinit(ζ, γ) 
Lζ[︁
γ + ζ (L − 1)





The elongation velocity (rate) u depends both on the current and the ribosome
density ρr  ρ/L via u  Js/ρr , where s is the step size (1 aa or 1 codon). This in
turn yields






6.2.1 Distribution of ribosomes across different classes
The total ribosome concentration rtot is
rtot  ri + rtr + rmin, (6.4)
where ri and rtr are the concentrations of non-initiated and translating ribosomes, re-
spectively. Translating ribosomes are distributed across numerous mRNA transcripts
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D̄  ΞρrD̄ , (6.5)
where Dp and ρr,p are the length and ribosome density of the p−th transcript,
respectively, M is the total number of transcripts and V the cell volume (Ξ  M/V
is the concentration of transcripts). The density of ribosomes ρr  ρ/L is a TASEP-
derived quantity and depends on the initiation attempt rate ζ and translocation
attempt rate γ. In the last step, we assumed for simplicity that the density of
ribosomes across the transcripts does not vary significantly between transcripts.
However, if transcripts do differ in their ribosomes densities, the ones with higher
densities will enter the translocation limiting regime (in which traffic jams form)
already at a smaller decrease in translocation attempt rate. If those transcripts
code for essential genes, this will correspondingly lead to a decrease in growth
rate already at such smaller decreases in translocation attempt rate. Such traffic
jams would still be relieved by lowering initiation rate even though traffic jams
have not developed on all other transcripts. Thus, the qualitative conclusions of the
analysis below would still hold, but the results would be quantitatively different.
However, taking differences between transcripts into account would require explicit
modeling of individual transcripts and is beyond the scope of this work. Assuming
similar ribosomes densities allows replacement of the sum with MD̄, where D̄ is
the average length of transcripts being translated; the proteome-weighted average
length is D̄ ≈ 209 [Milo and Phillips, 2016].
The growth rate is proportional to the elongation velocity of ribosomes along
the transcript u(ζ, γ) and to the number of translating ribosomes. However, there is
a limit for the maximal elongation rate umax because other processes (e.g., charged
tRNA delivery) become limiting at some point in a given nutrient environment.
We estimated the maximal elongation rate from the Michaelis-Menten-like relation
between RNA/protein (R/P) and translation rate obtained in Ref. [Dai et al., 2016]:
u  kel(R/P)/[(R/P) + Kel], where kel  22 aa/s and Kel  0.11. We calculated
the theoretical (R/P)  (R/P)min + λ0/κR/Pt ≈ 0.54, where κ
R/P
t  4.5 h
−1 and
(R/P)min  0.09 [Scott et al., 2010]. Plugging this (R/P) into the Michaelis-Menten
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function for the translation rate, we obtain umax ≈ 18 aa/s. Thus, the growth rate is
given as







However, the growth rate feeds back into the total ribosome concentration via the
growth law as








We can estimate Ξ at λ0 as
λ0
κt




Factor-dependent translocation attempt rate The ribosome will perform a spe-
cific step only when the associated factor is bound to it: the step-attempt rate is
proportional to the probability Pb of the ribosome being bound by a factor. This
probability can be calculated by assuming a population of elongation factors with
concentration cef  cef,b + cef,n and translating ribosomes rtr  rtr,b + rtr,n, where the
indices b and n denote the factor-bound and unbound subpopulations, respectively.
Binding is described by
drtr,b
dt
 koncef,nrtr,n − koffrtr,b, (6.9a)
dcef,b
dt
 koncef,nrtr,n − koffcef,b. (6.9b)
Solving for steady state, noting that rtr,b  cef,b and defining KD  koff/kon we obtain





(rtr − KD − cef) +
√︂
4KD rtr + (rtr − KD − cef)2
2rtr
. (6.10)
The binding constant of EF-G to the ribosome complex I (pre-translocation analog
with N-Ac-dipeptidyl-tRNA at the A-site and deacylated-tRNA in the P-site) [Yu
et al., 2009] is KD  0.27 ± 0.02 µM; we used this value in our calculations.
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6.2.2 Factor-dependent initiation attempt rate
Successful initiation events are not limited to a single L-codon long slot on a mRNA
(that can be free or occupied) but can occur on any transcript; and only the factor-
bound ribosomes can attempt an initiation event. Thus, the initiation rate can be





We can estimate Km from kinetic rates determined by Milon et al [Milon et al., 2012]
where the free 30S subunit is bound (almost simultaneously) by IF3 and IF2 with
rate (2 − 10) × 102 µM−1s−1 and dissociates at rate 30 s−1. From these values, we
estimate Km ≈ 0.05 µM.
6.2.3 Estimation of model parameters
It is useful to estimate if WT translation is in the initiation or translocation limited
regime, which we can obtain from the average WT ribosome density. We can
estimate the WT ribosome density as ρr  3βr Nr/(rm tm), where Nr , βr , rm and
tm are the number of ribosomes, the fraction of active ribosomes, the rate of
mRNA synthesis per cell, and the average mRNA life-time, respectively [Bremer
and Dennis, 1996]. The fraction of translating ribosomes βr is estimated from
fitting a Hill function to data from Ref. [Dai et al., 2016] (Fig. 6.4A).The average
lifetime of mRNA is assumed to be growth rate-independent [Klumpp et al., 2009]
at tm ≈ 1.5 min [Yu et al., 2006]. For higher growth rates, the relation between
growth rate and (calculated) WT ribosome density linearizes; extrapolating to
λ0  2.0 h−1, we obtain a rounded-up value of ρr ≈ 0.07 (Fig. 6.4B), which yields
Ξ ≈ 2.2 µM. For cells grown in LB, the average number of transcripts per cell was
measured as NmRNA ≈ 7800 [Bartholomäus et al., 2016]. To estimate the mRNA
concentration,we useΞ  NmRNA/Vcell  (NmRNA/mdry)×(mdry/mwet)×(mwet/Vcell),
where mdry/mwet ≈ 1/3.1 and mwet/Vcell ≈ 1.09 g/mL are growth-rate independent
quantities (see Supplementary Information of Ref. [Greulich et al., 2015]). We
obtained the dry mass of the cell at λ  2.0 h−1 by extrapolating from measured data
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A B C
Figure 6.4: Estimation of TASEP-model parameters. (A) Active ribosome fraction as a function of
growth rate in different nutrient environments. Data is from Ref. [Dai et al., 2016]. The solid line
represents a best-fit Hill function (x/a)/[1 + (x/a)], where a ≈ 0.12 h−1. (B) Calculated ribosome
density ρr  3βrNr/(rmtm). The solid line shows best fit. (C) Dry mass measurements from
Ref. [Bremer and Dennis, 1996] and best-fit linear function (solid line). Arrow denotes the density
for λ0  2.0 h−1.
at various growth rates [Bremer and Dennis, 1996] as mdry ≈ 1.01 pg/cell (Fig. 6.4C),
which in turn yields Ξ ≈ 4.5 µM. This value is higher than our estimate, since
the latter is skewed towards higher WT ribosome densities, which require fewer
transcripts at the same number of translating ribosomes.
The estimated WT ribosome density is ρr ≈ 0.07, which is lower than the
maximal attainable ribosome density of ρr,max  ρmax/L  1/(L+
√
L)|L25/3  0.089.
Thus, translation in the WT is likely in the initiation-limited regime. Therefore, the
equations for ribosomal density and elongation velocity for the initiation limiting
regime are used to estimate the apparent initiation and translocation attempt rates:
ρr(ζ) 
ζ
γ + ζ(L − 1) ≈ 0.07 and u  (γ − ζ)s ≈ 18 aa/s. (6.12)
The apparent rates are γ ≈ 21.0 s−1 and ζ ≈ 3.0 s−1. In the case of WT regulation
there are ∼ 0.83 EF-G molecules per ribosome and the expression of the factor is
coupled to the ribosome number (i.e., their ratio is constant) [Dai et al., 2016]. This
allows us to estimate γ0  γ/Pb , where we note that cef,WT ≈ 43.0 µM (estimated
from 0.83 × 51.9 µM where the ribosome concentration is calculated from the
growth law). Next, we estimate the number of translating ribosomes from Eq. (6.6)
as 32.6 µM, which yields Pb ≈ 0.98 [Eq. (6.10)] and finally γ0 ≈ 21.5 s−1. We further
note that there are 0.3 IF2 molecules per ribosome [Bremer and Dennis, 1996],
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implying [IF]WT ≈ 15.6 µM, from which we estimate ζ0 ≈ ζ/[IF]WT ≈ 0.19 µM−1s−1.
With these parameter values, our model is fully defined and the growth rate is
calculated (Mathematica function NSolve) as its output based on the concentration
of translation factors.
We further explored the effects of parameters on the model results. First, we
verified the impact of WT ribosome density ρr (one that supports maximal growth
rate at saturating factor concentrations), we systematically calculated the response
surfaces for different values of ρr between 0.0117 and 0.0817 (6.5A). With decreasing
WT ρr , the concentration of mRNA Ξ increases according to Eq. (6.8). When
Ξ ≫ ∆rL/ρmaxD̄, the traffic jams of ribosome are not possible anymore as there are
too many mRNAs that can carry more ribosomes than available. The critical WT
ribosome density is ρr,crit  λ0/(κt∆r) × ρr,max (6.5A).
Next, we systematically calculated the response surfaces for different values of
ribosome footprint size L and WT ribosome density ρr . Here, we varied ribosome
footprint size L since: (i) a small increase in L could be caused by the space required
by the movement of the ribosomal subunits during different phases of progression
along mRNA, and (ii) size estimates in the literature vary [Kang and Cantor, 1985;
Mitarai et al., 2008; Shaw et al., 2003b; Mohammad et al., 2019]. We varied L between
5 and 20 codons. We calculated the phase diagram of BD scores (6.5B,C). By doing
so, we checked the impact of physiological parameters on the outcome of the model,
and verified the mathematical relations discussed above more generally.
Without any free parameters, this generalized TASEP qualitatively reproduced
the suppressive effect of lowering the initiation rate under a translocation bottle-
neck (Fig. 6.6A). This suppression results from a phase transition between the
translocation- and the initiation-limited regime. In the translocation-limited regime
(black arrow in Fig. 6.6A), ribosome traffic is dense and cannot be further increased
by boosting the initiation attempt rate. Upon decreasing the initiation attempt rate ζ
(green arrow in Fig. 6.6A), a phase transition to the initiation-limited regime occurs.
Beyond the critical point of this phase transition (green triangle in Fig. 6.6A), the
elongation velocity, and with it the growth rate, begins to increase with decreasing










Figure 6.5: Variation of TASEP-model parameters. (A) Impact of varying the initial ρr on resulting
bottleneck dependency score for L  25/3. White symbols correspond to the examples showcased in
B,C. The white circle shows the result from the main text for the estimated value of WT ρr  0.07.
The solid green vertical line denotes the critical value λ0ρr,max/(κt∆r) above which traffic jams due to
translocation limitation can form. The dashed vertical line indicates the approximate point at which
suppression starts to develop due to factor sequestration (as obtained by ∂BD/∂ρr  0.3). (B) Phase
diagram of BD score as a function of WT ribosome density ρr and ribosome footprint size L. Purple
line and symbols corresponds to the cross-section in A. The “undefined” area corresponds to the
example in which translation is already in the regime with traffic jams and Eqs (6.12) do not have a
unique solution. White dashed line corresponds to ∂BD/∂ρr  0.3, above which (approximately)
suppression starts to develop. Green dashed line shows the λ0ρr,max/(κt∆r), above which traffic
jams can develop. (C) Response surfaces for ρr ≈ 0.025, 0.057, and 0.080 [from left to right; symbols
shown as in A,B]. Symbols in the upper-right corner correspond to the values shown in A,B. Dashed
blue lines show where 50% of the translating ribosomes are bound by the elongation factor; below
this line, this fraction decreases along the arrows. When ρr increases, suppression starts to develop.























Figure 6.6: TASEP-model predicts suppression between inhibition of translocation and initia-
tion. (A) The growth rate predicted by the generalized TASEP model recapitulates suppression of
translocation inhibition by lowered initiation; note that, unlike in Fig. 6.1A, axes show the concentra-
tions of translation factors. States below and to the right of the green line are in the translocation
limiting regime. (B) Cross-sections of the response surface. As the initiation factor level is decreased,
the critical point of the phase transition (green triangle) is reached; growth starts increasing after
passing the critical point, and decreases again after passing the maximum (red square) as the number
of translating ribosomes becomes limiting. (C) Bottleneck dependency (BD) score quantifies the
deviation from independent expectation (BD  0) for the response surfaces in Fig. 6.1A and A;
heights of bars corresponds to the medians and error bars are 90% bootstrap confidence intervals.
Medians and confidence intervals were estimated from n  100 bootstrap data points.
which ribosome traffic jams dissolve underlies the suppressive effect.
The densification of ribosomes on transcripts has an additional consequence: as
the number of ribosomes that are stuck on transcripts increases, more elongation
factors are sequestered by ribosomes. This in turn reduces the probability that an
individual ribosome is bound by a factor – a necessary condition for the ribosome
to attempt a translocation step. This situation results in a positive feedback loop in
which the reduced translocation attempt rate further amplifies ribosome congestion.
To compare measured and predicted surfaces, which have different axes, we
calculated their respective deviation from independence as for the bottleneck
dependency score (Fig. 5.3). By this measure, the model faithfully captured the
clear deviation from the multiplicative expectation (Fig. 6.6C); the agreement with
the experimental data is good, especially considering that the model results are
parameter-free and not a fit to the experimental data.
Taken together, these results show that suppressive drug interactions between
translation inhibitors are caused by the interplay of two different translation bottle-
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necks. Close agreement of the experiments with a plausible theoretical model of
ribosome traffic, which captures physiological feedback mediated by growth laws,
strongly suggests that suppression is caused by ribosome traffic jams. Such traffic
jams result from imbalances between translation initiation and translocation; they
dissolve in a phase transition that occurs when one of these processes is slowed,
leading to an overall acceleration of translation and growth. Stalled ribosomes
facilitate the formation of traffic jams by sequestering elongation factors. We con-
clude that a non-equilibrium phase transition in ribosome traffic is at the heart of
suppressive drug interactions between antibiotics targeting translation initiation
and translocation.
6.3 Effect of mRNA growth-rate dependence
The concentration of mRNA could in principle be growth rate-dependent. However,
direct dependence of mRNA on the growth rate is difficult to estimate from existing
literature as total RNA is mostly composed of rRNA and tRNA [Scott et al., 2010;
Dai et al., 2016]; estimation of the mRNA fraction is thus prone to errors. However, if
we assume proportionality between ribosome and mRNA concentration, a simplified
form can be written down as Ξ  Ξ0rtot/rtot,0, where Ξ0 and rtot,0  rmin + λ0/κt are
the estimates of mRNA concentration from the previous section and total ribosome
concentration in the unperturbed case, respectively. Plugging this dependence
into the model does not qualitatively change the suppressive interaction between
inhibition of initiation and translocation (Fig. 6.7). In this scenario, the increasing
number of mRNA transcripts partially alleviates the densification of ribosomes
on transcripts. However, the overall increasing number of translating ribosomes
sequesters the elongation factors – this effect is still alleviated by lowering the















Figure 6.7: Variation of TASEP-model parameters. (A) Two models of mRNA concentration
dependence. Black lines denote the dependence of mRNA on growth rate if the co-regulation
between total RNA and mRNA is assumed; solid and dashed lines correspond to variation of the
nutrient quality and translation perturbation, respectively. The arrow denotes the estimated mRNA
concentration; this concentration is assumed constant (dashed purple line) in the model shown in the




, traffic jams do not develop. Elongation
factors are still sequestered as the number of translating ribosomes increases, which in turn decreases
the growth rate. (B) Direct comparison of model predictions. Prediction with growth-dependent
mRNA concentration Ξ is depicted in grayscale; isoboles from the prediction assuming a constant
pool of mRNA are shown in purple. Both results are qualitatively equivalent.
6.4 Rescue mechanisms and inefficiency of a direct re-
sponse to translocation inhibition
Bacteria have evolved rescue mechanisms for stalled ribosomes (tmRNA, ArfA and
ArfB). However, these mechanisms are mostly aimed at the rescue of ribosomes
that were stalled due to limiting supply of building blocks or those in non-stop
complexes. The former is an unlikely scenario during translocation limitation;
as the building blocks are under-consumed, non-stop complexes can form via
the formation of damaged or truncated mRNA (e.g., via cleavage by RNases) or
via collision-induced frame-shifts [Simms et al., 2019; Keiler, 2015]. However, the
tmRNA pathway requires an empty A-site on the ribosome, which is occupied in
the pre-translocation complex, thus hindering the rescue initiation. Likewise, the
ArfA pathway is hindered by an occupied A-site – it requires release factor 2 to bind
to the A-site of the ribosome to initiate premature release and recycling. ArfB on the
other hand, can recover the lack of tmRNA and ArfA pathways only when heavily
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overexpressed [Chadani et al., 2011] and is considered ineffective in the WT regime.
In sum, established rescue mechanisms are unlikely to recover stuck ribosomes and
we therefore omit these mechanisms from the analysis.
Additionally, the cell could have an initiation-inhibiting mechanism in place as
a response to translocation inhibition. However, the observed responses of bacteria
to translation inhibition show global derepression of the translation machinery by
reducing the levels of ppGpp. Besides the upregulation of all translation components
mentioned in the main text [Maaløe, 1979; Gordon, 1970; Blumenthal et al., 1976;
Furano and Wittel, 1975], an additional effect of lower levels of ppGpp is a direct
increase of initiation. The catalytic function of the initiation factor is lowered when
ppGpp levels are high, and higher when ppGpp is reduced [Milon et al., 2006]. These
arguments show that an alleviating response of translocation inhibition by either
rescue mechanisms or by direct down-regulation of initiation is unlikely.
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7 Tools for quantitive characterization of
translation
In previous chapters, we focused on growth rate as the macroscopic response
to translation perturbation. While it comprehensively reflects the impact on the
overall physiology, it lacks a level of detail that allows a deeper understanding of
the perturbation effects. Therefore, we aimed to (i) develop tools to gain deeper
insight into translation and (ii) develop a model that would be based on measurable
parameters and would consolidate the measurements. In comparison to previous
chapters, this one will be more conceptual/technical and will illustrate an approach
rather than a complete solution.
While the growth laws proved to be remarkably robust, measuring ribosome
abundance for a particular perturbation would be useful as it would challenge
the validity of the growth laws and provide a numerical scale for comparing the
abundances of a particular protein (as in: how many translation factors per ribosome
are in the cell?). Next, if we perturb the translation genetically by titrating the
translation factor, it is of importance to know the abundance of said factor. Here, we
aim to obtain a physical quantity (i.e., number of molecules per cell), rather than a
value expressed in relative terms or proxy units (e.g., fluorescence or photon-counts-
per-second). Physical quantities allow us to evaluate the model in quantitative
terms and make the model independent of the particular measurement technique.
Additionally, to get a broad overview of the cellular physiology, we aim to determine
some macromolecular parameters of the cell, such as protein and RNA content.
We illustrate these approaches and techniques by investigating the effects of
initiation factor titration. Initiation – as we discussed in the Introduction – is a
process with many steps that are orchestrated by several auxiliary factors. Describing
the whole process in detail would require multiple parameters and would make the
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analysis highly complex. Similar to the TASEP model we introduced in the previous
chapter, we can use certain approximations that will simplify the analysis.
7.1 Impact of sub-saturating levels of initiation factors
on the growth rate
Below we describe a model in which the translation is perturbed by sub-saturating
levels of initiation factor. In the model, we divide total ribosome concentration rtot
into translating ribosomes ru and non-initiated ribosomes ri . We consider only a
few processes: initiation, elongation, and recycling. Because we consider the case in
which we throttle down initiation, we assume that the initiation is the only limiting
process. We in turn assume that the recycling of the ribosome is instantaneous,
i.e., the ribosomes do not transit through a sub-population of terminated, yet not
recycled ribosomes.
Here we do not take into account the full molecular complexity of the translation
initiation. We assume simple kinetics in which rate fc of the reaction ri → ru is





where [IF] is an intracellular concentration of initiation factor, ζ0 is a rate constant
and Km is a Michaelis constant of the reaction, as in Eq. (6.11).
Recycling rate of the ribosomes is much faster than the synthesis of new ones.
Figure 7.1: Modeling impact of sub-saturating
levels of initiation factors on the growth rate.
In the model, we distinguish translating ru and
inactive ribosomes ri . Rate of initiation fc depends
on the abundance of both non-initiated ribosomes
and initiation factor [see Eq. (7.1) and rounded
rectangle]. Ribosomes are recycled at the rate Krec.
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We can obtain a proxy for the rate of ribosome recycling from the equality
λMp  krec⟨m⟩, (7.2)
where Mp , krec, and ⟨m⟩ are (growth rate-dependent) protein mass, recycling rate,
and a typical mass of a protein, respectively. This expression states that the total
rate of protein synthesis equals the rate at which the peptide chains are completed
(which equals to recycling rate) multiplied by some typical mass of the protein.
Further, dividing by cell volume (which is growth rate-dependent) we obtain
concentration flux that we can later use in the dynamical system. We note that
1/V  (1/Mcd) × (Mcd/Mcw) × (Mcw/V), where Mcw and Mcd are the wet and the
dry cell mass, respectively. Since Mcw/V  1.09 g/mL [Kubitschek et al., 1984]
and Mcd/Mcw  1/3.1 [Cayley et al., 1991] are independent of the growth rate,











To estimate the value of ξ  ρMp/(Mcd⟨m⟩) and its possible dependence on the
growth rate, we calculated the ratio Mp/Mcd at different growth rates [Bremer
and Dennis, 1996]. We note that ratio is only weakly growth rate-dependent (in
line with Ref. [You et al., 2013]) and we therefore assumed it to be constant at
Mp/Mcd ≈ 0.574. To estimate the typical protein mass ⟨m⟩ in the E. coli, we assume
that the distribution of the protein lengths does not change as a function of the growth
rate and we calculate the molecular weight of the typical protein W⟨m⟩  ℓ̃Waa,
where ℓ̃  209 aa is a median length obtained from proteomic abundance weighted
distribution (in contrast to genomic length distribution) [Milo and Phillips, 2016] and
Waa  108 g/mole is an average molecular weight of the amino acid residue [Bremer
and Dennis, 1996]. This yields ξ  8.95 × 103 µM. If we consider a bacterial cell
with a volume of ≈ 1 fL, we can calculate that there are ≈ 3.7 × 106 finished proteins
per division. This is in line with the estimated number of proteins per bacterial
cell (2 − 4 × 106) [Milo and Phillips, 2016] and the agreement between these two
independent estimates suggests that the estimated value for ξ is reasonable.
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With these considerations at hand, we can write the dynamical system by adding
ribosome recycling rates λξ with opposite signs in differential equations for both
ru and ri :




ṙ i  −λri − [IF]ζ0
ri
Km + ri
+ s(λ) + λξ. (7.4b)
This system of ODEs resembles the one used for describing the binding of antibiotics.
Setting both time derivatives to 0 and summing the equations yields:
λ(ru + ri)  λrtot  s(λ), (7.5)











From the steady-state Eq. (7.4a) and Eq. (7.1) we note that
λ(ru + ξ)  fc  [IF]ζ0
ri
Km + ri
 fc , (7.7)
which allows rewriting the steady-state Eq. (7.4b) into




























⏞ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ⏟⏟ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ̄ ˉ⏞
λru fc
. (7.9)







This expression is a mathematical formulation of the following: when there are
no translating ribosomes (ru  0 and λ  0) then the whole dynamic range of the
ribosomes ∆r is allotted to the inactive ribosomes ri . However, when the inactive
ribosomes are immediately converted to the translating ribosomes, then the growth
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rate equals the unperturbed one, i.e., λ  λ0. We insert the Eq. (7.10) into the









Km + ∆r(1 − λ/λ0)
. (7.11)
After the multiplication of the expression above with the denominator of the right-
hand side and rearranging of the terms, we obtain an implicit expression for the





















− [IF]ζ0∆r  0, (7.12)
































Taking [IF] towards either 0 or ∞ reveals two limiting cases, where λ  0 and
λ  λ0, respectively, are the solutions to the Eq (7.13). We can further determine
[IF]50, i.e., the concentration of the initiation factor needed to support λ  λ0/2, and













We note that at conditions allowing for fastergrowth (higherλ0),higherconcentration
of the initiation factor is required. Alternatively, for high catalytic rates [ζ0 ≫
λ20/(4κt)], a lower concentration is required. Both make an intuitive sense, because
at rapid growth initiation has to be more rapid; however, if the catalytic rate is
higher (i.e., enzyme is more efficient), fewer initiation factors are required. With
these expressions at hand and by defining b  [IF]/[IF]50, R0  (rmin + ξ) κt/λ0,





















We note that the expression breaks down in the limit Km → 0, as the divergence
at y → 0 [caused by (1 − y) in the denominator of the first factor] disappears,
thus allowing the growth rates exceeding λ0. Limiting both R0 and Km to ∞, the
expression simplifies into Michaelis-Menten function, i.e., y  b/(b + 1), while for
R0 → ∞ and Km → 0 we obtain a linear increase in growth rate, i.e., y  b/2 for





Figure 7.2: Induction curve for initiation fac-
tor. Figure shows an example of Eq. (7.13) for
R0  100 and Km/∆r  0.1 (solid line). Gray area
is bounded by two limiting cases discussed in
the text and shown as dashed lines. Since con-
centrations are measured in units of [IF]50, both
curves go through the point (1, 1/2). Note, that
the chosen example lies within the boundaries
determined by the limiting cases.
which we term reversible and irreversible for Km → ∞ and Km → 0, respectively.
To adjust the parameters in the Eq. (7.13) we need the measurements of intracel-
lular concentration of the initiation factor. For that, we need to establish a precise
technique for determination of absolute abundances in the cell.
7.2 Scarless tagging of chromosomal genes
Quantitative measurements of particular physiological parameters are always a
tug-of-war between precision and ease of handling/throughput. Furthermore,
various methods differ in the level of invasiveness, i.e., whether the measurement
requires alteration of a native protein of interest, which might lead to fitness defects.
Additionally, not all methods allow convenient conversion of measured quantity
(e.g., fluorescence) into a physical quantity (e.g., number of proteins per cell.
The genome-wide techniques (e.g., quantitative proteomics) present a powerful
tool that gives an overview of the whole proteome [Hui et al., 2015]. However, the
handling of such rich datasets requires careful curation and might fail when the
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abundances of specific proteins are very low, which are often simply excluded from
the analysis. This is particularly problematic in our case, as we aim to lower the
abundance of an essential protein. Techniques that focus on the quantification of a
specific protein are based on various approaches. Immunostaining methods, for
example, require the development of specific antibodies, which are then hybridized
with the protein of interest. Alternatively, common protein tags, such as His- or Flag-
tag can be added to the protein and targeted with appropriate antibodies. Protein-
bound antibodies can be either directly or indirectly used in the measurement of the
amount of the protein, which is either based on colorimetry, chemiluminescence,
and radioactive- and fluorescence detection. Such immunostaining methods are
powerful tools for determining the presence of a specific protein but are deficient in
detecting small changes in protein abundances. Alternatively, a protein of interest
can be fused directly with a reporter. If we attach, for example, a fluorescent
reporter (that is ≈ 330 amino acids in size) on one end of the protein, we can in
principle measure its abundance directly since the latter is proportional to detected
fluorescence. However, this might come at the price of reduced catalytic activity of
the protein as well as disrupted physical properties (mobility, rotational defects). Yet,
it is relatively easy to perform high-throughput measurements as the measurements
can be effectively automatized. We demonstrate the effects of the problematic
reduced catalytic efficacy in the Appendix, where we describe the construction of a
strain with in-frame titratable GFP-fused initiation factor.
As we discussed in the Introduction, proteins involved in the translation enter
into this highly dynamic process in which the structure of a particular protein plays
an important role. Therefore, we developed a method with low invasiveness, high
precision of detection, and medium convenience of handling. Below we describe
the construction of the auxiliary tools and demonstrate the use of the method
on the quantification of initiation factor. Sections denoted with an asterisk (∗) are
more technical. Our method is based on commercially available HiBit technology
(Promega). The method is conceptually similar to immunostaining methods, as it
requires an eleven-amino acid long tag to be added to either end of the protein.
Quantification is performed by (i) lysis of cells, (ii) hybridization of the tagged
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protein with a complementary fragment, and (iii) measurement of the luminescence.
Due to wide dynamic range of detecion and lack of background, luminescence
measurement offers a broad and linear dynamic range, as we show below.
We describe the technique to attach the HiBit tag to the carboxyl-end of proteins
by scarless in-frame integration. We additionally add a flexible linker between the
endogenous protein and the HiBit tag to decouple these two parts as much as
possible and minimize the detrimental effects of tagging on the catalytic activity of
the protein. We based the method on galactose selection-counter selection method,
which allows us to remove the selection marker upon the integration of the tag.
7.2.1 Development of the technique for scarless tagging of chro-
mosomal genes
We developed the method for scarless chromosomal integration of genetic fragments.
The efficient fusion of the tag-encoding sequence to the 3′-end of the gene of interest
requires high specificity and ideally should leave no scar behind. However, as the
immediate neighborhood of the gene might be different from case to case, we aimed
to develop a flexible system for scarless chromosomal in-frame insertions of the tag.
We chose to use a recently developed galactose selection-counterselection [Warming
et al., 2005] method with modifications.
The basis of the galactose selection-counterselection is the double function
of galactokinase (encoded by galK). Galactokinase is involved in the first step of
galactose metabolism as it phosphorylates the galactose, which is then further
processed by other components of the system. Therefore, in the strain devoid of galK
will grow in galactose minimal medium only if the galK is successfully introduced
into the chromosome. This way, we can select for the presence of galK.
However, GalK phosphorylates galactose analog, 2-deoxy-galactose (DOG), as
well. The buildup of the phosphorylated analog is deleterious to the cell. In this case,
only the cells that lack galK can grow in the medium with DOG present. Therefore,
we can use the DOG to counterselect for the presence of galK. This dual-nature
of galK can be used in recombineering [Warming et al., 2005] or in fluctuating the
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selection pressure in studies of evolution [Tomanek et al., 2020].
Required strains
To use a galactose selection-counterselection, a strain that is deficient in galK is
required in the initial step. When attempting the deletion of the galK, the 3′-end
of galK should be left intact – there is a 7-nt overlap with a downstream galM.
The in-frame gene disruption strategy employed in the construction of the Keio
collection [Baba et al., 2006] leaves the last 21-nt intact and is suitable for this purpose –
this strategy also leaves the translation signals of the downstream gene unperturbed.
The deletion can be readily moved by using generalized P1 transduction and the
transduced cassette can be efficiently resolved by FLP-resolvase from the plasmid
pCP20. We verified the deletion by PCR in which primers bind in regions flanking
the deletion region. The galK-deficient strain should be checked for growth on
galactose minimal plates as well as for the loss of catalytic activity on MacConkey
galactose indicator plates (colonies should not appear pink but rather white). The
obtained strain serves as the platform for the recombineering. In establishing the
technique we used a derivative of laboratory strain MG1655 with the following
additional genotypic differences ∆lacIZYA::frt ∆galK::frt.
7.2.2 ∗Auxiliary plasmids
We aimed to construct a plasmid bearing a selection-counterselection cassette and a
linker-tag tandem upstream. This plasmid would serve as a PCR template to yield a
double-stranded DNA fragment used in recombineering. We aimed to build the
plasmid using modified Gibson assembly (HiFi-builder, New England Biolabs), from
four fragments: (i) the pir-dependent origin of replication and ampicillin resistance
cassette, (ii) TrrnB terminator with flexible linker [(GGGS)2]-HiBit tag tandem
introduced as its upstream overhang, (iii) strong λ-PR, and (iv) galK gene (Fig. 7.3).
The pir-dependent origin of replication prevents the recombineering interference
by template carry-over as it cannot replicate in the strains of interest (it shall be
maintained in pir+ strain, e.g., DH5α λpir). The plasmid has an excisable terminator
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Figure 7.3: Auxiliary plasmids used in scarless tagging of chromosomal genes. (A) Main features
of the plasmid. Multiple variants of the plasmid were attempted, each suited for different properties
of the tagged gene (see B) Orange semi-opaque square denotes part that misses from the plasmid used
in the text but will be included in future variants. (B) Different variants of the tagging segment with
a brief description of intended use. Orange semi-opaque square denotes variants under construction.
between the tag and galK promoter.
We PCR-amplified all fragments for the isothermal assembly except the λ-PR pro-
moter, which we obtained by annealing complementary synthetic oligonucleotides
(annealing was performed in TSE buffer: Tris 10 mM, NaCl 50 mM and EDTA 1 mM
with pH 7.7). Due to inefficient assembly of multiple fragments, we performed a
sequential assembly followed by PCR amplification of the assembled fragment,
which improved the efficiency. However, during the plasmid construction, we noted
multiple occurrences of mutation in the promoter, leading us to the conclusion that
the expression of the galK from a strong and constitutive λ-PR promoter presents
a burden for a host cell when expressed from a plasmid. In the plasmid that is
currently under development, we plan to introduce the temperature-dependent
repressor cI857 to inhibit the expression of the galK from λ-PR when cultivated
below 32◦C.
7.2.3 ∗Design of recombineering primers, recombineering, and
chromosomal modifications
The chief objective of our technique is to allow for a flexible design of integration
fragments without the need to construct new plasmids for every integration. There-
fore, with the template plasmid described above at hand, we only need to redesign
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the PCR primers that determine the chromosomal target. We illustrate the design of
primers whose 5′-overhangs serve as “landing pads” in recombineering.
We need to design the recombineering primers such that the proper open reading
frame is left intact after the integration of the tag. Both recombineering primers have
an annealing part to the auxiliary plasmid and a 5′-overhang that is homologous to
the targeted chromosomal. Forward primer begins with the last 50-bp before the stop
codon of the gene of interest (HF part) and continues with 40-bp that anneal to the
linker (PF: GGTGGTGGTTCTGGTGGTGGTTCTGTGAGCGGCTGGCGGC, Fig. 7.3).
Reverse primer begins with a reverse complement of the region downstream of the
stop codon of the gene of interest (HR). This part has more flexibility as the frame
was preserved with the forward primer. However, HR has to be designed such that
the downstream gene is not perturbed. For tagging, reverse complement of the 50-bp
immediately after stop codon can be used. The primer continues with a 45-bp long
reverse annealing region (PR: TTATCGTGAGGATGCTAGCTCAGCACTGTCCT-
GCTCCTTGTGATG, Fig. 7.3). Long primers make the PCR amplification the most
challenging part of the whole procedure. However, when successful, the fragment
is relatively short (≈ 1.5-kbp) which favorably improves the transformation and
recombineering efficiency. The fragment is recombined into the region of interest
using λ-red recombineering [Datta et al., 2006]. The obtained strain is selected
on agar plates containing D-galactose as the only carbon source. Grown colonies
are picked and restreaked on MacConkey indicator plates, where correct colonies
should turn pink (as opposed to white) thus confirming the GalK activity. After
PCR verification, a recombineering plasmid is reintroduced to allow for the removal
of the galK cassette.
Scarless removal of the selection cassette is attempted by recombineering a short
fragment that replaces the selection cassette. In this step, we design a 100-bp DNA
fragment whose initial 50-bp are the same as the last 50-bp of the linker-tag segment
[common removal fragment (RF): CTGGTGGTGGTTCTGTGAGCGGCTGGCGGCT-
GTTCAAGAAGATTAGCTAA] and the final 50-bps are reverse-complement to
segment HR from above. The fragment is assembled by annealing two complemen-
tary synthetic oligonucleotides in TSE buffer. Short fragments have superior trans-
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formation efficiency; while recombineering can be performed by single-stranded
oligonucleotides we opted for double-stranded fragments out of concern of un-
wanted structures formation and differences in recombination efficiencies between
lagging and leading strands. Upon electroporation, an extended outgrowth period
is necessary to completely segregate the unmodified chromosomal loci (due to
multiple replication rounds in the cell, not all loci are modified in recombination)
and to dilute out GalK. The latter would be detrimental in the counterselection even
though the gene has been eliminated. Counterselection is performed on agar plates
with glycerol as a carbon source and DOG as a counterselection compound. Grown
colonies are picked and restreaked on MacConkey indicator plates to verify the
loss of galK cassette as indicated by white colonies. After PCR verification and se-
quencing, the strain should contain a modified locus with no residual chromosomal
alterations.
7.2.4 ∗Scarless tagging of initiation factor 2 and measurement of
its abundance
We illustrate this procedure by describing the construction of the fusion between
endogenous infB and [(GGGS)2]-HiBit. We used this construct to determine the
native level of initiation factor and verify the integration technique. We started
with a galactose-auxotrophic strain. We designed the primers according to the
description above. Forward recombineering primer 5′-overhang contained the
forward homology (HF) to infB (GCGATGTGATCGAAGTATTCGAAATCATCGA-
GATCCAACGTACCATTGCT), followed by the PF segment that anneals to the
auxiliary plasmid described above (Fig. 7.3). Reverse primer 5′-overhang deter-
mined the second arm of the landing pad, which we chose as the immediate
50-nt after infB (CATGCCGGATGCAGCGTAAACGCCTTATCCCGCATGGAACCC-
TAAAAACC). The annealing region of the reverse primer continued with the PR
segment described in the previous section (Fig. 7.3).
After the PCR amplification of the fragment, it was recombined into the chromo-
some. Correct recombinants were selected on galactose (as described above) and
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verified by PCR and by streaking on MacConkey indicator plates. Correct clones
were transformed with recombineering plasmid in preparation for the removal
of the selection cassette. Here, we designed two complementary oligonucleotides.
The first half of the sense oligonucleotide is the common removal fragment RF
and the second half is reverse-complemented HR. This fragment was recombined
into the strain [Datta et al., 2006] and counterselected on DOG-glycerol plates. We
verified the cassette removal by streaking on MacConkey indicator plates and PCR.
Taken together, PCR confirmed the desired 60-nt alteration of the chromosomal
region. The tagging of the carboxyl-end of the protein captures potential isoforms
of a particular protein. Concretely, the transcript for infB gets translated as three
isoforms: IF2α, IF2β, and IF2β′ (full-length protein and start codons at positions
158 and 165, respectively). These isoforms do not have the same start codon but
share the same stop codon and with it a HiBit tag. This way, the quantification of
the tagged proteins lumps together all isoforms.
Next, we tested the precision of protein quantification and potential fitness
defects of the tagged strain. We grew WT and tagged strain in minimal medium
in shaking flasks immersed into a water bath with shaking. We measured OD
periodically; after each measurement, we replenished the removed medium with
fresh prewarmed one and corrected the measured OD accordingly. We noted that















Figure 7.4: Progression of the modifications of infB locus. Top: Schematic of the progression. Shown
are approximate position of the PCR primers. Black region indicates a linker. Bottom: Sequencing
electropherogram result compared to the consensus. Shown are more details of the immediate
neighborhood of the tag. Right: DNA bands corresponding to the PCR reactions for individual steps
shown on the right.
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the late exponential phase, we collected the bacteria, adjusted their density to the
same value and lysed the cells.
Figure 7.5: Growth curves of tagged and WT
strain. Time tracks of OD for WT (white cir-
cles) and tagged (gray circles) strain reveal that
there is only a marginal fitness defect caused by
tagging (growth rates in minimal M9 medium
with casamino acids and glucose: 1.13 ± 0.02 and
1.07 ± 0.02 h−1, respectively).
After obtaining the lysates of WT and tagged strain, we constructed a serial
dilution of the tagged lysate in WT lysate, thus mixing the proteomes of both such
that the ratio of the tagged-strain proteome halves in every step (Fig. 7.6). If strains
have globally the same proteomes except that the tagged strain contains a detectable
tag, such dilution will keep the amount of non-specific detection constant, yet it
will decrease the specific detection of the tagged protein accordingly. To obtain
the abundance of the tagged protein rather than just a readout, we constructed
another dilution series of WT lysate, which we spiked with a known quantity of
control protein (HiBit Control protein, Promega). By fitting a linear function to a
scatter plot of the readouts of both dilution series we obtain the ratio between the
initial concentrations of the standard and tagged protein (Fig. 7.6). Furthermore, by
including the control in which we perform the assay solely using the lysate of WT
cells, we can estimate the background and the sensitivity of the assay.
We additionally estimated the density of bacteria by plating a series of diluted
samples. This allowed us to obtain an estimate for the number of molecules per cell.
In so doing we estimated that there are around 2.2 × 103 initiation factor molecules
per colony-forming unit (CFU) (Fig. 7.6). Here, we must point out that the estimate
of cell density can vary significantly between technical replicates. In the next section,







Figure 7.6: Standard curve for quantification of
HiBit-tagged protein. By measuring the lumines-
cence of the dilution series ofknown concentration
of control protein and the dilution series of the
tagged-strain lysate. If the concentrations of both
are the same, the slope would be 1 (dashed line),
otherwise, the slope is different. Note, that the
difference between background and point with
the lowest signal is nearly a hundred-fold.
7.3 Model meets the experiment: initiation perturba-
tions
The aim of developing the precise technique for quantifying the abundance of
translation factors in physical units was to analyze the model from Sec. 7.1. Below
we illustrate the process of inferring phenomenological parameters that constrain
the induction curve [Eq. (7.13)]. We designed the experiment around a variation of
the initiation factor as in Chapter 5. To vary the expression of the initiation factor,
we recombined the tagged initiation factor into the galK locus under the control
of the PLlacO−1 promoter. Besides measuring the abundance of the initiation factor,
we aimed to determine the RNA and protein content to get a closer look into the
physiological state of the cell.
7.3.1 The growth conditions
We grew the strain with the titratable initiation factor at five different inducer
concentrations, which we chose to cover growth rates roughly between 50-100% of
the maximal one. We measured the growth rates of batch cultures by sampling the
cultures periodically and measuring the OD (Fig.7.7A). Besides five conditions in
which we grew the strain with titratable tagged initiation factors, we prepared two
separate cultures for a strain with a tagged endogenous copy of the initiation factor
as well as a WT strain. All strains were grown in M9 minimal medium with casamino
acids and glucose, supporting a growth rate of λ0 ≈ 1.0 h−1. By measuring the
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Figure 7.7: Growth curves and a resulting induction curve for the strain with titratable initiation
factor. (A) Time tracks of OD for five different conditions. Note how the slope of the curves decreases
as a result of lowered initiation factor expression. (B) The induction curve shows the dependence of
growth rates on inducer concentration. Symbols correspond to the growth curves shown in A.
growth rate we determined its dependence on the inducer concentration (Fig. 7.7B).
7.3.2 Quantification of the initiation factor abundance
With the factor-quantification method at hand (see Sec 7.2.4), we moved a step
closer to having the necessary data for constraining the parameters ζ0 and Km
in Eq. (7.13). We constructed factor-dilution curves using WT strain lysates and
standard proteins (Fig. 7.8).
The assay provided information on how many initiation factor molecules are
present per given density of cells (specified by measured optical density). However, to
obtain the intracellular factor concentration we needed to find a reasonable proxy for
calculating the cellular volume. Because we can calculate the ribosome concentration
from Eq. (7.13), we aimed to calculate how the initiation factor abundance changes
relative to ribosome abundance. To obtain ribosome abundance we quantified the
RNA as well as protein content.
7.3.3 Quantification of the protein and RNA content
To quantify the ribosome content, we determined the total RNA content by perform-
ing perchloric acid (HClO4) extraction as described in Ref. [Benthin et al., 1991] with














Figure 7.8: Quantification of the initiation factor abundance in factor-titration experiment. (A) A
photo shows a microtiter plate with luminescent samples in the wells. It showcases the strength of
the signal in comparison to the background and how signal decreases by serial dilution. We obtained
the photo using a macroscope camera with 30 s exposure without any filters. (B) Concentration
of the initiation factor is obtained from a scatter plot. See Sec. 7.2.4 and Fig. 7.6. Symbols are as in
Fig. 7.7. Lower abundance is reflected in a lower offset (due to log-log plot).
the cell pellet is washed with cold HClO4, followed by hydrolysis in KOH at 37◦C.
Supernatant is neutralized by cold HClO4 (which yields potassium perchlorate used
in rocketry) and the precipitate is washed again with perchloric acid. Spin-cleared
supernatant contains RNA, which is quantified by measuring the absorbance at
260 nm. The concentration of RNA is obtained by noting that the molar extinction
coefficient is 10.8×103 M−1cm−1 and molecular weight of average RNA nucleotide
weight of 324 Da, thus yielding cRNA ≈ 31 × OD260 µg/mL.
Figure 7.9: RNA to protein ratio reflects ribo-
some upregulation. By measuring the RNA and
protein content we can observe the upregulation
of the ribosome expression. Here, our measure-
ments reproduce the negative correlation between
the growth rate and RNA/protein. We excluded
one point due to issues with protein quantification.
We quantified the protein content by using colorimetric bicinchoninic acid assay
(also known as Smith assay, Sigma-Aldrich BCA1-1KT). This colorimetric assay is
based on the change in the color due to protein bonds reducing Cu2+ ions, which is
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reflected in changed color (similar to biuret test). To translate the change in color (as
measured by absorbance at 562 nm) to protein concentration, we performed the assay
on a series of protein samples (bovine serum albumin) of known concentrations;
such standard curve is well described by a quadratic function.
With these two quantifications at hand, we determined the RNA/protein ra-
tio (Fig. 7.9). This ratio reflects the ribosome content relative to the whole pro-
teome (see Introduction). Here, we observed the increase in RNA/protein ratio as we
lowered the expression of the initiation factor. We converted the RNA/protein ratio
to protein fraction by accounting 86% of the RNA is rRNA, the ratio of r-proteins
to rRNA mr−protein/mrRNA  0.53, and the ratio of r-proteins and extended transla-
tion machinery proteins is around 1.67 [Bremer and Dennis, 1996; Maaløe, 1979;
Scott et al., 2010]. This yields the conversion ϕR  (R/P)ρ, where R, P, and ρ  0.76
are RNA-, protein content, and conversion factor from R/P to ϕR, respectively.
We, however, observed a lower increase in protein fraction allotted to a ribosomal
fraction as reported in Ref. [Scott et al., 2010].
7.3.4 Inference of physiological parameters
The model presented in Sec. 7.1 requires two parameters: ζ0 and Km . To adjust these
two parameters, we first calculated the abundance of initiation factors relative to
the number of ribosomes. If we know the amount of total RNA, we can estimate the
number of ribosomes by noting that there are 4,566 RNA nucleotides per ribosome
with the average nucleotide molecular weight of 324 Da. In so doing, we estimated
how the growth rate changes with the ratio between initiation factor molecules per
ribosome (Fig. 7.10A).
Obtaining the ratio of initiation factor molecules per ribosome has the added
benefit of being easily convertible to the intracellular concentration of translation
factors. Here, we estimate the intracellular concentration of translation factors by
multiplying the ratio and the concentration of the ribosomes, which we estimate
from the growth law [Eq. (4.2)] (Fig. 7.10B). With this data at hand, we can fit the
model [Eq. (7.13)]. We obtained the values Km  0.36 µM and ζ0  2.21 µM−1s−1.
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Figure 7.10: Growth rate dependence on number of initiation factors in relation to ribosomes
and on concentration of factors. (A) Growth rate monotonically increases with the number of
initiation factor molecules per ribosome. Full growth rate is recovered already at ≈ 0.4 factors per
ten ribosomes. (B) Intracellular concentration of the initiation factor can be mapped to the growth
rate using the model [Eq. (7.13), solid line].
Coincidentally, the dissociation constant Km we obtained from the fit is higher than
the estimate we used in the TASEP modeling. In the latter case we used a value
obtained in vitro [Milon et al., 2012]. As we noted in the Introduction, the crowded
environment of the cell causes the slower diffusion of bulky proteins [Klumpp et al.,
2013; Milo and Phillips, 2016]. Here, the ratio between inferred and in vitro measured
value is ≈ 7.2, roughly comparable between the ratio of diffusion constants in
water and cytoplasm. The parameter values are burdened by measurement and
fitting imperfections, but it is still reassuring that the order-of-magnitude for
the ratio is in line with the expected estimates as based on Smoluchowski limit,
i.e., Km ≥ kinit/(4πDa) ∝ 1/D, where D is a diffusion constant, a is typical linear
dimension, and kinit is an initiation rate per ribosome [Klumpp et al., 2013]. The
low value of Km/∆r also suggest that the Eq. (7.13) will be close to the irreversible
limit since R0 ≈ 541 and Km/∆r ≈ 0.008. We further estimate the initiation factor
concentration that supports a 50% growth rate as [IF]50 ≈ 0.57 µM. We can further
explain higher value for ζ0 compared to the estimate in Chapter 6. Figure 7.10
shows that the full growth rate is recovered already at ≈ 0.4 initiation factors
per ten ribosomes, which is roughly ten times less than the estimate we used
previously [Bremer and Dennis, 1996]. Because we estimate the rate as ζ0  ζ/[IF],
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where ζ  3.0 s−1, this approximately ten-fold decrease results in the same fold-
increase in the estimate.
Predicting the effect of hyper-accurate ribosomes on the induction curve
Here, the advantage of such a model over a simple fit of a generic function can
be illustrated. Because the parameters have a physiological interpretation, we can
predict the change in the induction curve when parameters alter. The translation
rate of ribosomes can be reduced by specific mutations in the ribosomal proteins.
By fitting a sigmoidal function to the data in Fig. 7.10B, we can indeed map the
initiation factor concentration to the growth rate. However, we do not obtain a
mechanistic understanding of the fitted-function parameters.
Mutations in the ribosomal protein rpsL of the small ribosome subunit can
render ribosomes hyper-accurate to the extent that proof-reading becomes limiting
in translation [Ruusala et al., 1984]. The addition of streptomycin (which increases
the rate of mistranslation) increases the growth rate. Because κt is proportional to
the translation rate (see Introduction), we denote κt ,φ  κt ×φ, where φ is a relative
translation rate (φ  1 corresponds to WT translation rate). Put together, the growth
rate as a function of relative translation rate is λφ  λmaxλ0φ/[λ0(1 − φ) + φλmax],
where λmax  ∆rκt ≈ 2.8 h−1 and λ0 is a WT growth rate in this particular
medium. Additionally, we can predict the change in IF50 from Eq. (7.14) thus fully
constraining the induction curve without any free parameters. In the limit of R0 ≫ 1
and Km/∆r ≪ 1, IF50 ≈ λφ(rmin + ξ)/2ζ0 ∝ λφ, which offers a prediction for scaling
of the initiation factor concentration required to achieve 50% of the λφ.
This showcases the benefit of having a physiology-based model that offers a
mechanistic prediction, which we can trackback to a genetic perturbation. Here, the
effects of mutations that perturb catalytic rate ζ0 can be predicted as well. Here we
demonstrated how the reduced translation rate can alter the induction curve. If we
would like to pursue this further and investigate the effects of the translation rate
perturbations, it is of the essence to develop tools to measure the translation rate.
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7.4 Gene expression dynamics and the measurements
of the translation rate
In previous chapters, we focused primarily on the steady-state solutions. While
studying steady-state behavior is insightful for inference of global dependencies
between physiological processes, the dynamics of said processes can offer additional
information about the system. Furthermore, as we discussed in the Introduction,
many parameters that describe the steady-state behaviors are dependent on param-
eters describing the dynamics [Dai et al., 2016]. The dynamical properties of the
gene expression are directly connected with translation. Therefore, studying the
dynamics of gene expression can provide additional information about translation
parameters (e.g., translation rate) and those of related processes (e.g., mRNA tran-
scription or decay rate). Below we briefly discuss a simple model that describes the
dynamics of gene expression and experimental design that allows us to infer crucial
physiological parameters.
7.4.1 The dynamical system describing gene expression
We consider the following scenario: the transcription of a gene starts at t  0 when
new 5′-ends start appearing. These mRNA transcripts get degraded with the rate
proportional to their abundance, while non-degraded transcripts are translated.
However, a certain amount of time between the start and finish of translation is
required, since the ribosome processes a certain number of codons per second
(defined as a translation rate). On top, other processes (e.g., ribosome translation
initiation, ejection of a completed protein, etc.) delay the protein production. We
can lump all these contributions into a characteristic delay t0. Therefore, the rate of
new proteins appearing becomes proportional to the mRNA concentration at the
time t − t0. We note, that a different derivation that arrives to similar results is in
Ref. [Liang et al., 1999].
Let m be a concentration of mRNA; starting at the time of the induction, its time
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Figure 7.11: Main components of the model describing gene expression dynamics. (A) In the
model, we consider only simplified transcription and translation. In the transcription and translation
part, we consider synthesis and decay of mRNA and proteins, respectively. (B) The delay between
the start and the end of translation means that the rate of protein synthesis is proportional to the
abundance of mRNA at an earlier time.
derivative is
ṁ(t)  ω − m(t)ε, (7.16)
where ω and ε are an mRNA transcription and decay rate, respectively. Solving for







Here, we assumed that the transcription starts at t  0; in practice, induction of
transcription is also delayed relative to the “start” signal (i.e., the addition of the
inducer) – inducer has to enter into the cell and bind to the transcription factor,
RNAP initiates transcription, etc. As we discuss later, this delay can be accounted
for in delay time t0 as well. Equation (7.17) has the expected sigmoidal shape with
the limit limt→∞ m(t)  ω/ε, which is expected for a birth-death process.
We describe the time evolution of the protein concentration with a delay differ-
ential equation; protein synthesis rate at the time t is proportional to the amount of
mRNA at the time t − t0. The proportionality constant equals the initiation rate Σ
and the protein decay rate is given by Υ:
ṗ(t)  Σm(t − t0) − Υp(t). (7.18)
Here, we can mathematically delineate the sources of t0. Delay time t0 can be
separated into a variable and fixed component relative to the length of the ORF.
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Certain processes (e.g., ribosome binding to 5′-UTR and translation initiation) will
take the same time, invariant of the length of the downstream ORF: we lump all these
delays into a single number tlump. Because this number is the same forall transcripts, it
can account for delay times in transcription as well. On the other hand, ribosomes will
need a longer time for completing the translation of longer ORFs, i.e., tL  L/k, where
L and k are lengths of the ORFs (in codons) and translation speed. Parsing the onset
time into a fixed and variable component (i.e., t0  tlump+L/k) is useful in comparison
of the onset times of proteins of different lengths. Taking the difference between
the onset times of proteins A and B becomes ∆t  t0,A − t0,B  (LA − LB)/k  ∆L/k,
from which t follows that k  ∆L/∆t. Hence, knowing the onset times of proteins
of different (known) lengths can uncover the translation rate [Schleif et al., 1973;













and is zero for t < t0. The limit limt→∞ p(t)  ωΣ/(εΥ) is as expected for a steady-
state solution and represents the maximal attainable expression level at which
mRNA and protein synthesis (ω, Σ) and decay (ε, Υ) balance-out (Fig. 7.12A).
BA
Figure 7.12: Theoretical model of induction dynamics. (A) Time dependence of gene expression.
Rapid increase in gene expression slows down after passing the inflection point. We rescaled the
expression relative to its maximum ωΣ/(εΥ) and used mRNA lifetime tmRNA  1/ε as a time scale.
(B) Early stages of gene expression dynamics (before the inflection point). After τ0  t0ε a quadratic
increase (dotted line) is followed by gradual transition into a linear increase (dashed line). We used
τ0  0.25 and Σ/ε  0.1.
Since we are interested in the dynamics of the induction, we investigate the early
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behavior of the system, specifically around the time when the first proteins start to
appear. Expanding the Eq. (7.19) around t0, we obtain
p(t) ≈ ωΣ
2
(t − t0)2 . (7.20)
The quadratic behavior and independence of the degradation constants arise due to
low abundances of mRNA and proteins. Because degradation is proportional to
said abundances, it is low in comparison to the synthesis rates. We can heuristically
explain quadratic behavior by noting that if the mRNA abundance increases linearly
with time (in the absence of degradation) as m(t) ≈ ωt, protein synthesis then
equates ṗ ≈ Σω(t − t0). Integrating the latter between t0 and an arbitrary time t ≥ t0
yields p(t)  (ωΣ/2) × (t2 − 2t0t − t20)  (ωΣ/2) × (t − t0)
2 as in Eq. (7.20) [Schleif
et al., 1973]. In the early stages of the induction, we thus expect the quadratic increase
in expression (Fig. 7.12B).
Expression saturates after a long enough time. However, if in the early stages
expression increases quadratically (therefore with an upward concavity since
p̈(t) > 0) and flattens in the long term, it has to pass through the inflection







with 0. This yields a solution tinf  [t0ε − t0Υ + ln(ε/Υ)]/(ε − Υ). Taylor expansion
of a function around the inflection point yields a linear approximation due to van-
ishing second derivative. As we show later, this approximation contains additional
information about the system parameters. If we calculate the intercept of this linear
expansion with the time axis, we obtain
















In the limit ε ≫ Υ, Eq. (7.22) simplifies to tε  t0 + 1/ε. Consequently, this means
that if we determine the t0 [Eq. (7.20)] and the intercept tε [Eq. (7.22)], we can
estimate the average lifetime of mRNA, i.e., tmRNA  1/ε. Typically, proteins in
E. coli are relatively stable and are mostly diluted by the growth of cells. Therefore,
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the protein decay rate becomes Υ ≈ λ, which is in the order of 0.01-0.1 min−1.
Estimates of mRNA degradation are around 0.3-1 min−1 [Liang et al., 1999; Yu et al.,
2006], thus making these rates at most an order of magnitude apart. Thus, this
approximation essentially serves as an estimate for an upper bound of the lifetime
of mRNA. Thus, such a dynamic measurement can estimate the mRNA lifetime as
well as the translation rate.
Besides mRNA lifetime and translation rate, translation initiation rate is one of
the crucial parameters of translation as we have shown in Chapters 5,6, and Sec. 7.3.
In the following, we propose that as the variation of the ORF length uncovered
the translation rate, the variation of the transcript-specific initiation rate holds the
potential to reveal the relative changes in the initiation rates between different
conditions.
On the level of mRNA, multiple properties determine the initiation rate. The
contributions arise from: (i) energetics of hybridization between mRNA and rRNA
(SD-aSD) as well as the codon-anticodon pairing on the start site, (ii) energy
penalty of the suboptimal distance between rRNA binding site and start codon,
and (iii) energetics of the mRNA unfolding [Salis et al., 2009]. These properties
are directly determined by the sequence of mRNA and can be varied genetically.
From the point of statistical physics, the problem of the ribosome binding and
initiating the translation is similar to the polymerase binding to the promoter and
starting transcription. In the same spirit as in e.g., Ref. [Kinney et al., 2010], we can
describe the translation initiation using equilibrium statistical thermodynamics.
In this case, the initiation rate is proportional to the probability of binding given
with a Boltzmann weight, i.e., ∝ exp(−∆Etot/kBT), where ∆E is the sum of all energy
contributions described above [Salis et al., 2009].
With these considerations at hand, we can further parse the length-invariant
component tlump in the onset time t0. Namely, let us assume that













where trest(λ)  tsteps(λ) + L/k is the total time associated with all other required
translation steps except initiation. Denominator uti(λ) is an intrinsic translation
138
initiation rate,which we aim to determine. Here,λ encapsulates the growth condition
as well as the choice of the strain and is therefore variable. In Eq. (7.23), coefficient ϑi
denotes a characteristic weight, specific for i-th transcript. The value of this weight is
inversely proportional to the Boltzmann factor and is mRNA sequence-dependent,
specifically on the details of 5′-UTR.
In contrast to variation of the ORF lengths, modifications of the 5′-UTR do not
have a direct quantitative interpretation. As the actual values of ϑi are not known,
the direct inference of trest and uti is not possible. However, if we consider two
conditions (λ and λ′), we can infer the relative difference between uti(λ) and uti(λ′).
We start by inverting the Eq. (7.23) to express
ϑi  uti(λ) [t0(λ, ϑi) − trest(λ)] . (7.24)
Next, we plug the expression for ϑi [Eq. (7.24)] into the Eq. (7.23), but this time
for λ′:


















This expression allows the determination of the relative intrinsic initiation rate Γ.
The offset χ is independent of ϑi . If we consider a series of N transcripts of a
fixed length but with different 5′-UTR (different ϑi) with known onset times in
both conditions (λ and λ′), we can extract the Γ by fitting a line to a scatter plot of
onset times {(t0(λ, ϑ1), t0(λ′, ϑ1)), . . . , (t0(λ, ϑN), t0(λ′, ϑN))}. Experimentally, this
approach requires the determination of the onset times for a series of 5′-UTR variants
in a reference and studied condition. Fitting a line gives a slope, whose inverse value




The model we described above suggests a way of determining the translation
parameters if we can precisely measure the dynamics of gene expression. Specifically,
we require the measurement technique to have high sensitivity because we aim
to detect the emergence of first proteins. In turn, this requires low background.
Furthermore, high temporal precision is important to track events that have a typical
timescale of seconds to minutes. A classical method for determining low amounts
of proteins is using β-galactosidase (LacZ). This method has been used studies of
the induction kinetics of L-arabinose operon [Schleif et al., 1973] as well in later
refinements of the method for determining the translation rate [Zhu et al., 2016;
Liang et al., 1999; Liang et al., 2000]. While the β-galactosidase assay is highly precise,
it is also somewhat demanding to perform: it requires sampling of the culture
in regular intervals and lengthy processing of samples. Therefore, we aimed to
establish a technique that beside precision offers minimally invasive handling as
well.
We considered different reporters to replace the use of β-galactosidase assay. Flu-
orescent proteins, for example, offer convenient measurements. However, tracking
dynamical processes by measuring the fluorescence of proteins has a disadvantage:
fluorescent proteins are not fluorescent immediately after they exit the ribosome.
It can take many tens of minutes of maturation before fluorescence can be de-
tected [Iizuka, 2011]. Because we expect the typical time scale for translation of a
particular transcript to be in tens of seconds [Zhu et al., 2016; Bremer and Dennis, 1996;
Dai et al., 2016], this maturation process renders the fluorescent proteins less apt
for measurement of induction kinetics. We thus aimed to implement an induction
assay using bacterial luminescence.
Bacterial luminescence from Photorhabdus luminescens [Bjarnason et al., 2003]
requires an operon luxCDABE consisting of five genes, where genes luxC, luxD,
and luxE provide substrates (flavin mononucleotide FMNH2 and long-chain fatty
aldehyde) that bind to the heterodimeric complex of subunits α and β encoded by
luxA and luxB, respectively [Gregor et al., 2017]. The active site is located on the
140
α subunit, whose light yield depends on the presence of the β subunit. Thus, the
absence of the catalytic subunit α renders the cells non-luminescent. Therefore,
to track the induction kinetics, we aimed to put the luxA under inducible control.
This would allow us to cultivate a strain in the absence of an inducer and track
the induction kinetics upon the addition of a high concentration of the inducer.
Measuring luminescence can be done conveniently in an appropriate plate reader
and does not require manual sampling; thus, smaller sample volumes are required
and measurements can be done repeatedly. Furthermore, LuxA does not have to
undergo maturation after completing folding, which is faster (µs to ms [Kubelka
et al., 2004]) in comparison to GFP maturation times (minutes [Iizuka, 2011]). It is,
however, unclear how formation of a LuxA-LuxB dimer affects the measurements.
Additionally, as the model discussed above suggests, we wanted to make the
expressed gene longer by extending the 5′-end of the open reading frame. Further,
we required the system to allow quick modifications of the 5′-UTR. Therefore, we
aimed to build a compact genetical system that would allow convenient alterations
of the open reading frame as well as UTR. Below we describe the construction
and verification of such a system based on two plasmids and its eventual merger
into a compact one-plasmid platform. More technical sections are denoted with an
asterisk (∗).
7.4.3 ∗Construction of the platform
∗Deletion of luxA gene and inducible control
We began the construction of the plasmid platform by deleting the gene luxA from
the pCS-λ plasmid [Kishony and Leibler, 2003]. We deleted the luxA This was
done by site-directed mutagenesis using phosphorylated primers PCSdelLuxA-
F and PCSdelLuxA-R (Table 7.1). We DpnI digested gel-purified PCR product.
Ligation yielded pCS-λ plasmid ∆luxA, which we selected for by platting on LB
agar plates with 50 µg mL−1 kanamycin. Successful deletions were checked for the














Table 7.1: Oligonucleotides used in the construction of plasmids pCS-λ ∆luxA, pBAD24-
luxA, and pBAD24-lacZluxA. Annealing regions are printed in uppercase, underlined are
the restriction sites and bolded are start and stop codons (or the nucleotide, which will give
either after subcloning). Dashed underline indicates the linker.
Further steps require the introduction of luxA downstream of the PBAD promoter.
At this stage, we also included a (GGGS)2 linker (BioBrick identification: K1486003,
sequence GGTGGTGGTTCTGGTGGTGGTTCT) and the additional restriction site
AvrII for subsequent in-frame subcloning of lacZ upstream of the linker-luxA
tandem (additional bases CCAA between restriction sites in luxA-2-pBAD24-Fkpn
promote double-digestion and constrain the open reading frame). We amplified
the linker-flanked luxA gene from pCS-λ by primers luxA-2-pBAD24-Rhind and
luxA-2-pBAD24-Fkpn. PCR product was purified and digested with KpnI and
HindIII; plasmid pBAD24 [Guzman et al., 1995] underwent the same digestion
reaction but was additionally treated with rSAP to prevent spurious religation. The
ligation yielded pBAD24-luxA with an ampicillin resistance cassette (bla) and pMB1
origin (15-20 copies per cell) [Guzman et al., 1995]. Introduced restriction sites in
the primer luxA-2-pBAD24-Fkpn enabled subsequent digestion of pBAD24-luxA
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Figure 7.13: Construction of plasmids used in the measurement of the translation rate.
(A,B) We deleted luxA from the luminescence plasmid pCS-λ [Kishony and Leibler, 2003]
by using site-directed mutagenesis, yielding a plasmid pCS-λ∆luxA. (C) We put the gene
luxA under inducible control by subcloning into pBAD24; this step introduced an eight
amino acids long linker, enabling a fusion with lacZ, yielding pBAD24-lacZluxA in the
process. See the main text for details. (D) Promoter PBAD is repressed by AraC dimer by
forming a loop in DNA. When L-arabinose is added, AraC acts as an activator, which with
the help of cAMP-bound CAP recruits the RNA polymerase (RNAP) for transcription of the
downstream gene.
with KpnI and AvrII, which opened the cloning site to accept lacZ gene that was
amplified by primers kpn-lacZ-2-luxA-F and avr-lacZ-2-luxA-R. The overhang in
kpn-lacZ-2-luxA-F introduced additional adenine right after KpnI site to put the
gene into the correct reading frame. This yields a generic way for creating gene-luxA
fusions: forward primer begins with GGGGTACCA and continues with the sequence
of a gene after the start codon, while the reverse primer begins with AGTCCCTAGG
and continues with reverse-complemented sequence before the stop codon.
7.4.4 Experimental determination of the translation rate
We first tested whether the expression of luxA is tightly repressed in the absence of
arabinose and whether the addition of arabinose quickly derepresses the expression;




Figure 7.14: The measurement of induction dynamics reveals two distinct phases in
early expression. (A) The plot from Fig. 7.12 showing model results for easier side-by-
side comparison with the experiment. (B) Example of experimentally observed induction
dynamics. We added arabinose at t  0. After t0  147 s, a quadratic increase (dotted line)
in expression was recorded, followed by a smooth transition into a linear increase (dashed
line). The intersection of the linear approximation with the time axis is at t1  374 s.
measurements. However, because the PBAD promoter contains the CAP1-binding
site, we additionally verified the effect of adding cyclic-AMP (cAMP) before the
induction (Fig. B.7). The addition of cAMP before (but not at) induction makes the
expression stronger, but not quicker.
We showed that the promoter is tightly repressed in the absence of arabi-
nose and that we can detect the early stages of protein occurrence. We then
compared the experimentally observed induction dynamics with the model pre-
dictions (Fig. 7.12). Specifically, we wanted to see whether the expression time
track exhibits an initial quadratic increase that smoothly transitions into a linear
increase. Our experiments confirmed the existence of two different regimes in the
expression dynamics (Fig. 7.14). Concretely, after the delay of t0 we observed a
quadratic increase that gradually changed into linear. Further, we can now esti-
mate the mRNA lifetime from inferred times t0 and t1 as tmRNA ≈ t1 − t0. The
difference is t1 − t0  227 s or roughly 3.8 minutes, which is in line with current
estimates of mRNA lifetime that range between 1-5 minutes [Liang et al., 1999;
Yu et al., 2006]. However, mRNA lifetime is transcript-dependent as well, as demon-
1cAMP receptor protein
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strated for the toxin-antitoxin systems [Nikolic et al., 2018].
Next, we aimed to determine the translation rate in line with previously proposed
methods [Zhu et al., 2016]. We transformed HG105 with a supporting plasmid
pCS-λ∆luxA whose encoded proteins provide saturating amounts of LuxB and
substrate FMNH2. On top of the supporting plasmid, we transformed the strain with
the plasmid pBAD24-luxA or pBAD24-lacZluxA, i.e., reporter only or the extended
reporter (fusion lacZ-luxA), respectively. The addition of lacZ lengthens the open
reading frame by additional 1,022 codons. Therefore, by measuring the onset times
for reporter and extended reporter, we can determine the translation rate by dividing









1022aa Figure 7.15: The difference between onset times
for proteins of different length reveals the trans-
lation rate. By examining the quadratic increase
in expression in the early stages of induction, we
inferred the onset times for reporter and extended
reporter. Time tracks (white and gray disks for
reporter and extended reporter, respectively) fol-
low quadratic increase as demonstrated by linear
dependency upon square-root transformation.
We applied square-root transformation to the time traces of the expression
of the reporter and extended reporter. We observed that both traces complied
with the expected early-time dependency dictated by Eq. (7.20) – Fig. 7.15. The
average time difference between onsets amounted to ⟨∆t⟩ ≈ 82.8 s; because the
difference in lengths is 1,022 amino acids, we estimated the translation rate to
be ≈ 12.3 amino acids per second. This estimate is below the expected 18 amino
acids per second at λ0 ≈ 2 h−1 [Dai et al., 2016; Zhu et al., 2016]. However, our
measurement technique requires more optimization regarding the exact conditions
of the induction, e.g., cell density at the time of the measurement, pretreatment,
etc. Importantly, we demonstrated that the observed dynamics is consistent with
a mathematical model that predicts two distinct phases. Additionally, the values
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for physiological parameters (translation rate, mRNA lifetime) come close to the
previous estimates. Together with a convenient measurement approach (mix-and-
measure), this technique holds the potential to be readily used in the measurements
of translation parameters. However, our approach still requires two plasmids to be
simultaneously present in the cell.
∗Single-plasmid platform
Merging of the supporting plasmid and the induction-module bearing plasmid into
a single one would offer multiple benefits. It would decrease the burden plasmid
maintenance and expression of antibiotic cassettes. Additionally, it would require
a single transformation, thus making it useful for screening of translation rates
in various strains. Likewise, if designed appropriately, a single-plasmid platform
makes the genetic manipulations easier. Therefore, we aimed to construct a platform
for measuring translation rates that: (i) has a single antibiotic resistance cassette,
(ii) contains multiple cloning site for in-frame fusion with luxA, (iii) enable rapid
exchange of ribosome binding site (RBS) by flanking it with two unique restriction
sites, (iv) contains regulatory elements that lower the spurious read-throughs, and
(v) has a low-copy origin of replication. We aimed to construct such plasmid by using
Gibson assembly since it allows remarkable flexibility in designing new genetic
constructs (Fig. 7.16).
This process yielded a plasmid pTR-luxA that meets the requirements stated
above. Ribosomal binding site – specifically its SD – is flanked by NheI and EcoRI
restriction sites. This flanking allows rapid replacement of RBS with an oligo-duplex
made of annealed sense-antisense oligonucleotides. We can design the annealing
oligonucleotides such that they yield overhangs that are compatible with EcoRI-NheI
opening. Below we illustrate the procedure for the construction of RBS variants that
differ in two nucleotides of the SD.
We design the annealing nucleotides such that they anneal in 5′-CAGGNNG-
3′ on the sense strand; the sites NN differ between SD variants. We can choose
the two variable nucleotides to vary the strength of the RBS. There are sixteen































Figure 7.16: Gibson-assembled plasmid pTR-luxA enables the rapid creation of protein
fusions and the exchange of RBSs. (A,B) Fragments used in Gibson assembly. Matching
ends are denoted by numbers. This assembly removed EcoRI and AvrII restriction sites,
flanked the promoters with terminators, provided the low-copy number origin of replication,
and the ampicillin resistance cassette. Replacement of the RBS is based on ligation of the
duplex into the plasmid (B; bottom, typeset in black). (C) Plasmid provides a platform for
creating gene-luxA fusions (useful for determining translation rate) and quick exchange of
RBSs with annealed oligonucleotide duplexes with EcoRI and NheI overhangs. On the left
are shown candidate genes of different lengths.
initiation rate using a thermodynamic model [Salis et al., 2009]. From the calculated
translation initiation rates, we chose four variants whose calculated initiation rates
differ ∼ 2-fold (Table 7.2). With these variants at hand, we add CTAG and AATT to
5′-ends of the sense and antisense oligonucleotides. The overhangs of such duplex
are compatible with the sticky ends of digested pTR-luxA and new SD variants can
be efficiently ligated into the plasmid in a single step.
SD sense antisense init. rate [a.u.]
RBS1 5′-CTAGCAGGGAG-3′ 5′-AATTCTCCCTG-3′ 0.577
RBS2 5′-CTAGCAGGTGG-3′ 5′-AATTCCACCTG-3′ 0.182
RBS3 5′-CTAGCAGGGTG-3′ 5′-AATTCACCCTG-3′ 0.087
RBS4 5′-CTAGCAGGCCG-3′ 5′-AATTCGGCCTG-3′ 0.036
Table 7.2: Variants of Shine-Dalgarno sequence, corresponding sense-antisense oligonu-
cleotides, and relative initiation rate. Underlined is the annealing region. Calculated
initiation rates are obtained from RBS-calculator [Salis et al., 2009].
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The experiment presented at the beginning of this section illustrated how we can
determine the translation rate from a comparison of the onset times for reporter and
extended reporter. However, the translation rate we determine this way is specific for
a particular gene used in the extension. Therefore, to determine the global translation
rate, several genes should be used.If these are of different lengths (Fig. 7.16C), we can
fit a line to the onset times as a function of gene lengths. The slope would represent
the translation rate. The gene-specific translation rate, on the other hand, is useful
in dissecting the intricacies of specific genes and properties of their translation.
For example, a gene with many rare codons can be subcloned in-frame with the
reporter and we can infer its translation rate. We can deduce the best conditions
for its expression by varying the conditions or the expression strain. As such, this
tool can be of use beyond the basic studies of translation and can prove useful in
optimization processes in biotechnology.
7.5 Towards quantitative understanding of physiolog-
ical role of translation
This chapter illustrated efforts aimed at quantitative parsing of translation within
the context of physiology. As such, the presented results were conceptual rather
than conclusive. However, the chapter showcases that by using a simple theoret-
ical framework, we can analyze the observations tractably. Additional tools that
allow targeted changes in translation machinery would likewise reveal further
relationships between processes.
While the tools presented in this chapter still require optimization, preliminary
results are promising. We aimed at keeping the number of inferred parameters low
(one parameter per feature). If we balance the number of predictions with inferred
parameters, we can keep a constant check on used models.
If successful, a fully-characterized and verified quantitative model of translation
would offer a predictive tool that can explain multiple phenomena at once [Gregor,
2017]. As we elaborate in the next chapter, understanding of gene expression and
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its physical and biological constraints is crucial for many aspects of life sciences,
including evolution and synthetic biology.
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8 Discussion and outlook
We established a framework that combines mathematical modeling,high-throughput
growth rate measurements, and genetic perturbations to elucidate the underlying
mechanisms of drug interactions between antibiotics inhibiting translation. Kinetics
of antibiotic-target binding and transport together with growth laws, i.e., the physio-
logical response to translation inhibition (Introduction), form a biophysically realistic
baseline model for predicting antibiotic interactions from properties of individual
antibiotics alone (Chapter 4). This model explained many interactions, but not all,
failing specifically for suppressive interactions. Predictions improved by taking into
account the step-wise progression of ribosomes through the translation cycle (Chap-
ter 5). This was achieved by mimicking antibiotic perturbations of this progression
genetically, which directly identified the contribution of antibiotic-imposed transla-
tion bottlenecks to the observed drug interactions. Finally, to explain the origin of
suppressive interactions unaccounted for by the biophysical model, we modeled
the traffic of translating ribosomes explicitly. Our results show that translocation
inhibition can cause ribosomal traffic jams, which dissolve in a non-equilibrium
phase transition when initiation is inhibited simultaneously with translocation,
thereby restoring growth (Chapter 6). This phase transition explains the suppressive
drug interactions between antibiotics targeting initiation and translocation.
Taken together, our framework mechanistically explained 20 out of 28 observed
drug interactions, as classified based on stringent criteria. While 16 out of 28 of
interactions were already explained by the biophysical model, these include many
weak and additive interactions; in contrast, only the translation bottleneck approach
correctly predicted some of the strongest interactions and, in particular, suppression.
Furthermore, we only classified predictions as correct if the majority of growth
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Figure 8.1: Fraction of drug interactions ex-
plained. Biophysical model explained ≈ 57%
of interactions (orange), while including the
bottlenecks-based remapping (yellow) increased
this fraction to ≈ 71%. This is only slightly below
the empirical upper bound (75%, dashed line) ob-
tained by considering replicates as predictions.
rates across the dose-response surface quantitatively matched the prediction. As
a result, cases where the predicted and observed drug interaction type agree are
often still classified as false because the agreement is not quantitative. If the same
stringent criteria are applied to replicate measurements of drug interactions (shown
in Fig. E.2), only 75% of measurement replicates are classified as faithful predictions.
Thus, our conservative estimate of the fraction of explained interactions (71%) is
close to the maximum achievable at our measurement precision. Notably, even
cases rejected as quantitatively different can provide valuable insights. For example,
the remapping-based prediction of the CHL-FUS interaction (Fig. 5.10) is rejected
because it quantitatively exaggerates the suppression between these drugs. Never-
theless, remapping correctly predicts the occurrence of suppression as well as its
direction. Qualitative observations like these still advance our understanding of
drug interactions by highlighting drug interaction mechanisms that are distorted
by additional effects of unknown origin.
While we focused on translation inhibitors, key elements of our framework can
be generalized to drugs with other modes of action. Specifically, when considering a
drug that targets a specific process mediated by an essential enzyme, our approach
of equating the deprivation of the enzyme with the action of an antibiotic is readily
applicable. Depriving the cell of an essential enzyme would cause the formation
of a physiological bottleneck. Our observations also highlight the advantages of
factor deprivation compared to simple overexpression: the former produced a
quantitative prediction for drug interactions, while no meaningful prediction could
be made from overexpression data (Fig. B.4). The general approach of depleting key
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accessory proteins is particularly useful for antibiotics targeting multi-component
complexes or in cases where the effects of overexpressing the drug target are difficult
to interpret [Palmer and Kishony, 2014].
Similar to translation, transcription is a crucial step in gene expression and is a
target of antibiotics. The molecular machine at the core of transcription is a multi-
component enzyme RNA polymerase (RNAP). The rates of transcription depend
on the abundance of RNAP. Similarly to the translation apparatus, the expression
of RNAP and its activity are growth rate-dependent [Bremer and Dennis, 1996;
Shepheard et al., 1980]. Besides the synthesis of mRNA, RNA polymerases synthesize
crucial components of translation apparatus such as the ribosomal RNA. Because
ribosomes synthesize RNAP proteins, this interdependence constitutes another
branch of the autocatalytic process underlying ribosome biogenesis. Together, these
considerations result in another growth law that connects the number of ribosomes
and the number of polymerases with the growth rate [Kostinski and Reuveni, 2020].
By titrating the amount of RNAP (by controlling the expression of its subunits), the
global effects of transcription inhibition would occur [Izard et al., 2015]. Similarly,
transcription-targeting antibiotics (e.g., rifampicin) are expected to elicit similar
global effects and could be mimicked by titration of RNAP. As such, the titration of
RNAP would offer an insight into the idealized interference with the global rate of
transcription and its impact on physiology.
Several tempting antibiotic targets could be additionally considered within
the framework of physiological bottlenecks. Folate biosynthesis, for example, is a
target of multiple antibiotics (Introduction). Here, titration of targeted enzymes
(e.g., dihydrofolate reductase or dihydropteroate synthase [Walsh, 2003]) would
reveal the physiological consequences of inhibitions of various steps in the folate
biosynthesis. Importantly, in the case of sulfa drugs that target dihydropteroate
synthase, pools of essential metabolites are drained as the antibiotics divert the
flux towards nonproductive compounds [Walsh, 2003]. Titration of the enzyme
would help delineate the effects of an overall reduction in folate biosynthesis
compared to the accumulation of nonproductive compounds and drainage of the
metabolite pools. Further, titration of gyrase (encoded by gyrA,B) would mimic
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a canonical gyrase inhibitor like coumermycin A1 [Sugino et al., 1978]. Beyond
antibiotics, environmental conditions such as nutrient limitations and their interplay
with the action of antibiotics can be mimicked using similar genetic interventions.
For example, underexpression of lactose permease and glutamate dehydrogenase
mimic carbon or anabolic limitation, respectively [You et al., 2013; Hui et al., 2015].
In general, genetic perturbations enable precise investigations of essential cellular
processes – including those that cannot be currently targeted by drugs. In sum,
there are several attractive opportunities for mimicking the antibiotic effects with
equivalent physiological bottlenecks that could be explored in the future.
Mimicking the effects of two drugs with controllable genetic perturbations
generalizes the concept of genetic epistasis to continuous perturbations. Epistasis
studies compare the effects of double gene knockouts to those of single knockouts
and identify epistatic interactions – an approach that can reveal functional modules
in the cell [Segre et al., 2005; Constanzo et al., 2010; Tong et al., 2004]. Our results show
that continuous genetic perturbations provide valuable additional information on
genetic interactions (Chapters 5 and 6). Firstly, the direction of epistatic interactions
cannot be extracted from measurements of single and double mutants (Fig. 8.2).
Secondly, the quantitative information obtained from such “continuous epistasis”
Figure 8.2: Continuous variation of two rates re-
veals relationships between cellular processes.
While a point measurement (brown circle) can
detect suppression, its direction remains unclear.
A gradual change in rates specifies the direction
of suppression and offers quantitative insights
into the intertwining of processes.
measurements provides more stringent constraints for mathematical models of
biological systems. In particular, continuous epistasis data can be powerful for the
development of whole-cell models that describe the interplay of different functional
modules in the cell. Thirdly, this approach allows including essential genes in
epistatic interaction networks even for haploid organisms, which otherwise requires
the use of less well-defined hypomorphs. Hence, continuous epistasis measurements
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augment all-or-nothing genetic perturbations.
Continuous epistasis measurements further enable a deeper understanding
of previously mysterious antibiotic resistance mutations. Specifically, translation
bottlenecks that alleviate the effect of an antibiotic expose a latent potential for
resistance development. Indeed, mutations with effects equivalent to factor-imposed
bottlenecks occur under antibiotic selection pressure. For example, resistance to ERM
in E. coli can be conferred by mutations in proteins of the large ribosomal subunit,
that hinder its maturation and lower its stability [Zaman et al., 2007]. Consistent
with this observation, our results indicate that the action of ERM is alleviated by
lowering the stability of the 50S subunit (Fig. 5.3). Mutations in recycling factor were
observed in Pseudomonas aeruginosa evolved for resistance to the TET derivative
tigecycline [Sanz-Garcia et al., 2018]. The observed alleviation of TET action by a
recycling bottleneck (Fig. 5.3) offers a mechanistic explanation for the beneficial
effects of these mutations. Mutations in other genes predicted based on the effect of
translation bottlenecks may be difficult to observe, especially in clinical isolates, due
to the associated fitness cost and selection pressure for reverting the mutations in the
absence of antibiotic selection. Beyond mutations conferring resistance to individual
drugs, consistent or conflicting dependencies of different antibiotics on translation
bottlenecks may further indicate the potential for evolving cross-resistance and
collateral sensitivity, respectively [Baym et al., 2016]. Likewise, the framework could
facilitate the development of better strategies for antibiotic cycling.
Our work also demonstrated the potential of improved null models for drug
interactions that are based on generic biophysical and physiological considerations.
The number of parameters is minimal and the biophysical model we presented
makes parameter-free predictions. This model is readily extended to capture
phenomena such as an inactive fraction of ribosomes (Sec. A.5.1) or physical
interactions between antibiotics on the ribosome (Chapter 4. Including more detailed
mechanisms, e.g., interplay between different ribosome states that are targeted by
different antibiotics, would require additional parameters with unknown values. In
essence, such a detailed model and its parameters would have to be fine-tuned for
every antibiotic combination. Meaningful predictions would require independent
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quantitative measurements of multiple kinetic parameters such as the rates of
antibiotic binding to the ribosome in different states; for all practical purposes, such
a more detailed model would not be predictive. In contrast, the minimal biophysical
model we presented provides an improved null expectation for drug interactions.
Deviations from this expectation expose drug interactions for which additional
details of the antibiotic-ribosome interaction are important. We showed examples of
the latter experimentally by halting the ribosome in specific stages of the translation
cycle. Developing a fully parameterized mathematical model of the translation cycle
and how it is affected by different antibiotics is a formidable challenge for decades
to come.
Crucial to both the minimal biophysical and the TASEP-translation model (Chap-
ters 4 and 6) is the validity of the growth laws. By experimental validation of such
models, we showed that capitalizing on growth laws in theoretical models can
offer valuable insights into the interplay of cell physiology and antibiotic action.
Unexplained deviations are good starting points for the identification of situations
in which growth laws are violated. This underscores the importance of elucidating
such growth laws in other organisms.
In conclusion, we presented a systematic approach for discovering the mech-
anistic origins of drug interactions between antibiotics targeting translation. As
illustrated above, our approach of mimicking drug effects with continuous genetic
perturbations is general and can be extended to antibiotics with other primary
targets, other types of drugs, and other organisms. As the translation machinery is
highly conserved, the interaction mechanisms for drugs targeting specific steps of
translation we uncovered may generalize to diverse other organisms. Crucially, both
the biophysical model and bottleneck-mimicking of antibiotics have different scaling
than the brute-force measurement of all drug interactions between antibiotics.
Minimal model – for independent or competition binding scheme – requires only
parameters that are inferable from individual dose-response curves. As such, a
number of measurements that are needed to predict an interaction scales linearly
rather than quadratically with the number of antibiotics. The required number of
experiments within the bottlenecks framework scales quadratically with the number
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of targeted processes rather than with the number of antibiotics. Different scaling
offers physiologically-informed predictions for drug interactions at the reduced
experimental efforts. This advantage could facilitate the discovery of more powerful
antibiotic combinations and further strengthen the analogy between antibiotics
and genetics. In the long run, extending our combined experimental-theoretical
approach to other types of drugs and other biological systems will enhance our
understanding of drug modes of action and interaction mechanisms and provide
deeper insights into cell physiology.
Outlook
The aim of this thesis was a broad-stroke quantitative description of the trans-
lation perturbations. However, many additional aspects of translation and the
impact of antibiotics remain elusive. The thesis (specifically Chapter 7) suggests
that further quantitative characterization and formulation of quantitative models
could offer testable predictions that lead to additional insights into the biology of
bacteria. Specifically, by investigating translation as a core process, we make the
next steps towards the understanding of genetic circuits, metabolic control, and
growth physiology. As we sketch below in more detail, a tandem of modeling and
experimentation is instrumental in discerning the answers to evolutionary and
physiological questions.
Physical constraints and numerous tradeoffs shape the biological processes across
scales. For example, translating ribosomes are slower upon the introduction of hyper-
accuracy conveying mutations, which in turn inhibits the growth of bacteria [Ruusala
et al., 1984]. From an evolutionary point of view, this growth deficit represents a
fitness disadvantage – yet, for an isolated bacterium this “take-your-time” approach
might be beneficial if highly precise translation of proteins is more beneficial over
rapid growth. Additionally, the doubling time of the ribosome represents a hard-
bound on doubling time of bacteria; the smallest and fastest ribosomes can translate
their constituent proteins in approximately six minutes [Reuveni et al., 2017]. The
autocatalysis of ribosome synthesis is thus of particular importance: how is the
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replication of translation machinery by itself constrained? Recent work revealed
that the ribosomes appear optimized for the autocatalytic production by having a
predominant fraction of mass in a few ribosomal RNAs and multiple small proteins.
This suggests that minimizing the time ribosomes spend making themselves might
have been one of the utilities for which translation is optimized. Yet, it is far from
clear what are the other relevant utility functions. Successful establishment of a fully-
specified phenomenological model of translation offers the advantage of probing
multiple such questions simultaneously – utilities operate across a tightly-knit net
of constraints and tradeoffs, such as the proteome allocation.
Translation machinery can account for nearly half of E. coli’s proteome; as
we discussed in the Introduction, the expression of components of translation
machinery is regulated. While plentiful data is describing the stringent response
in the transition to a poor growth environment and its association with regulation
by ppGpp, it is still not fully understood how the regulation of translation is
implemented. Specifically, which translation parameters can the cell detect and
respond to? Importantly, a large part of regulation might arise – at least partially –
from passive, physical mechanisms. Here, the future aim should be the targeted
perturbations of particular steps in translation using genetics as presented in
Chapters 5-7. Systematic measurement of all targeted genetic perturbations would
consequently allow full quantitative characterization of the translation cycle. Not
only would the underlying mathematical model offer predictions on the behavior
of translation upon perturbations and environmental changes, but it would reveal
the physical and physiological constraints.
Probing the effects of translation bottlenecks in more detail would allow un-
covering additional constraints. Not only that the translation requires significant
resources in proteome terms, but it is also one of the most energy-demanding
processes in the cell [Maaløe, 1979]. Therefore, the interplay between energetics and
protein synthesis is of importance. While theoretical studies [Weisse et al., 2015]
have revealed the interplay of trade-offs, gene expression, and growth, a more com-
prehensive experimental study of protein synthesis energetics is required. Precise
quantitative measurements of ATP levels are necessary; while challenging, these
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suggest that ATP levels are roughly independent of the nutrient-dependent growth
rate [Schneider and Gourse, 2004]. Recent advances in the development of ATP
ratiometric sensors [Yaginuma et al., 2014] could aid the measuring of ATP levels in
multiple conditions. Furthermore, levels of ATP and GTP are not only involved in
providing the energy required in translation but might affect protein synthesis by
skewing homeostatic parameters. Specifically, NTPs chelate Mg2+ ions required for
the normal function of protein synthesis and stability of ribosomes [Pontes et al.,
2015]. Exploring the effects of pools of essential metabolites (such as ATP) and their
effects on translation would allow the construction of a more holistic picture of
protein synthesis within a physiological context. Additionally, these constraints
and interplay of trade-offs shaped the evolution of translation components and
translation regulation.
A multitude of intertwining processes makes classic epistasis measurements
challenging. While point-epistasis is certainly informative, continuous epistasis
provides richer information on the interplay between processes. As such, it has
important connotations in the understanding of the evolution of translation. As we
illustrated in Chapter 6, intricate relationships exist between cellular processes that
a smooth variation of them can reveal. By considering the growth rate as fitness,
a dose-response surface becomes a fitness landscape. If it arises from physical
constraints, selection could drive the evolution of translation machinery according
to these landscapes. Conversely, this can explain why some evolutionary trajectories
appear nonintuitive. As illustrated in Fig. 8.3, the shape of the fitness landscape
might transiently drive certain rates down to speed-up the evolution even though
Figure 8.3: Evolution on complex fitness land-
scapes. Fitness landscape determines the evolu-
tionary trajectory. As the rates of two processes
(green and orange wedges) can either evolve in-
dependently (brown symbols, arrows) or in con-
cert (white symbols, dashed line), relationship
between the processes will steer the evolutionary
trajectory.
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the highest fitness is achieved when both rates are high. Such a conceptual picture
is based on largely homogeneous populations in which a fixed mutant quickly
overtakes the entire population. However, the populations in the wild are rarely as
homogenous as tacitly assumed above. Not only can the populations be genetically
heterogenous, but can additionally exhibit a phenotypic heterogeneity. Departing
from an isogenic and average cell is of particular importance when we consider
evolution in niche environments.
To account for heterogeneity, we need to change the scale of our investigation.
While the modeling of bacterial physiology by deterministic differential equations
is a useful tool, it does not reflect the inherent randomness and discreteness of
the underlying processes [Samoilov and Arkin, 2006]. So-called deviant effects can
cause substantial differences between deterministically predicted average response
compared to the one obtained in a fully stochastic description [Kuwahara and Gao,
2013]. These stochastic effects in the context of antibiotic treatment might manifest
as the “growth rate-switching” between different growth modes (e.g., growing
and non-growing) or in increased variability of growth rates. Even for cellular
components with lower intrinsic noise (e.g., due to a high number of molecules)
stochastic events – such as component partitioning after a cell division – might
greatly affect cell physiology and the growth rate. While the growth rate has been
shown to be stable over many generations [Wang et al., 2010], this robustness
becomes questionable under antibiotic or other stress. Specifically, if the growth rate
distribution under stress becomes multimodal, further single-cell level implications
are of interest. For example, hysteresis effects can cause switching between growth
rates to be history-dependent and thus affect the dynamics of antibiotic therapy.
Additionally, connecting the results of the deterministic description with stochastic
phenomena could streamline the analysis. Associating the stochastic effects with
microscopic mechanisms would be of fundamental importance in going beyond
population level-studies.
By considering every bacterium as an independent unit, we can ask fundamental
questions of translation on the microscopic level. To start: it is not clear that the
growth laws, rates of translation kinetics, etc. measured in batch-cultures directly
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mirror the intricacies of a single cell. Thus, the development of tools allowing
single-cell quantitative characterization of translation and growth rate parameters
is necessary. On a batch-culture level, subpopulations with the highest growth rate
overtake the rest. However, these outcompeted subpopulations are a meaningful
part of bacterial biology. This is not only critical for bacterial response to antibiotics
but becomes crucial in ecological and evolutionary considerations. Especially when
we consider the utility of translation, single-cell experimentation can highlight
additional aspects of translation. How noisy is the translation and which step in the
translation cycle is the noisiest? How does the high number of components involved
in translation manifest in the overall performance of translation?
Physical constraints do not only embody the physiology of bacteria but will
affect our efforts towards the engineering of living organisms. These challenges
would be of particular importance in building of the minimal cell. In particular, the
construction of a synthetic cell necessitates a deep understanding of translation.
The translation is a core process that requires a multitude of components to work in
concert. Building a minimal cell is based on finding a minimal set of components
that support a self-replicating, functional cell; as such, it necessitates going beyond
the “black box” approach when trying to reconstitute translation systems. Yet,
this forward engineering predominantly uses in vitro approaches that often aim
to characterize individual components in detail rather than whole systems. As
demonstrated in Chapter 6, certain phenomena only emerge when we consider
several processes simultaneously rather than their components in isolation. The
reconstitution of a particular cellular module from its components in a bottom-up
fashion is a formidable challenge. Yet, this challenge has been solved by millions
of years of evolutionary tinkering. Therefore, studies of in vivo systems aid the
understanding of both evolutionary and engineering approaches. Mathematical
modeling can overarch both; importantly, a systemic approach can reveal the physical
constraints that affect both the engineering and evolutionary systems.
The central dogma of molecular biology is the basis of our current understanding
of life processes. The translation is a crucial process in central dogma and has
been investigated heavily. Yet many mysteries still remain; some questions are
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revisited and answers can change our interpretation of translation. While central
to translation, the ribosomes were long considered as “black boxes” converting
the information stored in mRNA into proteins. Many considered ribosomes and
mechanistic understanding of their function to be either of little value or simply
too complex to be solved [Ramakrishnan, 2018]. The structure of the ribosome
was eventually cracked and antibiotics proved remarkably useful in establishing
the dynamical landscape of translation progression on a structural level. In this
thesis, we demonstrated (albeit to a much more modest degree) that antibiotics can
be insightful even on higher levels of the physiological organization. Specifically,
a combination of both genetics and antibiotics offers an attractive approach for
deepening our understanding bacterial physiological regulation and how the
biophysical constraints shape these regulatory responses.
* * *
Nowadays, presented with abundant data, we can decide on the level of complexity
at which we would like to answer the question of the origin and mechanics of life.
However, current approaches often increase the dimensionality of data rather than
its ampleness [Młynarski et al., 2019]. Thus, our efforts should not only increase
the rate of data collection but also propose efficient methods of data analysis and
interpretation. The efficient coarse-grained models are of high practical value as we
can – due to clear assumptions – associate the deviations with processes included
in the model. As highlighted in Ref. [Młynarski et al., 2019], we need to define the
balance between inference and utility of proposed models. Especially crucial are
the models arising from first principles, which are common in physics but are still
scarce in biology. High-quality data motivates the construction of such models,
which we can illustrate with an analogy from history of physics [Jun et al., 2018]: as
Brahe’s precise measurements of the planetary orbits led Kepler to infer the laws of
planetary motions (which were phenomenological but correct and much simpler
than the “epicycles”). Newton, on the other hand, was able to derive these laws from
a single equation describing the dynamics of motion (a first principle). We should
hope for the latter but embrace the former.
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A Analysis of a mathematical model
A.1 Parameter reduction and the bifurcation point
In the following we derive expressions that constrain the parameter space in which
the system is bistable. We start by rewriting the steady-state solution with new
variables, which will facilitate reduction of parameters. We recast Eq. (4.4) so as
to express aex/2IC∗50 as function of growth rate; this is possible since aex/2IC∗50
occurs linearly in the equation. At this stage we introduce new variables and rewrite
parameters in a dimensionless form:
aex  c × IC50, (A.1a)
λ  y × λ0, (A.1b)
λ∗0  α × λ0, (A.1c)
where IC50 is concentration needed to halve the growth rate and λ0 is a drug-free















α2 + y2 − y3. (A.2)
To remove the ratio IC50/IC∗50 from the equation, we use the expression from






























This relation is obtained by plugging y  1/2 and c  1 into Eq. (A.2). Finally, we











This equation expresses the relative concentration c as a function of relative growth
rate y in which α is the sole parameter. Fitting an implicit function can be challenging;
we can estimate α from equating the implicitly calculated derivative of Eq. (A.4) to
the derivative of the Hill function with steepness parameter n, when both derivatives
are evaluated at c  1. An estimate for the response parameter is then α ≈
√︁
1/(n − 1).
Figure A.1: Surface of response curves as a function of a response parameter. With increasing
response parameter the dose-response curves become shallower. Below a critical value of a response
parameter, more than one growth rate y can correspond to a particular concentration.
A.1.1 Bifurcation point
To determine the critical value of the parameter α below which bistable concentration














8y3 − 4y2 + α2  0, (A.6)
we can determine values of y where the derivative of Eq. (A.5) is 0. Since the
equation is of third order, we expect either three real roots or one real together
with a conjugated pair of complex roots. The solutions [found using Mathematica
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We note that whether all roots are real is determined by the sign of 27α2 − 4; this
leads to a critical value of αcrit  2/(3
√
3) ≈ 0.385 – the system has a bistable region
when α < αcrit. To obtain the span of concentrations at which two bistable growth
rates exist (Fig. 4.2d), we plug Eqs. (A.7a) and (A.7c) into Eq. (A.4).
A.1.2 Linearized case of constitutively expressed resistance gene
As noted in the main text (Sec. 4.3.3), for high values of Krem the Michaelis-Menten
equation linearizes. In this case we can reuse the expression for growth-dependent
efflux from Ref. [Greulich et al., 2015]. Using the parameter reduction from above,


















α2  0. (A.8)
where Ω  Vmax/(poutKrem). This expression can be rewritten into reduced form as
c 
1














Here, we used the relation that follows directly from Eq. (A.8); IC50/IC∗50  (1/2α) ×[︁
1 + α2 (1 +Ω/2)
]︁
. By solving dc/dy  0 we obtain a condition −64α2 + 432α4 +
48α4Ω − 12α6Ω2 + α8Ω3 ≤ 0 for bistability to exist; heuristically, we note that the
leading term in Ω is of the third power and positive and will for high values of Ω
make the expression necessarily positive and will thus make the system monostable.
This illustrates the importance of non-linearity in the expression describing antibiotic
removal [Eq. (4.25)]; the presence of positive feedback alone is not sufficient for the
occurrence of bistability. In the limit Ω→ ∞, Eq. (A.9) becomes simply y  1 − c/2
for c ≤ 2 and y  0 otherwise.
A.2 Calculation of dose-response surface for additive
interaction and Loewe interaction score
An additive interaction is characterized by linear isoboles. In this section we briefly
sketch the derivation. Let cA and cB be relative concentrations (measured in IC50 of
respective antibiotics) of antibiotics A and B, respectively. Individual dose-response
curves are given by fA and fB. To construct the additive surface, the growth rate in any
point (cA , cB) has to be calculated solely from known responses to individual drugs.
As isoboles are linear, there is an isobole that passes through this point but terminates
in some unique (cA,0, 0) and (0, cB,0), from which it follows that cB  cB,0(1− cA/cA,0).








× (1 − cA/cA,0) for
cA,0 is sought, which depends on cA and cB. If such solution is termed ĉA,0(cA , cB)
then the whole dose-response surface is given as fA (ĉA,0(cA , cB)). Integration of
Eq. (4.10) is performed over an area where growth rate is above a chosen threshold.
Throughout the systematic calculation of phase diagrams, this threshold is set




We evaluated the steady-state solution of the system Eqs. (4.6) by forward time
integration of the differential equations. We used λ0  2 h−1, which is the drug-
free growth rate in rich lysogeny broth (LB) medium at 37◦C. We rescaled the
time by defining t  Tτ, where T  (αA + αB)−1 × (1/λ0) and τ is a real number.







; concentrations of all species were rescaled by M. To





. To mimic the situation in which exponentially growing unperturbed
bacterial culture is exposed to antibiotic, we set the initial condition to y  1; the
rest of the species were set to 0. We integrated the rescaled differential equations
forward in time until τ  9 × 103 for by using Mathematica function NDSolve.
In computations, KD and kon values were set for both antibiotics to 0.1 µM and
100 µM−1h−1, respectively. The results are largely invariant of the choice of these
numeric constants as long kon ≫ κt and KD is roughly between 0.01 − 1 µM.
Upon fitting α to the normalizeddose-response curves,we fixed kon  100µM−1h−1
(which gave consistent results for all dose-response curves). For each dose-response
curve, we determined the optimized value of KD (Fig. A.2). We used these optimized
values in all computations used in comparison between the model and the data. We
verified the impact of uncertainties in fitted response parameters by bootstrapping.
166
A B
Figure A.2: Example of an effect of numerical parameters (KD and kon) on root-mean-square
error (in comparison to the experimental data). These parameters are required for forward time
integration. The root-mean-square error was normalized relative to the maximal error in the scanned
interval. (A) Effective dissociation constant KD exhibits roughly two orders of magnitude wide
plateau (double-headed arrow; minimum is denoted by a circle). (B) First-order binding rate constant
kon does not exhibit a plateau but rather flattens out – -consistently with the requirement that
kon ≫ κt.
A.4 Analytical solution in the limit of strong inhibi-
tion and reversible binding
The system of ODEs [Eqs. (4.6a-d)] can be linearized for near-zero growth rates (i.e.,
λ ≪ λ∗0, λ0) which is the case when the external concentrations of antibiotics are
high enough (aex,i ≫ IC50,i). In the latter case one can postulate two constraints:
(i) Ribosome synthesis is up-regulated to the theoretical maximum, i.e., rtot 
rmax and (ii) internal concentration of the i-th antibiotic is a′i ≈ aex,ipin,i/pout,i .
These constraints eliminate the dynamical equations for internal concentrations of
antibiotics [Eq. (4.6a)]. The fully specified and expanded system of equations reads
ṙu  −(ru − rmin)(kon,Aa′A + kon,Ba
′
B) + rb ,Akoff,A + rb ,Bkoff,B , (A.10a)
ṙb ,A  kon,A(ru − rmin)a′A + δoff,Bkoff,Brd − δon,Bkon,Brb ,Aa
′
B − koff,Arb ,A , (A.10b)
ṙb ,B  kon,B(ru − rmin)a′B + δoff,Akoff,Ard − δon,Akon,Arb ,Ba′A − koff,Brb ,B , (A.10c)








The system is linear and thus the steady-state solution exists in a closed and
unique form. We initially derive the stationary solution for independent binding,
i.e., δσ,i  1:
ru 
∆r(︂
1 + a′A/KD ,A
)︂ (︁
1 + a′B/KD ,B
)︁ + rmin, (A.11a)
rb ,A  ∆r
a′A
a′A + KD ,A
1
1 + a′B/KD ,B
, (A.11b)
rb ,B  ∆r
1
1 + aA/KD ,A
a′B




a′A + KD ,A
a′B
a′B + KD ,B
. (A.11d)
Each product term can be rewritten as a function of a′i/KD ,i , which can be fur-





/4. Together, these expressions allow rewriting Eq. (A.11a) using




/(α2i λ0), which finally leads to the Eq. (4.11). To
obtain Eq. (4.12) the general solution of Eqs. (A.10) is evaluated; the latter is further
simplified by assuming that koff,A ≈ koff,B, which approximately holds for reversibly
binding antibiotics.
A.5 Effect of dose-response curve concavity on the
shape of isoboles
For intermediate values of α ∼ 1 and increasing δ, we observed that the isoboles of
the dose-response surface at lower drug concentrations indicate strong antagonism,
whereas at higher concentrations, they indicate synergism (Fig. A.3A). Is it possible
to determine a concentration value above which increasing δ will cease to increase
antagonism but rather increase synergism? Intuitively, the interaction-characteristic
shape of isoboles is determined by the sign of the mean curvature, the latter being
defined as





















Figure A.3: Dose-response surface can locally have both antagonistic and synergistic isoboles, de-
pending on the concavity of the individual dose-response curves. (A) Examples of dose-response
surfaces with α  0.4 and with either independent (left, δ  1) or strongly cooperative binding
(right, δ  104). Purple box highlights the area showcased in (B). Dashed black lines denote an
approximate area in which increasing δ increases antagonism. (B) A detail [highlighted rectangle
in (A)] of dose-response surfaces for different values of α. For α < 2 black dashed line denotes the
boundary below which the increasing cooperativity δ increases antagonism (shades of yellow);
above it synergistic character is enhanced (blue). Two isoboles are showcased for each example:
purple and black lines correspond to δ  1 and δ  104, respectively. Note, that below cinf isoboles
in the case of strong cooperativity become steeper than the independent ones; above cinf isoboles
become shallower, which is indicative of synergy.
where k1 and k2 are principal curvatures. Full dependency of Ka is not accessible as
an analytical expression for y(cA , cB) is not known; however in the limit δ → ∞ the
antagonistic isoboles become nearly perpendicular to the axes, thus rendering all
derivatives along perpendicular directions equal to zero. Hence, the expression for











As the denominator is always positive the sign of Ka depends only on the sign of
the second derivative along the axis.
To find this point, we need to determine the inflection point of the relative growth
rate y along either of the axes. Here, we need to solve d2 y/d2c  0 for α; since y is
given only implicitly in Eq. (4.5), the second implicit derivative is calculated. This
leads to inflection point at relative growth rate yinf  3
√︁
α2/4 for α > αcrit, at which







From the expression for yinf we observe that we have a relevant solution only
for α < 2; this leads to the first conclusion – the intermediate regime of surfaces
having both antagonistic and synergistic contours exists only up to α  2. This also
implies that for every response parameter α, given a high enough concentration of
an antibiotic, the isoboles will become synergistic. However, at low growth rates
at high concentrations the approximation [Eq. (4.14)] becomes relevant (Fig. A.3B).
Numerically computed dose-response surfaces for δ  1 and δ  104 illustrate that
indeed above the cinf character of the isoboles is different and that the transition
happens due to vanishing second derivative.
A.5.1 Ribosome subpopulations
If we consider that translation inhibitors can bind only to a specific subpopulation
of ribosomes, we can extend the model from above to incorporate this effect. In the
following, we assume for simplicity that there are only two distinct subpopulations
of ribosomes (rt,A and rt,B) that can be bound by different antibiotics (A and B,
respectively). Ribosomes cycle between two stages as per
drt,A
dt
 −kArt,A + kBrt,B, (A.15)
drt,B
dt
 kArt,A − kBrt,B, (A.16)
where kA and kB are the cycling rates. Here, assuming that cycling equilibrates
quickly, the steady-state solution is simply rt,A  ηrt,B, where η  kB/kA; because
ru−rmin  rt,A+rt,B it follows that rt,B  (ru−rmin)/(1+η) and rt,A  (ru−rmin)η/(1+η).
This effectively means that the binding rates are simply rescaled by these factors
accordingly, namely k′on,A  kon,Aη/(1 + η) and k
′
on,B  kon,B/(1 + η), where the
primed constants are those that would be observed in vivo, whereas rates without
a prime would be observed if a particular population of ribosomes in a specific
stage is exposed to the antibiotic in vitro. As these considerations are valid for the







Figure A.4: Ribosome subpopulations and translation inhibitors. Two subpopulations of ribosomes
rt ,A and rt ,B , here exemplified as non-initiated and initiated ribosomes, are being cycled between as
per rates kA and kB . The fraction of the total translation-capable ribosomes (ru − rmin) in a particular
stage is determined by the ratio of rates η  kB/kA. These two subpopulations of ribosomes are
bound by specific antibiotics, here exemplified by antibiotic binding only to subpopulation B (black
disk).
the response parameter α. Together with the assumption that the antibiotics bind
only ribosomes in a specific stage, these considerations are equivalent to setting
the δon,i  0, which results in additivity. This example suggests that the possibility
of partitioning ribosomes is already implicitly taken into account, yet it does not
recover any secondary effect such as traffic jams, factor deprivations, etc. from which




Escherichia coli K-12 MG1655 strain was used as a wild-type (WT) strain. When
necessary, the selection on kanamycin was performed at 25 µg mL−1 (for post-
recombineering selection, see below) or at 50 µg mL−1 (for P1 transduction and
plasmid selection). A concentration of 100 µg mL−1 was used for ampicillin (pCP20,
resistance cassette resolution) and spectinomycin (pSIM19, recombineering). The
selection for overexpression plasmids was done at 35 µg mL−1 of chloramphenicol.
To measure the bioluminescence time traces, pCS-λ encoding the bacterial lux-
CDABE operon driven by the constitutive λ-PR promoter was transformed into the
strains of interest [Kishony and Leibler, 2003]. Selection for the luminescence plasmid
was used during the preparation of glycerol stocks (kanamycin 50 µg mL−1) but
was omitted during the measurements to avoid unknown interactions between the
antibiotics used. The plasmid was stably maintained as we observed no significant
fitness defect due to pCS-λ and no apparent spontaneous loss of the plasmid as
verified by plating on selective and non-selective plates (Fig. B.1). To this end, we
tracked the growth of bacterial cultures in flasks, shaking in a water bath in four
conditions. We either actively selected for plasmid maintenance and/or applied
antibiotic stress by adding 2 µg mL−1 of CHL, which led to ≈ 50% inhibition. We
measured optical density by standard methods (using Hitachi U-5100 cuvette spec-
trophotometer); after each measurement, we replenished 1 mL of removed medium
with fresh, prewarmed medium and corrected the optical density measurements
accordingly. After reaching the late exponential phase, we promptly diluted the












Figure B.1: Stacker-based setup and incubator box. (A) Time courses of optical density (OD)
measurements of batch cultures in shaking flasks with or without selection for pCS-lambda by
kanamycin (KAN) and with or without antibiotic stress [2 µg/mL chloramphenicol (CHL)]. Selection
does not alter the response to the CHL. Lines shown in the plot were fitted to log-transformed OD
values from the shaded area. (B) The ratio of colony-forming units (CFUs) on selective (KAN) and
non-selective (LB) agar plates obtained from batch cultures from (A). Cultures grown in the absence
of selection do not significantly differ from those with applied selection, indicating that the loss of
plasmid is non-significant (p-values obtained by the two-sided Mann-Whitney test, Mathematica
function MannWhitneyTest). Box-and-whisker charts: whiskers extended to the full range of data
points, box edges show a 25%-75% range, and centerline is a median value. The number under the
boxes denote the number of independent technical replicates, whose values are overlaid on the boxes.
(C) Examples of LB agar plates for four different conditions in (A), imaged with a camera in bright
field with a long-exposure time (30 s) to detect luminescence; all colonies are luminescent.
The translation factor titration platform was established in strain HG105 (MG1655
∆lacIZYA) [Garcia et al., 2011]. Briefly, endogenous genes encoding for translation
factors were first sub-cloned into the pKD13 vector under the control of PLlacO−1
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Figure B.2: Construction of a strain with a titratable initiation factor. (A) Regulatory elements
(the promoter PLlacO-1 and the rrnB terminator) are introduced through cloning into pZA12 vector.
Subsequent cloning into pKD13 next to the FRT flanked KanR cassette is needed for removal of
the marker upon chromosomal integration. (B,C) Upon integration into the galK locus using λ-red
recombineering, KanR cassette is removed by the action of FLP resolvase. Used restriction sites are
denoted in grey. Symbols are not to scale.
tor upstream and downstream of the gene, respectively (Fig. B.2) [Scott et al., 2010;
Lutz and Bujard, 1997; Klumpp et al., 2009; Datsenko and Wanner, 2000]. The tandem
of kanR and a gene with all regulatory elements was integrated into the chromosome
(galK locus) using λ-red recombineering (plasmid pSIM19 [Datta et al., 2006]). The
kanamycin resistance cassettes here and in the following steps were resolved using
yeast FLP resolvase expressed from pCP20 [Cherepanov and Wackernagel, 1995].
Loss of the resistance cassette and curing of the pCP20 plasmid were checked
by streaking on selection agar plates with antibiotics and by junction PCR (for
resolution). Following the resolution of kanR, the endogenous factor was inactivated
by in-frame deletion: kanR was integrated into the gene locus and then resolved,
which left a 34 residue peptide [Datsenko and Wanner, 2000]. We were unable to
introduce kanR directly into the strain with PLlacO−1 driven frr; therefore, we first
performed the deletion in an auxiliary strain MG1655 ∆frr::kanR bearing the ASKA
plasmid with frr [Kitagawa et al., 2005] [JW0167(-GFP)], which complemented the
chromosomal deletion when IPTG was added. The deletion was possible in the
auxiliary strain. We then moved the deletion by generalized P1 transduction [Lennox,
1955]. For tufAB, we P1-transduced the deletions (∆tufA::kanR and ∆tufB::kanR)
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sequentially from the respective gene deletion strains from the KEIO collection [Baba
et al., 2006]. All other deletions were performed directly in the strains of interest
using λ-red recombineering using pKD13 as a template for the cassette amplifica-
tion [Datsenko and Wanner, 2000]. In the last step, lacI driven by the PLlacO−1 pro-
moter (yielding growth-rate independent negative autoregulation [Scott et al., 2010;
Klumpp et al., 2009]) together with the FRT-flanked kanR was integrated into the intS
locus and the resistance cassette was resolved. The allele ∆intS::kanR-PLlacO−1-lacI-
TrrnB was moved into the strains by generalized P1 transduction. All chromosomal
modifications were validated by PCR. The factor titration platform and the repressor
operon were Sanger-sequenced at the integration junctions using PCR primers or a
primer binding into the kanR promoter region (which is upstream of the PLlacO−1
promoter prior the resolution). The final genotype for the strains bearing the fac-
tor titration platforms is HG105 ∆galK::frt-PLlacO−1-x ∆x::frt ∆intS::frt-PLlacO−1-lacI,
where x denotes the chosen factor. These strains contained no plasmids and no
antibiotic resistance cassettes but had a single copy of a translation factor under
inducible control.
To generate the strain with independently regulated initiation and translocation
factors,we started with a strain carrying a single infB copy driven by PLlacO−1 (Fig. B.3).
Then, the negatively autoregulated tetR repressor was integrated into the chromo-
some, followed by FLP resolvase-mediated resolution of the selection marker. This
enabled the integration of PLtetO−1-driven fusA into the intS locus; the resolution
was followed by the disruption of the endogenous copy of fusA. Furthermore,
we introduced a negatively auto-regulated lacI into the xylB locus. This yielded
a marker-less strain with the two essential genes infB and fusA under inducible,
negatively autoregulated, and independent control. The final genotype is: HG105
∆galK::frt-PLlacO−1-infB ∆infB::frt ∆ycaCD::frt-PLtetO−1-tetR ∆intS::frt-PLtetO−1-fusA
∆fusA::frt ∆xylB::frt-PLlacO−1-lacI.
Oligonucleotide sequences, targeted template, restrictions sites (when used),
and a brief description of use are listed in Table F.4. All DNA modifying enzymes
and Q5 polymerase used in PCR were from New England Biolabs.
















































































Figure B.3: Construction of a double titration strain. Ladder is GeneRuler 1kB. Phage symbol,
FLP, and λ-red denote a step based on P1 transduction, FLP-resolution, and λ-red recombineering,
respectively. Here, we useda shorthand PLac for PLlacO−1.
above. We have cloned cat gene into a plasmid with pKD13 background, in which
resistance gene was driven by a synthetic promoter PLlacO−1 [Lutz and Bujard, 1997].
Promoter was unregulated (constitutive) as the background strain HG105 (MG1655
∆lacIZYA) [Garcia et al., 2011] is devoid of the entire lac operon, including the
lac-repressor. We amplified the tetA and cat from the strain MS004A [Steinrück
and Guet, 2017] and plasmid pZA32 [Lutz and Bujard, 1997], respectively. We
were unable to clone tetA into a plasmid; we therefore assembled the kanamycin
cassette, PLlacO−1 promoter, and tetA gene with a rrnB terminator in vitro using
HiFi Assembly Mix (NEB), PCR-amplified the fragment, and integrated it into
the intS locus. CAT-coding gene was integrated into galK locus. Both CERGs
were integrated into the chromosome by lambda-red recombineering, selected on
kanamycin, which was followed by the resolution of the kanamycin cassette by
FLP-resolvase [Datta et al., 2006; Deris et al., 2013; Datsenko and Wanner, 2000;
Cherepanov and Wackernagel, 1995]. We verified modified chromosomal segments
with PCR and Sanger sequencing. For CERG experiments we dissolved TET and
CHL directly in LB, followed by filter-sterilization.
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We constructed overexpression strains by transforming HG105 with pCS-λ and
plasmids from the ASKA library [Kitagawa et al., 2005] and its derivatives (Fig. B.4).
We used ASKA plasmids in which GFP has been excised from the reading frame; we
had to repeat the excision of GFP from the infB-bearing plasmid by NotI digestion
and subsequent ligation as per Ref. [Kitagawa et al., 2005]. All plasmids were Sanger-
sequenced. For controls we used (i) plasmid pAA31 (gift from A. Angermayr), in
which the open reading frame is cleanly deleted, as transcription-only control, and
(ii) the ASKA plasmid bearing lacZ as a neutral protein overexpression control. We
note that the overexpression of proteins leads to growth inhibition [Scott et al., 2010;
Dong et al., 1995]; hence, we actively selected for plasmid maintenance by adding

























Figure B.4: Overexpression of translation factors conveys little information about the action of
tetracycline. (A) The overexpression system is based on ASKA library plasmids. High copy plasmid
with chloramphenicol resistance (cat) provides a constitutively expressed lacI repressor, which
controls the expression of PT5−lac-driven gene x. The chromosomal copy of the translation factors was
left intact. The high copy number of a plasmid enables the overexpression of proteins. (B) Example
of the tetracycline dose-response curve in the presence or absence of fusA overexpression. White and
gray circles denote measurements of the dose-response curve in the absence and presence of inducer,
respectively. Best-fit Hill functions are shown as solid lines. Dashed lines denote the apparent IC50
and corresponding growth rate compared to the no antibiotic at both inducer concentrations. Growth
rate is decreased as a consequence of overexpression. Gray dose-response curve is a cross-section
of the dose-response surface shown in (C): see arrow. (C) Dose-response surfaces for gene-less
control (pAA31), protein-overexpression control (lacZ) and all six translation factors as indicated. In
general, growth rate decreases with overexpression and the action of the antibiotic is not alleviated
by overexpressing any of these genes. Cross-section of the dose-response surface shown in (b)
for fusA is indicated by a dashed gray line. (D) Dependencies of the IC50/IC50,ϕ ratios (IC50,ϕ
corresponds to IC50 in the absence of inducer) for different overexpression cases as a function of
inducer concentration. At each inducer concentration, the apparent IC50 is determined from a fit of a
Hill function. In general overexpression leads to mild sensitization of bacteria to tetracycline and
this trend is largely independent of specific overexpressed gene. The occasional slight increase is
mostly due to the poor fits of the dose-response curve or the occurrence of spontaneous mutants.
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B.2 Growth rate assay and two-dimensional concentra-
tion matrices
Rich lysogeny broth (LB) medium, which at 37◦C supports a growth rate of 2.0 ±
0.1 h−1, was used. LB medium was prepared from Sigma Aldrich LB broth powder
(L3022), pH-adjusted to 7.0 by adding NaOH or HCl, and autoclaved. Antibiotic
stock solutions were prepared from powder stocks (for catalog numbers, see Supple-
mentary Table 1), dissolved either in ethanol (CHL, ERM, and TET), DMSO (LAM
and TMP) or water (KAN, CRY, LCY, KSG, FUS, and STR), 0.22 µm filter-sterilized
and kept at -20◦C in the dark until used. Antibiotics were purchased from Sigma
Aldrich or AvaChem. Some of the antibiotics (e.g., ERM, FUS, LCY) are not used
in the clinic against certain Gram-negative bacteria due to generally poor efficacy;
however, at higher concentrations (yet still well below the solubility limit) inhibition
of growth is observed.
A previously established growth-rate assay based on photon counting was
used to precisely quantify the absolute growth rates for 5-9 generations [Kishony
and Leibler, 2003]. Cultures were grown in 150 µL of media in opaque white
96-well microtiter plates (Nunc 236105), which were tightly sealed by transparent
adhesive foils (Perkin-Elmer 6050185 TopSeal-A PLUS) to prevent contamination and
evaporation. We prepared glycerol stocks of WT and factor-titration platform strains
from saturated overnight cultures. We inoculated the cultures with ∼ 102 cells per
well (1:106 dilution) from either thawed glycerol stocks (for the drug interaction
network) or from liquid cultures in which we first incubated the bacteria containing
the factor titration-platform for 1 h in the absence of IPTG (inoculated by 1:2000
dilution of the glycerol stock) to partially dilute out the remaining factor molecules
before additional 1:1000 dilution into measurement plates. Between 10-20 plates
were cycled through a plate reader using a stacking system (Tecan M1000, controlled
by Tecan i-control software, v1.10.4). We built a custom incubator box around the
stacker towers to facilitate ventilation and fix the temperature to 37◦C (Fig. B.5).
This incubator was designed and troubleshot by B.K. and Andreas Angermayr (IST









Figure B.5: Stacker-based setup and incubator
box. Stacker-based setup and incubator box. Mi-
crotiter plates are stacked vertically in stacker
towers and cycled (white arrows) through the
Tecan M1000 plate reader (dark grey box) in which
plates are shaken and luminescence is measured.
After all plates are stacked in the right tower, the
stacking mechanism re-stacks the plates into the
left tower to repeat the measurement. Fans cir-
culate the air in the incubator to equilibrate the
temperature.
was read every 20-40 min and was shaken (orbital 10 s, 582 rpm) immediately before
reading (settle time 10 ms, integration time 1 s). Plates were manually pipetted and
concentration gradients of antibiotics and inducers (IPTG, aTc) were prepared by
serial dilution (0.70-fold).
Growth rates were determined as a best-fit slope of a linear function fitted to
the log-transformed photon counts per second. The fitting procedure and examples
of growth curves are shown in Fig. E.3. In rare cases of occurrence of mutants (as
evidenced by sudden growth) we manually removed the measurement (only in the
case of tufA titration). We verified that the luminescence-based technique leads to
the same results as a classical optical density-based one (Fig. B.6).
We measured the dose-response surfaces for all 28 drug interactions in duplicate.
As the dose-response surface was measured over a 12×16 grid, the duplicates
swap the drug axes (12×16→16×12 across two 96-well plates) on different days to
check for effects coming from spreading the measurements over different plates.
The experimental and analysis procedure led to reproducible measurements of
growth rates between days (Fig. E.3D, ρ ≈ 0.86). For the double factor titration
experiment, the inducer gradients were set up across 6 plates to form a 24×24 grid.
Each response surface is thus based on multiple measurements and the impact of
individual points is assessed by bootstrapping. In total, we measured over 20,000
growth curves. We automatized the collection and analysis of the data to allow for
unbiased interpretation of the data.
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Figure B.6: Verification of the growth-measurement technique. (A) Comparison of OD and
luminescence-based growth rates for the CHL dose-response curve in the presence or absence
of selection. Scatterplot reveals high-correlation between measurements, irrespective of selection.
(B) Comparison of luminescence-based growth rates in the presence or absence of selection. (C) Dose-
response curve for CHL, obtained by OD or luminescence assay. Qualitatively, curves match to a
high degree. (D) Shape parameters of the dose-response curves as obtained from curves in (G). Black
lines show standard errors as obtained from fitting.
B.3 Measurement of induction dynamics.
We simultaneously transformed the strain HG105 with both pCS-λ∆luxA and
pBAD24-luxA. After growing the strain in rich SOB medium with antibiotics, we
pipetted five 108 µL portions of the exponentially growing culture into a white
96-well plate. After a short incubation, we added either the 5 µL+5 µL of water, or
water and cAMP. The cultures were incubated for 10 minutes at 37◦C with shaking
to enable cAMP to enter the cells. After the incubation, plate was put on the plate
reader tray and 10 µL of water, arabinose or arabinose with cAMP was rapidly
pipetted into the wells and the measurement of the luminescence time track began.
Time tracks are shown in the Fig. B.7.
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Figure B.7: Induction is rapid and is made even faster by pretreatment with cAMP. Panels
show different induction protocols, with indicated pretreatment (10 minutes before the
induction) and the assayed induction. Tracks indicate that cAMP alone cannot facilitate
induction, but if applied before the induction, the expression is more rapid. Applying the
cAMP together with arabinose does not accelerate the expression.
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C Data analysis methods
C.1 Normalization of dose-response surfaces
All growth rates were normalized relative to the average growth rate in the
drug-free medium [for factor-titration strains at the highest inducer concentra-
tion (5 mM)]. Small differences between individual dose-response curves were
inevitable due to known challenges of preparing identical concentrations gra-
dients on different days. To correct for such day-to-day variability, we rescaled
the concentration units to the IC50 for each drug. The IC50 was obtained from




to the individual dose-response
curves. The dose-response curve of each drug was measured seven times and
averaged. The IC50 and corresponding errors reported in Table 3.1 are extracted
from such average dose-response curves (Fig. E.1). Induction curves were normal-
ized slightly differently, using a shifted and increasing Hill function in the form
g(b)  [(b + b0)/IC50]n /
{︁
1 + [(b + b0)/IC50]n
}︁
, where b0 is a concentration offset.
The latter parameter was required as the complete cessation of growth was not
achievable in some cases even in the absence of inducer as the promoter PLlacO−1 is
leaky. Inducer concentrations were thus rescaled via b → (b + b0)/IC50.
C.2 Smoothing of dose-response surfaces
To reduce noise when plotting response-surfaces, we smoothed the data using a cus-
tom Mathematica script that implements locally weighted regression (LOESS) [Cleve-
land and Devlin, 1988]. This approach only smoothed the contours and did not alter
the character of dose-response surfaces. Smoothing was only used for plotting and
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not for the analysis in which only linear interpolations between points were used
(Mathematica function Interpolation).
C.3 Quantification of the drug interaction types and
bottleneck dependencies
C.3.1 Loewe interaction score








where g(x1, x2) and gadd(x1, x2) are the measured and the predicted additive dose-
response surfaces over a 2D concentration field (x1, x2), respectively. The LI score
is a log-transformed ratio of volumes underneath the dose-response surfaces. It is
positive for antagonistic and suppressive interactions, zero for perfectly additive,
and negative for synergistic interactions. To avoid imposing arbitrary bounds for
classifying a measured interaction as synergistic or antagonistic/suppressive (rather
than additive), we performed smooth bootstrapping on a set of ideal additive
response surfaces to establish a distribution of interaction indices expected for
perfectly additive but noisy surfaces. To achieve this, we generated additive dose-
response surfaces for drugs with a Hill steepness parameter n between 1.8 and 6.6
(obtained as 10% and 90% percentiles of the distribution of steepness parameters for
measured dose-response curves). We estimated the variabilities of measurements
σv from data from eight replicated dose-response curves with seven replicates per
data point and fitting errors σf from the slope of all growth rate fits. Both error and
variability distributions were well described by log-normal distributions. For each





f , where both σv and σf were drawn from respective log-normal
distributions. We calculated the LI score for 2,000 response surfaces and obtained the
distribution shown in Fig. C.1A. We determined boundaries separating synergistic
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Figure C.1: Distribution and measurements of LI scores. (A) Distribution of Loewe interaction
scores of noisy additive surfaces for pairs of drugs with different steepnesses, as obtained by
bootstrapping. Note, that this reveals a slight bias towards antagonism. Here, LI scores were calculated
for 2×103 bootstrap surfaces. See section “Loewe interaction score” for details. (B) Reproducibility of
LI scores between replicates. Each LI score was evaluated for replicated measurements on different
days for 28 different antibiotic combinations. The indicated Pearson correlation can be interpreted as
an upper bound for the correlation between any predicted and measured LI scores.
and antagonistic LI scores (blower and bupper, respectively) from additive interval as
Bonferroni-corrected percentiles (for 5%/28 ≈ 0.18% and 100% − (5%/28) ≈ 99.82%)
of the bootstrapped distribution (Fig. C.1). Mean LI scores for measured response
surfaces falling outside of the interval with these boundaries were classified as
synergistic or antagonistic; otherwise, the interaction was classified as additive.
C.3.2 Bottleneck dependency score
Similar to LI, the bottleneck dependency score BD is an integrative quantity that
concisely reports on the response-averaged deviation from independence. To
calculate this score, the antibiotic and inducer concentrations are first converted
into corresponding responses using the induction- and antibiotic dose-response
curves (Fig. C.2). Mathematically, this means that rx  y(c) and ry  g(b) for
antibiotic and inducer, respectively. In response space, the null-expectation is
independence, i.e., the expected response is a product of individual responses. Thus,









Figure C.2: Response-response surface and BD score. (A) Examples of response surfaces over
the response-response grid for FUS and LCY in combination with translocation bottleneck. In
the response space (rx,ry), independence is defined as rxry. The logarithm of the ratio of volumes
underneath the measured and independent surface yields a bottleneck dependency score. For
every antibiotic, six bottleneck dependency scores together yield a bottleneck dependency vector.
(B) Values of bottleneck dependency scores for all bottleneck-antibiotic pairs.
This score is zero when the two perturbations (bottleneck and antibiotic) are
independent; it is positive or negative for alleviation and aggravation, respectively.
As for the LI score, we evaluated the independence interval of BD scores by
bootstrapping the BD score for independent surfaces at given induction and
antibiotic dose-response curves. Evaluating the percentiles of such null-distributions
gave the boundaries for evaluation of the type of deviation from independence
(alleviation or aggravation).
C.3.3 Clustering of bottleneck-dependency vectors
We performed the clustering of BD vectors projected on a space of lower dimen-
sionality. For dimensionality reduction, we used Principal Component Analysis
(PCA). We used the first three principal components which explained ≈ 95.38%
of the variance. In this projected three-dimensional space, we performed unsuper-
vised agglomerative clustering (Mathematica function FindClusters) with cosine
distance as a measure of cluster cohesion.
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Figure C.3: Bootstrapped clustering of random-
ized vectors yields a series of clustering results.
With these clustering results at hand, we calculate
the Rand indices RI(w , w′) for n  104 bootstrap
replicates. From the distribution of RI(w , w′), we
estimate the empirical cumulative distribution
function and corresponding empirical p-value for
the clustering result
We estimated the p-value of the observed clustering by bootstrapping. We used
the Rand index (RI) [Rand, 1971] as a criterion for evaluating the difference between
clustering results. For example, if w is the clustering obtained for the reshuffled
sample and (consensus) clustering w′ is obtained for PCA projection of median
bottleneck dependency vectors (shown in Fig. C.2), then the Rand index is
RI(w , w′) 
∑︁N
i< j ψi j
N(N − 1)/2 ∈ [0, 1]. (C.3)
Here, ψi j is 1 if the i-th and j-th data points are either inside or outside of the
same cluster and 0 otherwise; the denominator is the total number of unique pairs
between N elements. We generated 104 reshuffled datasets, evaluated RI for each
clustering of the dataset, and calculated the cumulative distribution function. We
evaluated an empirical p-value as





≈ 3 × 10−4, (C.4)
which is an estimate of the probability for obtaining the observed clustering of
median BD vectors by chance. The cluster areas shown in Fig. 3 were obtained by
smooth bootstrapping of median BD vectors for a given noise statistics, which were
PCA projected, and subsequent calculation of the minimal convex hull (Mathematica
function ConvexHullMesh). The additional response vectors for LAM, TMP, and NIT
were PCA projected (using Mathematica function DimensionReduction obtained
for the median values of BD vectors).
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C.4 Remapping
Our remapping procedure converts inducer concentrations b into the concentrations
c of an idealized antibiotic that precisely targets the translation step controlled by
the titrated factor. This requires an induction curve and a dose-response curve. The
former is described by an increasing Hill function g(b), and the latter by solving
Equation (A.4) for y. The conversion between concentrations is formally described




at a given α, which can be arbitrarily chosen for the idealized
antibiotic. When α < αcrit, the dose-response curve is bistable and has a region in
which more than one response will yield the same concentration – in these cases we
consider only the concentration corresponding to the highest stable growth rate
as the other solutions are either unstable or will be outcompeted. Further, higher
inducer concentrations are remapped to lower antibiotic concentrations and an
infinite inducer concentration corresponds to zero antibiotic concentration. As this
is impractical, we considered all mimicked concentrations (normalized relative to
IC50) that are below 0.1 as equivalent to 0.
C.4.1 Regularization of surfaces
Strains containing the factor titration platform have mostly very similar antibiotic
dose-response curves to the wild-type at maximal inducer concentrations. However,
to correct for small deviations, we rescaled the antibiotic concentrations on the
antibiotic-inducer grid. The shape of this transformation is derived from equat-
ing the responses of two Hill functions with different steepnesses. Consider two
Hill functions with Hill exponents nWT and nt, for WT and factor-titrating strain,
respectively. Then, by equating the responses captured by these Hill functions,
we calculated the rescaled relative (relative to IC50) antibiotic concentrations as
ca,WT  c
nt/nWT
a,t . We refer to this conversion as the “power-law transform”. Such
regularized surface was then used in remapping.
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C.4.2 Remapping-based equivalence
Factor deprivation is equivalent to the action of a specific antibiotic if both perturba-
tions can be substituted for each other. Upon remapping the inducer concentration,
the response surface for an equivalent inducer-antibiotic pair is transformed into
an additive response surface. To determine if the deprivation of a specific factor
is equivalent to the action of a specific antibiotic, we performed the remapping
in tandem with bootstrapping. Bootstrapping assesses the effects of uncertainties
in the remapping parameter α (obtained as a response parameter α from a fit of
inverted Eq. (A.4) to a drug dose-response curve), artifacts of the response surface
over inducer-antibiotic grid and sampling, and inherent noisiness of growth rate
determination. We first restricted the dataset to data points with relative growth
equal to 0 or above 0.1 with growth rate coefficient of determination R2 > 0.8. In
each round of bootstrapping, the following steps are carried out:
1. drawing of a remapping parameter α from a normal distribution, centered
at the best-fit-value and with standard deviation estimated from fitting, and
remapping,
2. drawing of a random sample from remapped data points that is of random
size (between 75% and 100% of the data set),
3. the addition of Gaussian noise to the growth rates (estimated from the growth
rate fit),
4. calculation of the ideal additive surface at a given α for comparison, and
5. calculation of LI score.
This procedure was repeated 100 times for each bottleneck-antibiotic pair and
yielded a set of distributions. Each LI distribution was then statistically evaluated
for being inside the additive interval. We obtained the cumulative distribution
function (CDF) for each distribution and we calculated its value on both ends of




is below p  0.05,
the pair is considered inequivalent – this is the case in which the remapped surface
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A B
Figure C.4: Examples of LI histograms and tentative modes of action. (A) Examples of histograms
of LI for remapped surfaces for CRY in combination with a translocation and recycling bottleneck,
respectively. Each histogram is calculated for n  100 bootstrapped LI scores. (B) Color-coded
sequential evaluation of equivalence between bottleneck and translation inhibitor from Fig. E.6. Red
and yellow denote that LI was outside or inside of the additive interval, respectively. From the cases
in which the LI is statistically inside the additive interval, the case with highest correlation was
chosen as the putative primary mode of action (green). This approach correctly identified the mode
of action for all cases in which it is known from the literature (CRY, FUS, STR, KSG, and TET).
is unlikely to be additive. For each antibiotic, more than one of the bottlenecks could
be statistically equivalent – we thus deemed the bottleneck-antibiotic pair with the
highest correlation between average remapped and ideal additive growth rates to
be the primary candidate for equivalence of perturbations.
C.5 Quantitative comparison of predicted and mea-
sured response surfaces
Both measured and predicted surfaces match along the individual concentration
axes, as these were obtained from the fits of dose-response curves. Thus, points
corresponding to such measurements are always a good match and in turn increase
the Pearson correlation invariantly of a potential mismatch in surface segments
further away from individual axes. The Loewe interaction score is a good measure
of interaction strength; however, it is not well suited for comparing the predicted
and measured surfaces. Crucially, the same value of LI can be obtained for two
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A Bmatchmismatch
Figure C.5: Comparison of LI scores for predicted and measured surfaces. A,B Scatter plots show
median values of predicted and measured LI scores for all possible predictions for biophysical model
and remapping, respectively. Error bars show 90% bootstrap confidence intervals obtained from 100
bootstrap repetitions. White and gray symbols correspond to match and mismatch cases, respectively,
as determined by isobole sliding. In A, the LI score was computed for the best prediction with the
binding scheme. Note, that this correlation is not expected to exceed that of replicated LI scores in
Fig. C.1.
very different surfaces. For example, if the same suppressive interaction surface is
rotated by 90◦, the LI score would remain the same, even though the direction of
suppression is completely different. We therefore sought an applicable metric that
would identify systematic deviations from predicted isoboles.
We developed an “isobole sliding” method in which we determine a mean
deviation of points close to some predicted growth rate from measured values. It
provides a concise, quantitative description of differences between predicted and
measured isoboles and identifies the most discrepant areas of the surfaces. For
this, we systematically move along the (ordered) predicted growth values gi and
select S  20 consecutive points and average their deviations from measured values
of growth rate hi . This yields a deviation trajectory t( ĝ) of a mean deviation as a
function of average predicted growth rate













Keeping the number of points S fixed in the window allows the comparison between
different subsets of the data.
To assess the probability of observing such deviation by chance, we created a
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A B
Figure C.6: Illustration of isobole sliding method. (A) two examples of deviation trajectories
t( ĝ) for ERM-TET (top) and KSG-STR (bottom). Thin gray and red lines show n  100 bootstrap
repetitions of predicted and benchmark trajectories. Two trajectories (thick black and red lines
for measured and benchmark, respectively) are highlighted. Black and purple arrows denote the
maximal deviation of the trajectory from zero for predicted and benchmark trajectory. The length of
the arrow is maximal average deviation s. (B) All s values from n  100 bootstrapped repetitions are
collected in the histogram. The pair of ERM-TET offers a better match with benchmark distribution
compared to KSG-STR.
benchmark dataset by replacing all measured values with predicted ones to which
we added Gaussian noise (estimated from bootstrapped dispersion, but of at least
0.05 relative growth units). For each bootstrapped realization (obtained either by
remapping or the biophysical model), we randomly drew a subset of random size
(between 75% and 100% of the data set) to estimate the robustness of the prediction
concerning a low number of outliers. We collapsed each isobole sliding trajectory
into a single number s by calculating a maximal deviation, s  max ĝ |t( ĝ)|, thus
yielding a distribution of s values for both measured and benchmark trajectory
maxima.
Ideally, the distribution of maximal average deviations should either overlap
or be below the benchmark distribution. To assess the statistical deviation, we
evaluated the CDF of predicted-measured distribution at the 95% percentile of the
benchmark distribution. If the value was below 0.05, we rejected the prediction. This
method requires that there are no systematic deviations over the whole surface, thus







Figure C.7: Performance of biophysical model
against the measurements. The upper and bot-
tom half of each circle denote independence or
competition, respectively, as denoted. Green and
red color denote match and mismatch, respec-
tively. Match means that both replicates agree
that a certain scheme faithfully predicts observed
surface.
Thus, even if two surfaces match qualitatively, isobole sliding might still return a
statistically significant mismatch.
To estimate the upper bound of prediction-measurement agreement, we checked
for consistency of the measured replicates. For this, we considered one of the
replicates as a prediction of the other. In doing so, we observed that twenty-one
out of twenty-eight (75%) surfaces act as statistically significant predictions for one
another. This serves as an approximate upper bound for how many predictions-
measured pairs can be expected to match at the given experimental variability.
C.5.1 Assessment of predictive power
At this point, we can assess the consistency of predictions. Using the method
described above, we evaluated both independent and competitive binding schemes
for their congruence with measured surfaces. The scheme that led to the distribution
with the smallest mean maximal deviation,was considered as a best-match. However,
both schemes can yield a good match – by asking how many of the schemes
yield a match in both replicates, we obtain an estimate for a fraction of correct
predictions (Fig. C.7). By counting cases in which at least one of the schemes yields
a match between replicates, we find that sixteen out of twenty-eight interactions
can be accounted for by a biophysical model.
Applying isobole sliding to the prediction of remapping shows that even small
quantitative deviations will lead to the discarding of the prediction (Figure E.7).
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However, counting additionally explained interactions by remapping (TET-CRY,
TET-FUS, KSG-CHL, CRY-KSG) increases the total tally of explained interactions to
twenty out of twenty-eight (≈71.4%), which is below the estimated self-consistency
bound of 75%. As discussed above, qualitative matches are not included in this
metric.
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D Tagging of chromosomal proteins with
GFP
Mapping from the inducer concentration to expression of the gene of interest is not di-
rectly accessible,as we discussed in the Chapter 7. We aimed to construct a C-terminal
fusions of the integrated factors with fluorescent reporter. We used pKD13 as a vector
for construction of the GFP-tagging plasmid. We used a GFPuv4 mutated version
of GFP [Ito et al., 1999] and corresponding N-end five amino acid linker (nucleotide
sequence GGCCTATGCGGCCGC, i.e., amino-acids GlyLeuCysGlyArg) from ASKA
library parent vector pCA24N(+)GFP [Kitagawa et al., 2005]. Used mutated version
of GFP can be used at 37◦C and has a maturation time of 15.2 minutes [Ito et al., 1999;
Iizuka, 2011]. With this template plasmid at hand, we can fuse a GFP with chromo-
somal genes. Presented strategy is related to a method in Ref. [Watt, 2007].
D.1 GFP-tagging plasmids
We constructed a plasmid pKD13-GFPtag (Fig. D.1), which carries a spacer-flanked
GFP upstream of TrrnB terminator, followed by a FRT-flanked kanamycin resistance
cassette. We amplified GFP and the linker from pCA24N(+)GFP using primers o-ClaI-
link-GFP-2-pKD13-F and o-KpnI-link-GFP-2-pKD13-R (Table D.1). We introduced
KpnI restriction site by full plasmid PCR using primers o-ClaI-pKD13-full-R and
o-KpnI-pKD13-full-F (Fig. D.1, Table D.1); ClaI restriction site is naturally present
upstream of TrrnB terminator but we introduced specific overhangs in the forward
primer. Both PCR amplicons were KpnI, DpnI, and ClaI digested gel purified. After
ligation, ligation products were transformed into DH5α-λpir cells and selected on
kanamycin and ampicillin.
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A integration homologies span
the last 50 nt before stop codon





resolution yields only infB-gfp




















Figure D.1: Construction of GFP-tagging plasmids and illustration of tagging strategy in
the case of galK-integrated infB gene. (A) Spacer and GFPuv4 are PCR amplified from ASKA
library parent vector and restriction cloned into pKD13 upstream of rrnB transcriptional
terminator (KpnI site is introduced through full-plasmid PCR), which yields plasmid
pKD13-GFPtag. (B,C) Chromosomal homologies HF and HR determine the integration site.
After integration, gene is in-frame with GFP and has a removable marker downstream.
primer sequence
o-ClaI-link-GFP-2-pKD13-F CC ATCGAT ACCATCACCATACGGATCCG
o-KpnI-link-GFP-2-pKD13-R GG GGTACC CAGGAGTCCAAGCTCAGCTA
o-ClaI-pKD13-full-R CC ATCGATGCAGGTGGCACTTT
o-KpnI-pKD13-full-F GG GGTACC GATGGTAGTGTGGGGTCTCC
Table D.1: Oligonucleotides for construction of GFP-tagging plasmids. Restriction sites
are in bold. Underlined are the annealing regions.
D.1.1 In-frame gene-GFP fusion
The GFP-tagging plasmid enables a general approach for the construction of in-frame
GFP-fusions only by redesigning recombination primers. Forward primer has a 20-nt
annealing homology (PF: GGCCTATGCGGCCGCAGTAA) that spans over spacer.
The overhang is specific to the gene of interest and spans over last 50 nucleotides
before stop codon (for tagging infB; GCGATGTGATCGAAGTATTCGAAATCATC-
GAGATCCAACGTACCATTGCT), which is excluded to open the frame. Figure D.2
shows successful fusion of infB integrated into galK locus with fluorescent protein.
Reverse primer is pKD13-to-galK-R from Table F.4. We successfully tagged the galK-
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integrated infB. However, while tagging resulted in detectable and well resolved
fluorescence, it also caused a growth defect of about 10% (1.03 h−1 and 0.92 h−1 for






Figure D.2: Verification of infB-GFP fusion. Sequencing revealed that infB reading frame
was correctly opened and extended by the linker and GFPuv4.
D.2 Fluorescence measurements and the induction curve
Tagged proteins become fluorescent only after the GFP chromophore has undergone
a maturation process. To correct for this effect we derive a correction factor (following
Ref. [Garcia et al., 2011]) that maps the detected of fluorescent proteins f to the
concentration of all proteins p  f + x, where x is a concentration of proteins with
non-matured fluorescent tag. Time derivative of x reads as ẋ  αp m − λx − γx,
where m, αp and γ are the steady-state concentration of mRNA transcripts, protein-
synthesis rate, and maturation rate, respectively. This yields the steady state solution
x  αp m/(λ + γ). Concentration of the fluorescent protein f changes in time
according to ḟ  −λ f + γx. From this we see that in the steady state f  xγ/λ
and total protein concentration is p  f (1 + λ/γ). Since fluorescence of the tagged
protein F is assumed to be proportional to f , we conclude that p ∝ F(1+λ/γ) or that
only a fraction γ/(λ + γ) of tagged proteins is actually fluorescent (which accounts
to 80% for γ  0.25 h−1 and λ  1 h−1).
Even in the absence of the fluorescently tagged proteins, bacterial culture exhibits
a certain basal level of fluorescence. To correct for this effect, experiments are always
conducted in parallel with tagged and non-tagged strain. Autofluorescence changes
with the cell density (measured absorbance a being its proxy); it is assumed that
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autofluorescence is a continuous function (not necessarily linear) function of cell
density. We assume that measured fluorescence Fm is given as:
Fm(a)  F( f ) + Fbck + Fauto(λ, a), (D.1)
where Fbck and Fauto(λ, a) are the background fluorescence and autofluorescence,
respectively. Background fluorescence can be obtained from the few first initial
data points of the given tagged culture, i.e., before the signal from autofluorescence
and protein fluorescence is detected. Since translational fusion of a protein and
GFP can exhibit decreased enzymatic activity (due to perturbation of folding, active
site accessibility, diffusion rate, etc), it is not necessarily best to take the non-tagged
culture in the same environment as a autofluorescence reference, but it is better to
take the non-tagged culture with the same response.
In practice this means that for each tagged culture, non-tagged culture with
most similar growth rate is found and fluorescence tracks of the latter is used for
autofluorescence correction. Once the reference culture is found, data points from an
absorbance interval [amin, amax] are extracted, binned with ∆a  0.01, bin-averaged
and low-pass filtered (Mathematica function LowpassFilter) to reduce noise. Using
interpolation with Hermite polynomials, approximative continuous Fauto(λ, a) is
obtained, which is then subtracted from the measured FM(a) − Fbck at the given
absorbance a. For a steadily growing culture we assume that F( f ) ∝ f a, i.e., the
denser the culture more abundant is the protein of interest in the well. Taking F( f )/a
and averaging the value should give an estimate for the f , that is average fluorescence
per absorbance. However, since such approach involves dividing by absorbance,
this can lead to building up of noise effects at low fluorescence signal and low
absorbance values. To avoid division, we simply fit a line with zero offset to obtain
the value of f . Lastly, obtained estimate is corrected for maturation effect (Sec. D.2)
and accompanied by the estimate error and goodnes of fit R2, which is later used
for data selection.
With these corrections at hand, we can adjust the parameters of the model
presented in Sec. 7.3. Here, however, adjusted parameters do not have a direct





Figure D.3: Induction curve for GFP-tagged ini-
tiation factor. Gray dots correspond to fluorescent
measurements for titratable strain grown in M9
minimal medium with glucose, casamino acids,
and nucleotides. Fitted model is used to predict a
induction curve for titration curve in M9 minimal
medium with glucose and casamino acids that
supports lower growth rate.
described by the model, its rate ζ0  2.2 × 10−3 ABS/(s×RFU), which requires a
conversion factor, cannot be interpreted directly. However, with this model at hand,




Figure E.1: Dose-response curves for all antibiotics. Where error bars are invisible, they are smaller
than the symbols. Each dose-response curve was measured n  7 times and non-zero growth rates














Figure E.2: All dose-response surfaces. Duplicates of dose-response surfaces for all 28 antibiotic
pairs. Due to small, but systematic variability in concentrations between replicates done on different
days, we rescaled concentration axes relative to the IC50. Dose-response surfaces were smoothed
using LOESS (Methods). Black and gray dots denote measured points from different experiments.
Isoboles from duplicates are in high agreement; small deviations are caused by occasional outliers






















Figure E.3: Examples of growth curves and fitting procedure. (A) An example of a dose response
surface. (B) An example of growth curves over a 12×16 grid. Note, that here the concentrations
geometrically change between wells, i.e., the ratio between concentrations in neighboring wells is
fixed. Star denotes the curve shown in the next panel. (C) Exemplary growth curve from (B) and
details of the fitting procedure. The growth rate is determined by fitting a line in the regime of
exponential growth. The determination of this regime in the growth curve is carried out automatically;
procedure: (i) check if the maximum value of luminescence is above the lower bound of the fitting
interval lummin  103 cps and take points before the maximum, (ii) take points that are the latest
to rise over lummin, (iii) determine the upper limit (bnd) of the fitting interval to be either ten-fold
above the lummin (guaranteeing log2 10 ≈ 3.3 doublings of a fitting interval) or eight-times less than
the track maximum (three doublings away from saturation) and (iv) fit a line to the log-transformed
values of the luminescence signal if there are at least three data points. If lummin is not exceeded,
the well is counted as having no growth; if any of the other criteria are not fulfilled, growth is
characterized as undetermined. For strains with titratable factors, we slightly widened the fitting
interval by decreasing the lummin to 500 cps, and the number of doublings from saturation to ≈ 2.6.
(D) Reproducibility of absolute growth rate measurements between replicates. The smooth kernel
representation of replicate measurements (Mathematica function SmoothKernelDistribution),
performed on different days and different plate arrangements, demonstrates a good agreement
overall. Only non-zero growth rates of sufficient quality (R2 > 0.5 and relative error < 0.5) are














Figure E.4: All predictions of a biophysical model for replicated measurements. Predicted surface
is shown in full; overlaid thick and dashed purple isobole denote 20% and 50% isobole, respectively,
of the measured surface. Each prediction is evaluated for goodness of prediction as described in
Methods. Checkmark and cross denote a match and mismatch, respectively. Inset text denotes
the best-matching binding scheme. The bootstrapped-LI scores for predicted and measured (in














Figure E.5: Dose-response curves and surfaces for all bottleneck-antibiotic pairs. Top row:
bottleneck dose-response curves. Bottom: Surfaces were smoothed using LOESS (Methods). Note
the different characters of deviations from independence.
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Figure E.6: Scatter plots of growth rates expected for additivity and obtained by self-remapping.
Error bars correspond to the standard deviation of n  100 bootstrap repetitions. The distribution of
LI was compared statistically to the boundaries of the additive interval. Red crosses denote that LI
fell outside the additive interval. Green checkmarks and yellow question-marks denote that LI did
not fall outside of the additivity interval; in these cases, the rounded correlation ρ is reported. For a
given antibiotic, the bottleneck with the highest correlation with the additive expectation is marked














Figure E.7: All predicted surfaces as obtained by remapping. The predicted surfaces obtained by
remapping are shown in full; overlaid thick and dashed purple contour denote 20% and 50% isobole,
respectively, of the measured surface. Each prediction is evaluated for the goodness of prediction as





































Figure E.8: Double titration platform and growth curves. Schematics represent the genetic elements
of double titration control: negatively auto-repressed transcription factors lacI and tetR that control
the expression of initiation factor 2 (infB) and elongation factor G (fusA), respectively; expression
is dependent on the shown inducers (IPTG and aTc). The grid shows the growth curves for the
response surface in Fig. 6.1. Different shades of gray show the growth rate. Only fits of good quality
and with growth rates above 0.199 are included.
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F Supplementary tables
Antibiotic Response parameter α
CHL 1.04 ± 0.04
ERM 1.06 ± 0.14
TET 0.73 ± 0.09
KSG 0.23 ± 0.09
CRY 0.59 ± 0.04
FUS 0.70 ± 0.09
LCY 0.64 ± 0.06
STR 0.46 ± 0.07
Table F.1: Typical response parameters for used translation inhibitors. Response parameter values
and errors were obtained in fitting to dose-response curves in Fig. E.1.
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Type Chemical name Catalog numbers Supplier
Antibiotics Kanamycin sulfate K4000-5G Sigma-Aldrich
Tetracycline hydrate 268054-25G Sigma-Aldrich
Streptomycin sulfate S6501-25G Sigma-Aldrich
Lincomycin hydrocloride 62143-1G/5G Sigma-Aldrich
Fusidic acid sodium salt F0881-1G/5G Sigma-Aldrich
Capreomycin sulfate C4142-1G Sigma-Aldrich
Kasugamycin hydrochloride K4013-10G Sigma-Aldrich




Spectinomycin sulfate PHR1441-1H Fluka
Ampicillin sodium salt A9518-5G Sigma-Aldrich
Inducers IPTG 2316.4 Roth
Anhydrotetracycline 631310 Takara
Anhydrotetracycline hydrochloride 37919-100MG-R Sigma-Aldrich
Media LB L3022 Sigma-Aldrich
Table F.2: Chemicals used in this study. Table contains chemical names and purpose categories,
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